Name,Empirical formula,CAS,SMILES,Canonical SMILES,"Mw, g*mol-1","CC50/IC50/EC50, mM","Statistics (95% CI, SEM, SD, RMSE, SE etc.)","Incubation time, h",Cell line,Method,Reference (author+year+journal),doi,Notes
"(E)-1-decyl-3-(6-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)hexyl)-1H-imidazol-3-ium bromide",C41H61BrF4N4O2,2906053-36-7,N(=N/C1=CC=C(OCCCCCCCCCC)C=C1)\C2=C(F)C(F)=C(OCCCCCC[N+]3=CN(CCCCCCCCCC)C=C3)C(F)=C2F.[Br-],CCCCCCCCCCOc1ccc(/N=N/c2c(F)c(F)c(OCCCCCC[n+]3ccn(CCCCCCCCCC)c3)c(F)c2F)cc1.[Br-],797.861,0.00284,0.002474-0.00294 (SD),24,HeLa,MTT,"Babamale, 2022, J. Mol. Struct.",10.1016/j.molstruc.2022.132470,
"(E)-1-decyl-3-(6-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)hexyl)-1H-imidazol-3-ium bromide",C41H61BrF4N4O2,2906053-36-7,N(=N/C1=CC=C(OCCCCCCCCCC)C=C1)\C2=C(F)C(F)=C(OCCCCCC[N+]3=CN(CCCCCCCCCC)C=C3)C(F)=C2F.[Br-],CCCCCCCCCCOc1ccc(/N=N/c2c(F)c(F)c(OCCCCCC[n+]3ccn(CCCCCCCCCC)c3)c(F)c2F)cc1.[Br-],797.861,0.00845,0.00788-0.00902 (SD),24,Hs27,MTT,"Babamale, 2022, J. Mol. Struct.",10.1016/j.molstruc.2022.132470,
"(E)-3-(10-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)decyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C51H81BrF4N4O2,,FC1=C(/N=N/C2=CC=C(OCCCCCCCCCC)C=C2)C(F)=C(F)C(OCCCCCCCCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)=C1F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCCCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],938.131,0.0014,0.00134-0.00150 (SD),24,HeLa,MTT,"Babamale, 2022, Arch. Pharm.",10.1002/ardp.202200085,
"(E)-3-(10-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)decyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C51H81BrF4N4O2,,FC1=C(/N=N/C2=CC=C(OCCCCCCCCCC)C=C2)C(F)=C(F)C(OCCCCCCCCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)=C1F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCCCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],938.131,0.00789,0.00770-0.00808 (SD),24,Hs27,MTT,"Babamale, 2022, Arch. Pharm.",10.1002/ardp.202200085,
"(E)-3-(11-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)undecyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C52H83BrF4N4O2,,FC1=C(/N=N/C2=CC=C(OCCCCCCCCCC)C=C2)C(F)=C(F)C(OCCCCCCCCCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)=C1F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCCCCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],952.158,0.00167,0.00155-0.00179 (SD),24,HeLa,MTT,"Babamale, 2022, Arch. Pharm.",10.1002/ardp.202200085,
"(E)-3-(11-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)undecyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C52H83BrF4N4O2,,FC1=C(/N=N/C2=CC=C(OCCCCCCCCCC)C=C2)C(F)=C(F)C(OCCCCCCCCCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)=C1F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCCCCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],952.158,0.00344,0.00325-0.00363 (SD),24,Hs27,MTT,"Babamale, 2022, Arch. Pharm.",10.1002/ardp.202200085,
"(E)-3-(12-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)dodecyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C53H85BrF4N4O2,,FC1=C(/N=N/C2=CC=C(OCCCCCCCCCC)C=C2)C(F)=C(F)C(OCCCCCCCCCCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)=C1F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCCCCCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],966.185,0.00174,0.00152-0.00196 (SD),24,HeLa,MTT,"Babamale, 2022, Arch. Pharm.",10.1002/ardp.202200085,
"(E)-3-(12-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)dodecyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C53H85BrF4N4O2,,FC1=C(/N=N/C2=CC=C(OCCCCCCCCCC)C=C2)C(F)=C(F)C(OCCCCCCCCCCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)=C1F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCCCCCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],966.185,0.00615,0.00608-0.00622 (SD),24,Hs27,MTT,"Babamale, 2022, Arch. Pharm.",10.1002/ardp.202200085,
"(E)-3-(3-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)propyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C44H67BrF4N4O2,,FC1=C(/N=N/C2=CC=C(OCCCCCCCCCC)C=C2)C(F)=C(F)C(OCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)=C1F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],839.942,0.01242,0.01210-0.01274 (SD),24,HeLa,MTT,"Babamale, 2022, Arch. Pharm.",10.1002/ardp.202200085,
"(E)-3-(3-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)propyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C44H67BrF4N4O2,,FC1=C(/N=N/C2=CC=C(OCCCCCCCCCC)C=C2)C(F)=C(F)C(OCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)=C1F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],839.942,0.02042,0.001931-0.002152 (SD),24,Hs27,MTT,"Babamale, 2022, Arch. Pharm.",10.1002/ardp.202200085,
"(E)-3-(4-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)butyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C45H69BrF4N4O2,,CCCCCCCCCCOC1=CC=C(/N=N/C2=C(F)C(F)=C(OCCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)C(F)=C2F)C=C1.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],853.969,0.0052,0.005107-0.005293 (SD),24,HeLa,MTT,"Babamale, 2022, Arch. Pharm.",10.1002/ardp.202200085,
"(E)-3-(4-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)butyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C45H69BrF4N4O2,,CCCCCCCCCCOC1=CC=C(/N=N/C2=C(F)C(F)=C(OCCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)C(F)=C2F)C=C1.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],853.969,0.01666,0.001600-0.001731 (SD),24,Hs27,MTT,"Babamale, 2022, Arch. Pharm.",10.1002/ardp.202200085,
(E)-3-(4-hydroxy-3-(((5-oxo-2-thioxoimidazolidin-1-yl)imino)methyl)benzyl)-1-methyl-1H-imidazol-3-ium chloride,C15H16ClN5O2S,,CN1C=C[N+](CC2=CC=C(O)C(/C=N/N(C(NC3)=S)C3=O)=C2)=C1.[Cl-],Cn1cc[n+](Cc2ccc(O)c(/C=N/N3C(=O)CNC3=S)c2)c1.[Cl-],365.846,0.03258,0.00135 (SD),48,MCF-7,MTT,"Abu Ali, 2023, Inorg. Chim. Acta",10.1016/j.ica.2023.121460,
(E)-3-(4-hydroxy-3-(((5-oxo-2-thioxoimidazolidin-1-yl)imino)methyl)benzyl)-1-methyl-1H-imidazol-3-ium chloride,C15H16ClN5O2S,,CN1C=C[N+](CC2=CC=C(O)C(/C=N/N(C(NC3)=S)C3=O)=C2)=C1.[Cl-],Cn1cc[n+](Cc2ccc(O)c(/C=N/N3C(=O)CNC3=S)c2)c1.[Cl-],365.846,0.14977,0.00385 (SD),48,HDFa,MTT,"Abu Ali, 2023, Inorg. Chim. Acta",10.1016/j.ica.2023.121460,
(E)-3-(4-hydroxy-3-(((5-oxo-2-thioxoimidazolidin-1-yl)imino)methyl)benzyl)-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C15H16BF4N5O2S,,CN1C=C[N+](CC2=CC=C(O)C(/C=N/N(C(NC3)=S)C3=O)=C2)=C1.F[B-](F)(F)F,Cn1cc[n+](Cc2ccc(O)c(/C=N/N3C(=O)CNC3=S)c2)c1.F[B-](F)(F)F,417.197,0.02381,0.00145 (SD),48,MCF-7,MTT,"Abu Ali, 2023, Inorg. Chim. Acta",10.1016/j.ica.2023.121460,
(E)-3-(4-hydroxy-3-(((5-oxo-2-thioxoimidazolidin-1-yl)imino)methyl)benzyl)-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C15H16BF4N5O2S,,CN1C=C[N+](CC2=CC=C(O)C(/C=N/N(C(NC3)=S)C3=O)=C2)=C1.F[B-](F)(F)F,Cn1cc[n+](Cc2ccc(O)c(/C=N/N3C(=O)CNC3=S)c2)c1.F[B-](F)(F)F,417.197,0.10187,0.00339 (SD),48,HDFa,MTT,"Abu Ali, 2023, Inorg. Chim. Acta",10.1016/j.ica.2023.121460,
(E)-3-(4-hydroxy-3-methoxy-5-((thiazol-2-ylimino)methyl)benzyl)-2-methyl-1H-imidazol-3-ium chloride,C16H17ClN4O2S,2804018-43-5,CC1=[N+](C=CN1)CC2=CC(/C=N/C3=NC=CS3)=C(C(OC)=C2)O.[Cl-],COc1cc(C[n+]2cc[nH]c2C)cc(/C=N/c2nccs2)c1O.[Cl-],364.858,0.037,0.03388-0.04013 (ND),?,MCF-7,MTT,"Serag, 2021, J. Mol. Struct.",10.1016/j.molstruc.2021.131041,CAS for neutral compound
"(E)-3-(5-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)pentyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C46H71BrF4N4O2,,FC1=C(/N=N/C2=CC=C(OCCCCCCCCCC)C=C2)C(F)=C(F)C(OCCCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)=C1F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],867.996,0.00364,0.00333-0.00395 (SD),24,HeLa,MTT,"Babamale, 2022, Arch. Pharm.",10.1002/ardp.202200085,
"(E)-3-(5-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)pentyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C46H71BrF4N4O2,,FC1=C(/N=N/C2=CC=C(OCCCCCCCCCC)C=C2)C(F)=C(F)C(OCCCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)=C1F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],867.996,0.01199,0.001169-0.001229 (SD),24,Hs27,MTT,"Babamale, 2022, Arch. Pharm.",10.1002/ardp.202200085,
"(E)-3-(6-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)hexyl)-1-dodecyl-1H-imidazol-3-ium bromide",C43H65BrF4N4O2,2906053-38-9,N(=N/C1=CC=C(OCCCCCCCCCC)C=C1)\C2=C(F)C(F)=C(OCCCCCC[N+]3=CN(CCCCCCCCCCCC)C=C3)C(F)=C2F.[Br-],CCCCCCCCCCCCn1cc[n+](CCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],825.915,0.00142,0.00115-0.00169 (SD),24,HeLa,MTT,"Babamale, 2022, J. Mol. Struct.",10.1016/j.molstruc.2022.132470,
"(E)-3-(6-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)hexyl)-1-dodecyl-1H-imidazol-3-ium bromide",C43H65BrF4N4O2,2906053-38-9,N(=N/C1=CC=C(OCCCCCCCCCC)C=C1)\C2=C(F)C(F)=C(OCCCCCC[N+]3=CN(CCCCCCCCCCCC)C=C3)C(F)=C2F.[Br-],CCCCCCCCCCCCn1cc[n+](CCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],825.915,0.004,0.00394-0.00406 (SD),24,Hs27,MTT,"Babamale, 2022, J. Mol. Struct.",10.1016/j.molstruc.2022.132470,
"(E)-3-(6-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)hexyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C47H73BrF4N4O2,2906053-42-5,N(=N/C1=CC=C(OCCCCCCCCCC)C=C1)\C2=C(F)C(F)=C(OCCCCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)C(F)=C2F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],882.023,0.00073,0.00062-0.00083 (SD),24,HeLa,MTT,"Babamale, 2022, Arch. Pharm.",10.1002/ardp.202200085,
"(E)-3-(6-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)hexyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C47H73BrF4N4O2,2906053-42-5,N(=N/C1=CC=C(OCCCCCCCCCC)C=C1)\C2=C(F)C(F)=C(OCCCCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)C(F)=C2F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],882.023,0.00218,0.00166-0.00270 (SD),24,Hs27,MTT,"Babamale, 2022, Arch. Pharm.",10.1002/ardp.202200085,
"(E)-3-(6-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)hexyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C47H73BrF4N4O2,2906053-42-5,N(=N/C1=CC=C(OCCCCCCCCCC)C=C1)\C2=C(F)C(F)=C(OCCCCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)C(F)=C2F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],882.023,0.00072,0.00052-0.00092 (SD),24,HeLa,MTT,"Babamale, 2022, J. Mol. Struct.",10.1016/j.molstruc.2022.132470,
"(E)-3-(6-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)hexyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C47H73BrF4N4O2,2906053-42-5,N(=N/C1=CC=C(OCCCCCCCCCC)C=C1)\C2=C(F)C(F)=C(OCCCCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)C(F)=C2F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],882.023,0.00218,0.00209-0.00227 (SD),24,Hs27,MTT,"Babamale, 2022, J. Mol. Struct.",10.1016/j.molstruc.2022.132470,
"(E)-3-(6-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)hexyl)-1-tetradecyl-1H-imidazol-3-ium bromide",C45H69BrF4N4O2,2906053-40-3,N(=N/C1=CC=C(OCCCCCCCCCC)C=C1)\C2=C(F)C(F)=C(OCCCCCC[N+]3=CN(CCCCCCCCCCCCCC)C=C3)C(F)=C2F.[Br-],CCCCCCCCCCCCCCn1cc[n+](CCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],853.969,0.00177,0.00139-0.00215 (SD),24,HeLa,MTT,"Babamale, 2022, J. Mol. Struct.",10.1016/j.molstruc.2022.132470,
"(E)-3-(6-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)hexyl)-1-tetradecyl-1H-imidazol-3-ium bromide",C45H69BrF4N4O2,2906053-40-3,N(=N/C1=CC=C(OCCCCCCCCCC)C=C1)\C2=C(F)C(F)=C(OCCCCCC[N+]3=CN(CCCCCCCCCCCCCC)C=C3)C(F)=C2F.[Br-],CCCCCCCCCCCCCCn1cc[n+](CCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],853.969,0.00372,0.00320-0.00424 (SD),24,Hs27,MTT,"Babamale, 2022, J. Mol. Struct.",10.1016/j.molstruc.2022.132470,
(E)-3-(6-(4-((4-(decyloxy)phenyl)diazenyl)-2.3.5.6-tetrafluorophenoxy)hexyl)-1-octadecyl-1H-imidazol-3-ium bromide,C49H77BrF4N4O2,2906053-44-7,N(=N/C1=CC=C(OCCCCCCCCCC)C=C1)\C2=C(F)C(F)=C(OCCCCCC[N+]3=CN(CCCCCCCCCCCCCCCCCC)C=C3)C(F)=C2F.[Br-],CCCCCCCCCCCCCCCCCCn1cc[n+](CCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],910.077,0.00061,0.00049-0.00075 (SD),24,HeLa,MTT,"Babamale, 2022, J. Mol. Struct.",10.1016/j.molstruc.2022.132470,
(E)-3-(6-(4-((4-(decyloxy)phenyl)diazenyl)-2.3.5.6-tetrafluorophenoxy)hexyl)-1-octadecyl-1H-imidazol-3-ium bromide,C47H73BrF4N4O2,2906053-44-7,N(=N/C1=CC=C(OCCCCCCCCCC)C=C1)\C2=C(F)C(F)=C(OCCCCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)C(F)=C2F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],882.023,0.00237,0.00225-0.00249 (SD),24,Hs27,MTT,"Babamale, 2022, J. Mol. Struct.",10.1016/j.molstruc.2022.132470,
"(E)-3-(7-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)heptyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C48H75BrF4N4O2,,FC1=C(/N=N/C2=CC=C(OCCCCCCCCCC)C=C2)C(F)=C(F)C(OCCCCCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)=C1F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],896.05,0.00298,0.00274-0.00321 (SD),24,HeLa,MTT,"Babamale, 2022, Arch. Pharm.",10.1002/ardp.202200085,
"(E)-3-(7-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)heptyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C48H75BrF4N4O2,,FC1=C(/N=N/C2=CC=C(OCCCCCCCCCC)C=C2)C(F)=C(F)C(OCCCCCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)=C1F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],896.05,0.02209,0.02188-0.02230 (SD),24,Hs27,MTT,"Babamale, 2022, Arch. Pharm.",10.1002/ardp.202200085,
"(E)-3-(8-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)octyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C49H77BrF4N4O2,,CCCCCCCCCCOC1=CC=C(C=C1)/N=N/C2=C(C(F)=C(C(F)=C2F)OCCCCCCCC[N+]3=CN(C=C3)CCCCCCCCCCCCCCCC)F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],910.077,0.00118,0.00114-0.00122 (SD),24,HeLa,MTT,"Babamale, 2022, Arch. Pharm.",10.1002/ardp.202200085,
"(E)-3-(8-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)octyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C49H77BrF4N4O2,,CCCCCCCCCCOC1=CC=C(C=C1)/N=N/C2=C(C(F)=C(C(F)=C2F)OCCCCCCCC[N+]3=CN(C=C3)CCCCCCCCCCCCCCCC)F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],910.077,0.01302,0.01288-0.01316 (SD),24,Hs27,MTT,"Babamale, 2022, Arch. Pharm.",10.1002/ardp.202200085,
"(E)-3-(9-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)nonyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C50H79BrF4N4O2,,FC1=C(/N=N/C2=CC=C(OCCCCCCCCCC)C=C2)C(F)=C(F)C(OCCCCCCCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)=C1F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],924.104,0.00185,0.00175-0.00195 (SD),24,HeLa,MTT,"Babamale, 2022, Arch. Pharm.",10.1002/ardp.202200085,
"(E)-3-(9-(4-((4-(decyloxy)phenyl)diazenyl)-2,3,5,6-tetrafluorophenoxy)nonyl)-1-hexadecyl-1H-imidazol-3-ium bromide",C50H79BrF4N4O2,,FC1=C(/N=N/C2=CC=C(OCCCCCCCCCC)C=C2)C(F)=C(F)C(OCCCCCCCCC[N+]3=CN(CCCCCCCCCCCCCCCC)C=C3)=C1F.[Br-],CCCCCCCCCCCCCCCCn1cc[n+](CCCCCCCCCOc2c(F)c(F)c(/N=N/c3ccc(OCCCCCCCCCC)cc3)c(F)c2F)c1.[Br-],924.104,0.01607,0.01580-0.01634 (SD),24,Hs27,MTT,"Babamale, 2022, Arch. Pharm.",10.1002/ardp.202200085,
1-((2-hydroxyethoxy)methyl)-3-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O5,2222826-38-0,O=C([O-])C=1C=CC=CC1O.OCCOCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCOCCO)c1.O=C([O-])c1ccccc1O,308.334,>0.1,,72,MCF-7,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
1-((2-hydroxyethoxy)methyl)-3-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O5,2222826-38-0,O=C([O-])C=1C=CC=CC1O.OCCOCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCOCCO)c1.O=C([O-])c1ccccc1O,308.334,>0.1,,72,MDA-MB-231,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
1-((2-hydroxyethoxy)methyl)-3-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O5,2222826-38-0,O=C([O-])C=1C=CC=CC1O.OCCOCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCOCCO)c1.O=C([O-])c1ccccc1O,308.334,>0.1,,72,PC3,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
1-((2-hydroxyethoxy)methyl)-3-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O5,2222826-38-0,O=C([O-])C=1C=CC=CC1O.OCCOCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCOCCO)c1.O=C([O-])c1ccccc1O,308.334,>0.1,,72,HeLa,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
1-((2-hydroxyethoxy)methyl)-3-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O5,2222826-38-0,O=C([O-])C=1C=CC=CC1O.OCCOCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCOCCO)c1.O=C([O-])c1ccccc1O,308.334,0.00926,,72,HT29,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
1-((2-hydroxyethoxy)methyl)-3-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O5,2222826-38-0,O=C([O-])C=1C=CC=CC1O.OCCOCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCOCCO)c1.O=C([O-])c1ccccc1O,308.334,>0.1,,72,A549,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
1-(2-(cinnamyloxy)ethyl)-3-methyl-1H-imidazol-3-ium chloride,C15H19ClN2O,,C[N+]1=CN(CCOC/C=C/C2=CC=CC=C2)C=C1.[Cl-],C[n+]1ccn(CCOC/C=C/c2ccccc2)c1.[Cl-],278.783,6,3.47-8.53 (CI),24,CaCo-2,MTS,"Vavina, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.118673,
1-(4-(cinnamyloxy)butyl)-3-methyl-1H-imidazol-3-ium chloride,C17H23ClN2O,,C[N+]1=CN(CCCCOC/C=C/C2=CC=CC=C2)C=C1.[Cl-],C[n+]1ccn(CCCCOC/C=C/c2ccccc2)c1.[Cl-],306.837,1.8,1.40-2.20 (CI),24,CaCo-2,MTS,"Vavina, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.118673,
1-(4-(cinnamyloxy)butyl)-3-methyl-1H-imidazol-3-ium cinnamate,C26H30N2O3,,C[N+]1=CN(CCCCOC/C=C/C2=CC=CC=C2)C=C1.O=C([O-])/C=C/C3=CC=CC=C3,C[n+]1ccn(CCCCOC/C=C/c2ccccc2)c1.O=C([O-])/C=C/c1ccccc1,418.537,2.31,1.64-2.97 (CI),24,CaCo-2,MTS,"Vavina, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.118673,
1-(4-acetoxybutyl)-3-methyl-1H-imidazol-3-ium chloride,C10H17ClN2O2,,C[N+]1=CN(CCCCOC(C)=O)C=C1.[Cl-],CC(=O)OCCCCn1cc[n+](C)c1.[Cl-],232.711,36.9,29.26-44.54 (CI),24,CaCo-2,MTS,"Vavina, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.118673,
"1-(4-hydroxy-3,5-dimethoxybenzoyl)-3-octyl-1H-imidazol-3-ium bromide",C20H29BrN2O4,,O=C(N1C=C[N+](CCCCCCCC)=C1)C2=CC(OC)=C(C(OC)=C2)O.[Br-],CCCCCCCC[n+]1ccn(C(=O)c2cc(OC)c(O)c(OC)c2)c1.[Br-],441.366,0.0173,,24,HaCat,MTT,"Forero-Doria, 2022, Bioorg. Chem.",10.1016/j.bioorg.2022.105914,
"1,2-dimethyl-1H-imidazol-3-ium chloride",C5H9ClN2,34531-53-8,CC1=[NH+]C=CN1C.[Cl-],Cc1[nH+]ccn1C.[Cl-],132.594,53.32,41.05-65.59 (CI),24,HEK293T,MTS,"Egorova, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120450,pH at CC50: 4.2
"1,2-dimethyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C17H17F3N4O5S2,,[O-]C(=O)C(F)(F)F.CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C=C3S2)S(C)(=O)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccc(S(C)(=O)=O)cc2s1.O=C([O-])C(F)(F)F,478.474,0.174,0.01 (SD),48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C17H17F3N4O5S2,,[O-]C(=O)C(F)(F)F.CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C=C3S2)S(C)(=O)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccc(S(C)(=O)=O)cc2s1.O=C([O-])C(F)(F)F,478.474,0.169,0.007 (SD),48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C17H17F3N4O5S2,,[O-]C(=O)C(F)(F)F.CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C=C3S2)S(C)(=O)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccc(S(C)(=O)=O)cc2s1.O=C([O-])C(F)(F)F,478.474,0.167,0.008 (SD),48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C17H17F3N4O5S2,,[O-]C(=O)C(F)(F)F.CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C=C3S2)S(C)(=O)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccc(S(C)(=O)=O)cc2s1.O=C([O-])C(F)(F)F,478.474,0.171,0.009 (SD),48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium bromide",C15H17BrN4O3S2,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C=C3S2)S(C)(=O)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccc(S(C)(=O)=O)cc2s1.[Br-],445.364,0.187,0.008 (SD),48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium bromide",C15H17BrN4O3S2,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C=C3S2)S(C)(=O)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccc(S(C)(=O)=O)cc2s1.[Br-],445.364,0.178,0.011 (SD),48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium bromide",C15H17BrN4O3S2,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C=C3S2)S(C)(=O)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccc(S(C)(=O)=O)cc2s1.[Br-],445.364,0.198,0.007 (SD),48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium bromide",C15H17BrN4O3S2,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C=C3S2)S(C)(=O)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccc(S(C)(=O)=O)cc2s1.[Br-],445.364,0.193,0.006 (SD),48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium hexafluorophosphate(V)",C15H17F6N4O3PS2,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(S(C)(=O)=O)C=C3S2)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccc(S(C)(=O)=O)cc2s1.F[P-](F)(F)(F)(F)F,510.422,0.239,0.011 (SD),48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium hexafluorophosphate(V)",C15H17F6N4O3PS2,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(S(C)(=O)=O)C=C3S2)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccc(S(C)(=O)=O)cc2s1.F[P-](F)(F)(F)(F)F,510.422,0.248,0.008 (SD),48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium hexafluorophosphate(V)",C15H17F6N4O3PS2,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(S(C)(=O)=O)C=C3S2)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccc(S(C)(=O)=O)cc2s1.F[P-](F)(F)(F)(F)F,510.422,0.241,0.009 (SD),48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium hexafluorophosphate(V)",C15H17F6N4O3PS2,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(S(C)(=O)=O)C=C3S2)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccc(S(C)(=O)=O)cc2s1.F[P-](F)(F)(F)(F)F,510.422,0.251,0.007 (SD),48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium tetrafluoroborate",C15H17BF4N4O3S2,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(S(C)(=O)=O)C=C3S2)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccc(S(C)(=O)=O)cc2s1.F[B-](F)(F)F,452.264,0.186,0.007 (SD),48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium tetrafluoroborate",C15H17BF4N4O3S2,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(S(C)(=O)=O)C=C3S2)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccc(S(C)(=O)=O)cc2s1.F[B-](F)(F)F,452.264,0.179,0.007 (SD),48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium tetrafluoroborate",C15H17BF4N4O3S2,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(S(C)(=O)=O)C=C3S2)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccc(S(C)(=O)=O)cc2s1.F[B-](F)(F)F,452.264,0.178,0.004 (SD),48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium tetrafluoroborate",C15H17BF4N4O3S2,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(S(C)(=O)=O)C=C3S2)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccc(S(C)(=O)=O)cc2s1.F[B-](F)(F)F,452.264,0.168,0.006 (SD),48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C17H17F3N4O3S,,[O-]C(=O)C(F)(F)F.CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C)C=C3S2)=C1C,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3C)sc2c1.O=C([O-])C(F)(F)F,414.409,0.149,0.006 (SD),48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C17H17F3N4O3S,,[O-]C(=O)C(F)(F)F.CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C)C=C3S2)=C1C,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3C)sc2c1.O=C([O-])C(F)(F)F,414.409,0.137,0.005 (SD),48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C17H17F3N4O3S,,[O-]C(=O)C(F)(F)F.CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C)C=C3S2)=C1C,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3C)sc2c1.O=C([O-])C(F)(F)F,414.409,0.154,0.007 (SD),48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C17H17F3N4O3S,,[O-]C(=O)C(F)(F)F.CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C)C=C3S2)=C1C,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3C)sc2c1.O=C([O-])C(F)(F)F,414.409,0.155,0.004 (SD),48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium bromide",C15H17BrN4OS,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C)C=C3S2)=C1C,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3C)sc2c1.[Br-],381.299,0.21,0.008 (SD),48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium bromide",C15H17BrN4OS,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C)C=C3S2)=C1C,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3C)sc2c1.[Br-],381.299,0.189,0.007 (SD),48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium bromide",C15H17BrN4OS,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C)C=C3S2)=C1C,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3C)sc2c1.[Br-],381.299,0.23,0.011 (SD),48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium bromide",C15H17BrN4OS,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C)C=C3S2)=C1C,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3C)sc2c1.[Br-],381.299,0.194,0.006 (SD),48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium hexafluorophosphate(V)",C15H17F6N4OPS,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(C=C3S2)C)=O)=C1C,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3C)sc2c1.F[P-](F)(F)(F)(F)F,446.357,0.168,0.007 (SD),48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium hexafluorophosphate(V)",C15H17F6N4OPS,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(C=C3S2)C)=O)=C1C,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3C)sc2c1.F[P-](F)(F)(F)(F)F,446.357,0.156,0.003 (SD),48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium hexafluorophosphate(V)",C15H17F6N4OPS,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(C=C3S2)C)=O)=C1C,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3C)sc2c1.F[P-](F)(F)(F)(F)F,446.357,0.167,0.008 (SD),48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium hexafluorophosphate(V)",C15H17F6N4OPS,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(C=C3S2)C)=O)=C1C,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3C)sc2c1.F[P-](F)(F)(F)(F)F,446.357,0.143,0.007 (SD),48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium tetrafluoroborate",C15H17BF4N4OS,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(C=C3S2)C)=O)=C1C,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3C)sc2c1.F[B-](F)(F)F,388.199,0.098,0.009 (SD),48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium tetrafluoroborate",C15H17BF4N4OS,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(C=C3S2)C)=O)=C1C,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3C)sc2c1.F[B-](F)(F)F,388.199,0.088,0.004 (SD),48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium tetrafluoroborate",C15H17BF4N4OS,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(C=C3S2)C)=O)=C1C,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3C)sc2c1.F[B-](F)(F)F,388.199,0.115,0.005 (SD),48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium tetrafluoroborate",C15H17BF4N4OS,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(C=C3S2)C)=O)=C1C,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3C)sc2c1.F[B-](F)(F)F,388.199,0.089,0.003 (SD),48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1,2-dimethyl-3-pentyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide",C12H19F6N3O4S2,1234261-34-7,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=C(N1C)C)CCCCC,CCCCC[n+]1ccn(C)c1C.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,447.423,<0.1,,72,CCO,WST-1,"Cvjetko Bubalo, 2015, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2014.10.029,
"1,3-dibenzyl-1H-imidazol-3-ium 3-oxo-3H-benzo[d]isothiazol-2-ide 1,1-dioxide",C24H21N3O3S,958869-86-8,O=C1[N-]S(=O)(=O)C=2C=CC=CC12.C=1C=CC(=CC1)CN2C=C[N+](=C2)CC=3C=CC=CC3,O=C1[N-]S(=O)(=O)c2ccccc21.c1ccc(Cn2cc[n+](Cc3ccccc3)c2)cc1,431.517,14.013,,4,CaCo-2,MTT,"Frade, 2009, Green Chem.",10.1039/b914284n,
"1,3-dibenzyl-1H-imidazol-3-ium dicyanamide",C19H17N5,958869-85-7,N#C[N-]C#N.C=1C=CC(=CC1)CN2C=C[N+](=C2)CC=3C=CC=CC3,N#C[N-]C#N.c1ccc(Cn2cc[n+](Cc3ccccc3)c2)cc1,315.38,10.823,,4,CaCo-2,MTT,"Frade, 2009, Green Chem.",10.1039/b914284n,
"1,3-diethyl-1H-imidazol-3-ium bromide",C7H13BrN2,54304-66-4,[Br-].C1=C[N+](=CN1CC)CC,CCn1cc[n+](CC)c1.[Br-],205.099,>1,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=3 (uM)
"1,3-diethyl-1H-imidazol-3-ium ethyl sulfate",C9H18N2O4S,516474-04-7,O=S(=O)([O-])OCC.C1=C[N+](=CN1CC)CC,CCOS(=O)(=O)[O-].CCn1cc[n+](CC)c1,250.32,20.44,1.44 (SD),24,NHDF,MTS,"Dzida, 2018, ACS Sustain Chem Eng.",10.1021/acssuschemeng.8b02318,
"1,3-dimethyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide",C7H9F6N3O4S2,174899-81-1,O=S([N-]S(=O)(C(F)(F)F)=O)(C(F)(F)F)=O.CN1C=[N+](C)C=C1,Cn1cc[n+](C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,377.288,4.23,1.35-7.1 (CI),24,HEK293T,MTS,"Egorova, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120450,pH at CC50: 7.0
"1,3-dimethyl-1H-imidazol-3-ium chloride",C5H9ClN2,79917-88-7,C[N+]1=CN(C)C=C1.[Cl-],Cn1cc[n+](C)c1.[Cl-],132.594,38.21,29.45-46.98 (CI),24,HEK293T,MTS,"Egorova, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120450,pH at CC50: 7.9
"1,3-dimethyl-1H-imidazol-3-ium methyl sulfate",C6H12N2O4S,97345-90-9,O=S(=O)([O-])OC.C1=C[N+](=CN1C)C,COS(=O)(=O)[O-].Cn1cc[n+](C)c1,208.239,81.24,24.76 (SD),24,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
"1,3-dimethyl-1H-imidazol-3-ium methyl sulfate",C6H12N2O4S,97345-90-9,O=S(=O)([O-])OC.C1=C[N+](=CN1C)C,COS(=O)(=O)[O-].Cn1cc[n+](C)c1,208.239,31.69,14.53 (SD),48,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
1-benzoyl-3-decyl-1H-imidazol-3-ium bromide,C20H29BrN2O,,O=C(C1=CC=CC=C1)N2C=C[N+](CCCCCCCCCC)=C2.[Br-],CCCCCCCCCC[n+]1ccn(C(=O)c2ccccc2)c1.[Br-],393.369,>0.032,,24,HaCat,MTT,"Forero-Doria, 2022, Bioorg. Chem.",10.1016/j.bioorg.2022.105914,
1-benzyl-3-octadecyl-1H-imidazol-3-ium bromide,C28H47BrN2,,[Br-].CCCCCCCCCCCCCCCCCC[N+]1=CN(CC2=CC=CC=C2)C=C1,CCCCCCCCCCCCCCCCCC[n+]1ccn(Cc2ccccc2)c1.[Br-],491.602,0.00692,,48,K562,SRB,"Starling, 2022, J. Mol. Struct.",10.1016/j.molstruc.2021.132062,
1-benzyl-3-octadecyl-1H-imidazol-3-ium bromide,C28H47BrN2,,[Br-].CCCCCCCCCCCCCCCCCC[N+]1=CN(CC2=CC=CC=C2)C=C1,CCCCCCCCCCCCCCCCCC[n+]1ccn(Cc2ccccc2)c1.[Br-],491.602,0.0119,,48,SK-OV-3,SRB,"Starling, 2022, J. Mol. Struct.",10.1016/j.molstruc.2021.132062,
1-benzyl-3-octadecyl-1H-imidazol-3-ium bromide,C28H47BrN2,,[Br-].CCCCCCCCCCCCCCCCCC[N+]1=CN(CC2=CC=CC=C2)C=C1,CCCCCCCCCCCCCCCCCC[n+]1ccn(Cc2ccccc2)c1.[Br-],491.602,0.01341,,48,DU-145,SRB,"Starling, 2022, J. Mol. Struct.",10.1016/j.molstruc.2021.132062,
1-benzyl-3-octadecyl-1H-imidazol-3-ium bromide,C28H47BrN2,,[Br-].CCCCCCCCCCCCCCCCCC[N+]1=CN(CC2=CC=CC=C2)C=C1,CCCCCCCCCCCCCCCCCC[n+]1ccn(Cc2ccccc2)c1.[Br-],491.602,0.02435,,48,MRC-5,SRB,"Starling, 2022, J. Mol. Struct.",10.1016/j.molstruc.2021.132062,
1-butyl-1H-imidazol-1-ium chloride,C7H13ClN2,71614-56-7,CCCC[NH+]1C=CN=C1.[Cl-],CCCC[NH+]1C=CN=C1.[Cl-],160.648,11.9,7.64-16.16 (CI),24,HEK293T,MTS,"Egorova, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120450,pH at CC50: 4.5 ; C4ImCl*0.678H2O. CAS for neutral compound
1-butyl-3-(2-ethylphenyl)-1H-imidazol-3-ium bromide,C15H21BrN2,1176200-06-8,[Br-].C=1C=CC(=C(C1)[N+]=2C=CN(C2)CCCC)CC,CCCCn1cc[n+](-c2ccccc2CC)c1.[Br-],309.251,0.123,0.110-0.145 (CI),?,IPC-81,WST-1,"Stolte, 2013, ACS Sustain. Chem. Eng.",10.1021/sc300146t,
1-butyl-3-(2-ethylphenyl)-1H-imidazol-3-ium iodide,C15H21IN2,1176200-04-6,[I-].C=1C=CC(=C(C1)[N+]=2C=CN(C2)CCCC)CC,CCCCn1cc[n+](-c2ccccc2CC)c1.[I-],356.251,0.105,0.098-0.110 (CI),?,IPC-81,WST-1,"Stolte, 2013, ACS Sustain. Chem. Eng.",10.1021/sc300146t,
1-butyl-3-(4-(ethoxycarbonyl)phenyl)-1H-imidazol-3-ium bromide,C16H21BrN2O2,1426080-65-0,[Br-].O=C(OCC)C=1C=CC(=CC1)[N+]=2C=CN(C2)CCCC,CCCCn1cc[n+](-c2ccc(C(=O)OCC)cc2)c1.[Br-],353.26,0.468,0.437-0.501 (CI),?,IPC-81,WST-1,"Stolte, 2013, ACS Sustain. Chem. Eng.",10.1021/sc300146t,
1-butyl-3-(4-ethoxyphenyl)-1H-imidazol-3-ium bromide,C15H21BrN2O,1176200-16-0,[Br-].O(C=1C=CC(=CC1)[N+]=2C=CN(C2)CCCC)CC,CCCCn1cc[n+](-c2ccc(OCC)cc2)c1.[Br-],325.25,0.085,0.069-0.107 (CI),?,IPC-81,WST-1,"Stolte, 2013, ACS Sustain. Chem. Eng.",10.1021/sc300146t,
1-butyl-3-(p-tolyl)-1H-imidazol-3-ium bromide,C14H19BrN2,1426080-64-9,[Br-].C1=CC(=CC=C1[N+]=2C=CN(C2)CCCC)C,CCCCn1cc[n+](-c2ccc(C)cc2)c1.[Br-],295.224,0.214,0.191-0.251 (CI),?,IPC-81,WST-1,"Stolte, 2013, ACS Sustain. Chem. Eng.",10.1021/sc300146t,
1-butyl-3-vinyl-1H-imidazol-3-ium bromide,C9H15BrN2,1033461-45-8,[Br-].CCCCN1C=C[N+](C=C)=C1,C=C[n+]1ccn(CCCC)c1.[Br-],231.137,1.987,,24,A549,WST-8,"Chen, 2014, JCCS",10.1002/jccs.201300632,The incubation time is unclear.
1-butyl-3-vinyl-1H-imidazol-3-ium chloride,C9H15ClN2,657394-65-5,[Cl-].CCCCN1C=C[N+](C=C)=C1,C=C[n+]1ccn(CCCC)c1.[Cl-],186.686,0.991,,24,A549,WST-8,"Chen, 2014, JCCS",10.1002/jccs.201300632,The incubation time is unclear.
1-decyl-1H-imidazol-1-ium chloride,C13H25ClN2,2538955-82-5,CCCCCCCCCC[NH+]1C=CN=C1.[Cl-],CCCCCCCCCC[NH+]1C=CN=C1.[Cl-],244.81,0.06,0.05-0.08 (CI),24,HEK293T,MTS,"Egorova, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120450,pH at CC50: 4.9
1-dodecyl-3-vinyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C19H31F6N3O4S2,866947-54-8,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.CCCCCCCCCCCCN1C=C[N+](C=C)=C1,C=C[n+]1ccn(CCCCCCCCCCCC)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,543.596,0.0056,,24,A549,WST-8,"Chen, 2014, JCCS",10.1002/jccs.201300632,The incubation time is unclear.
1-ethyl-3-hexyl-1H-imidazol-3-ium bromide,C11H21BrN2,547719-00-6,[Br-].C1=C[N+](=CN1CC)CCCCCC,CCCCCC[n+]1ccn(CC)c1.[Br-],261.207,0.102,0.001 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=2.01, 0.06 (CI) (uM)"
1-ethyl-3-hexyl-1H-imidazol-3-ium bromide,C11H21BrN2,547719-00-6,[Br-].C1=C[N+](=CN1CC)CCCCCC,CCCCCC[n+]1ccn(CC)c1.[Br-],261.207,0.102,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=2.01 (uM)
1-ethyl-3-hexyl-1H-imidazol-3-ium tetrafluoroborate,C11H21BF4N2,393550-29-3,F[B-](F)(F)F.C1=C[N+](=CN1CC)CCCCCC,CCCCCC[n+]1ccn(CC)c1.F[B-](F)(F)F,268.107,0.182,0.001 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=2.26, 0.05 (CI) (uM)"
1-ethyl-3-hexyl-1H-imidazol-3-ium tetrafluoroborate,C11H21BF4N2,393550-29-3,F[B-](F)(F)F.C1=C[N+](=CN1CC)CCCCCC,CCCCCC[n+]1ccn(CC)c1.F[B-](F)(F)F,268.107,0.182,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=2.26 (uM)
1-ethyl-3-propyl-1H-imidazol-3-ium bromide,C8H15BrN2,637348-59-5,[Br-].C1=C[N+](=CN1CC)CCC,CCC[n+]1ccn(CC)c1.[Br-],219.126,>1.995,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=3.3 (uM)
1H-imidazol-3-ium 2-hydroxybenzoate,C10H10N2O3,36364-49-5,O=C([O-])C1=C(C=CC=C1)O.N2C=[NH+]C=C2,O=C([O-])c1ccccc1O.c1c[nH+]c[nH]1,206.201,>0.1,,72,MCF-7,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,CAS for neutral compound
1H-imidazol-3-ium 2-hydroxybenzoate,C10H10N2O3,36364-49-5,O=C([O-])C1=C(C=CC=C1)O.N2C=[NH+]C=C2,O=C([O-])c1ccccc1O.c1c[nH+]c[nH]1,206.201,>0.1,,72,MDA-MB-231,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,CAS for neutral compound
1H-imidazol-3-ium 2-hydroxybenzoate,C10H10N2O3,36364-49-5,O=C([O-])C1=C(C=CC=C1)O.N2C=[NH+]C=C2,O=C([O-])c1ccccc1O.c1c[nH+]c[nH]1,206.201,>0.1,,72,PC3,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,CAS for neutral compound
1H-imidazol-3-ium 2-hydroxybenzoate,C10H10N2O3,36364-49-5,O=C([O-])C1=C(C=CC=C1)O.N2C=[NH+]C=C2,O=C([O-])c1ccccc1O.c1c[nH+]c[nH]1,206.201,>0.1,,72,HeLa,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,CAS for neutral compound
1H-imidazol-3-ium 2-hydroxybenzoate,C10H10N2O3,36364-49-5,O=C([O-])C1=C(C=CC=C1)O.N2C=[NH+]C=C2,O=C([O-])c1ccccc1O.c1c[nH+]c[nH]1,206.201,0.03994,,72,HT29,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,CAS for neutral compound
1H-imidazol-3-ium 2-hydroxybenzoate,C10H10N2O3,36364-49-5,O=C([O-])C1=C(C=CC=C1)O.N2C=[NH+]C=C2,O=C([O-])c1ccccc1O.c1c[nH+]c[nH]1,206.201,0.02303,,72,A549,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,CAS for neutral compound
1-methyl-1H-imidazol-1-ium bis((trifluoromethyl)sulfonyl)imide,C6H7F6N3O4S2,353239-08-4,C[NH+]1C=CN=C1.O=S([N-]S(=O)(C(F)(F)F)=O)(C(F)(F)F)=O,C[NH+]1C=CN=C1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,363.261,6.54,3.55-9.52 (CI),24,HEK293T,MTS,"Egorova, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120450,pH at CC50: 4.7. CAS for neutral compound
1-methyl-1H-imidazol-1-ium bromide,C4H7BrN2,101023-58-9,C[NH+]1C=CN=C1.[Br-],C[NH+]1C=CN=C1.[Br-],163.018,67.83,53.45-82.20 (CI),24,HEK293T,MTS,"Egorova, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120450,pH at CC50: 3.3. CAS for neutral compound
1-methyl-1H-imidazol-1-ium chloride,C4H7ClN2,35487-17-3,C[NH+]1C=CN=C1.[Cl-],C[NH+]1C=CN=C1.[Cl-],118.567,67.75,47.65-87.84 (CI),24,HEK293T,MTS,"Egorova, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120450,pH at CC50: 3.5. CAS for neutral compound
1-methyl-1H-imidazol-1-ium hydrogen sulfate,C4H8N2O4S,681281-87-8,C[NH+]1C=CN=C1.O=S(O)([O-])=O,C[NH+]1C=CN=C1.O=S(=O)([O-])O,180.185,26.42,15.96-36.88 (CI),24,HEK293T,MTS,"Egorova, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120450,pH at CC50: 2.0. CAS for neutral compound
1-methyl-1H-imidazol-1-ium nitrate,C4H7N3O3,156204-43-2,C[NH+]1C=CN=C1.[O-][N+]([O-])=O,C[NH+]1C=CN=C1.O=[N+]([O-])[O-],145.118,72.75,49.24-96.25 (CI),24,HEK293T,MTS,"Egorova, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120450,pH at CC50: 3.9. CAS for neutral compound
1-methyl-1H-imidazol-1-ium trifluoromethanesulfonate,C5H7F3N2O3S,99257-94-0,C[NH+]1C=CN=C1.O=S(C(F)(F)F)([O-])=O,C[NH+]1C=CN=C1.O=S(=O)([O-])C(F)(F)F,232.183,47.43,27.69-67.16 (CI),24,HEK293T,MTS,"Egorova, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120450,pH at CC50: 3.4. CAS for neutral compound
1-methyl-3-((methylthio)methyl)-1H-imidazol-3-ium chloride,C6H11ClN2S,1427172-68-6,[Cl-].S(C)C[N+]=1C=CN(C1)C,CSC[n+]1ccn(C)c1.[Cl-],178.688,>0.5,,24,HeLa,MTT,"Bachowska, 2012, ChemistryOPEN",10.1002/open.201100003,
1-methyl-3-((methylthio)methyl)-1H-imidazol-3-ium chloride,C6H11ClN2S,1427172-68-6,[Cl-].S(C)C[N+]=1C=CN(C1)C,CSC[n+]1ccn(C)c1.[Cl-],178.688,>0.5,,48,HeLa,MTT,"Bachowska, 2012, ChemistryOPEN",10.1002/open.201100003,
1-methyl-3-((methylthio)methyl)-1H-imidazol-3-ium chloride,C6H11ClN2S,1427172-68-6,[Cl-].S(C)C[N+]=1C=CN(C1)C,CSC[n+]1ccn(C)c1.[Cl-],178.688,>0.5,,24,K562,MTT,"Bachowska, 2012, ChemistryOPEN",10.1002/open.201100003,
1-methyl-3-((methylthio)methyl)-1H-imidazol-3-ium chloride,C6H11ClN2S,1427172-68-6,[Cl-].S(C)C[N+]=1C=CN(C1)C,CSC[n+]1ccn(C)c1.[Cl-],178.688,>0.5,,48,K562,MTT,"Bachowska, 2012, ChemistryOPEN",10.1002/open.201100003,
1-methyl-3-((methylthio)methyl)-1H-imidazol-3-ium chloride,C6H11ClN2S,1427172-68-6,[Cl-].S(C)C[N+]=1C=CN(C1)C,CSC[n+]1ccn(C)c1.[Cl-],178.688,>0.5,,24,HUVEC,MTT,"Bachowska, 2012, ChemistryOPEN",10.1002/open.201100003,
1-methyl-3-((methylthio)methyl)-1H-imidazol-3-ium chloride,C6H11ClN2S,1427172-68-6,[Cl-].S(C)C[N+]=1C=CN(C1)C,CSC[n+]1ccn(C)c1.[Cl-],178.688,>0.5,,48,HUVEC,MTT,"Bachowska, 2012, ChemistryOPEN",10.1002/open.201100003,
1-methyl-3-((octyloxy)methyl)-1H-imidazol-3-ium 2-(2-isopropyl-5-methylphenoxy)acetate,C25H40N2O4,3036015-11-6,O=C([O-])COC1=CC(=CC=C1C(C)C)C.O(C[N+]=1C=CN(C1)C)CCCCCCCC,CCCCCCCCOC[n+]1ccn(C)c1.Cc1ccc(C(C)C)c(OCC(=O)[O-])c1,432.605,0.0111,0.000947 (SD),72,B16F10,MTT,"Pałkowski, 2022, Molecules",10.3390/molecules27061974,
1-methyl-3-((octyloxy)methyl)-1H-imidazol-3-ium 2-(4-allyl-2-methoxyphenoxy)acetate,C25H38N2O5,3036015-15-0,O=C([O-])COC1=CC=C(C=C1OC)CC=C.O(C[N+]=1C=CN(C1)C)CCCCCCCC,C=CCc1ccc(OCC(=O)[O-])c(OC)c1.CCCCCCCCOC[n+]1ccn(C)c1,446.588,0.0111,0.000834 (SD),72,B16F10,MTT,"Pałkowski, 2022, Molecules",10.3390/molecules27061974,
1-methyl-3-((octyloxy)methyl)-1H-imidazol-3-ium 2-(4-formyl-2-methoxyphenoxy)acetate,C23H34N2O6,3036015-13-8,O=CC1=CC=C(OCC(=O)[O-])C(OC)=C1.O(C[N+]=1C=CN(C1)C)CCCCCCCC,CCCCCCCCOC[n+]1ccn(C)c1.COc1cc(C=O)ccc1OCC(=O)[O-],434.533,0.0111,0.00105 (SD),72,B16F10,MTT,"Pałkowski, 2022, Molecules",10.3390/molecules27061974,
1-methyl-3-((octyloxy)methyl)-1H-imidazol-3-ium 2-(5-isopropyl-2-methylphenoxy)acetate,C25H40N2O4,3036015-07-0,O=C([O-])COC1=CC(=CC=C1C)C(C)C.O(C[N+]=1C=CN(C1)C)CCCCCCCC,CCCCCCCCOC[n+]1ccn(C)c1.Cc1ccc(C(C)C)cc1OCC(=O)[O-],432.605,0.0101,0.000562 (SD),72,B16F10,MTT,"Pałkowski, 2022, Molecules",10.3390/molecules27061974,
1-methyl-3-((octyloxy)methyl)-1H-imidazol-3-ium 4-hydroxybenzenesulfonate,C19H30N2O5S,3036015-04-7,O=S(=O)([O-])C1=CC=C(O)C=C1.O(C[N+]=1C=CN(C1)C)CCCCCCCC,CCCCCCCCOC[n+]1ccn(C)c1.O=S(=O)([O-])c1ccc(O)cc1,398.525,0.0122,0.000502 (SD),72,B16F10,MTT,"Pałkowski, 2022, Molecules",10.3390/molecules27061974,
1-methyl-3-((octyloxy)methyl)-1H-imidazol-3-ium benzenesulfonate,C19H30N2O4S,3036015-05-8,O=S(=O)([O-])C=1C=CC=CC1.O(C[N+]=1C=CN(C1)C)CCCCCCCC,CCCCCCCCOC[n+]1ccn(C)c1.O=S(=O)([O-])c1ccccc1,382.526,0.0122,0.000942 (SD),72,B16F10,MTT,"Pałkowski, 2022, Molecules",10.3390/molecules27061974,
1-methyl-3-((octyloxy)methyl)-1H-imidazol-3-ium chloride,C13H25ClN2O,99874-28-9,[Cl-].O(C[N+]=1C=CN(C1)C)CCCCCCCC,CCCCCCCCOC[n+]1ccn(C)c1.[Cl-],260.809,0.0197,0.0038 (SD),72,B16F10,MTT,"Pałkowski, 2022, Molecules",10.3390/molecules27061974,
1-methyl-3-((octyloxy)methyl)-1H-imidazol-3-ium formate,C14H26N2O3,3036015-08-1,O=C[O-].O(C[N+]=1C=CN(C1)C)CCCCCCCC,CCCCCCCCOC[n+]1ccn(C)c1.O=C[O-],270.373,0.0184,0.000849 (SD),72,B16F10,MTT,"Pałkowski, 2022, Molecules",10.3390/molecules27061974,
1-methyl-3-((octyloxy)methyl)-1H-imidazol-3-ium pivalate,C18H34N2O3,3036015-16-1,O=C([O-])C(C)(C)C.O(C[N+]=1C=CN(C1)C)CCCCCCCC,CC(C)(C)C(=O)[O-].CCCCCCCCOC[n+]1ccn(C)c1,326.481,0.0163,0.000509 (SD),72,B16F10,MTT,"Pałkowski, 2022, Molecules",10.3390/molecules27061974,
1-methyl-3-((octyloxy)methyl)-1H-imidazol-3-ium propionate,C16H30N2O3,3036015-09-2,O=C([O-])CC.O(C[N+]=1C=CN(C1)C)CCCCCCCC,CCC(=O)[O-].CCCCCCCCOC[n+]1ccn(C)c1,298.427,0.0158,0.00255 (SD),72,B16F10,MTT,"Pałkowski, 2022, Molecules",10.3390/molecules27061974,
"1-methyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C16H15F3N4O5S2,,[O-]C(=O)C(F)(F)F.CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C=C3S2)S(C)(=O)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccc(S(C)(=O)=O)cc3s2)c1.O=C([O-])C(F)(F)F,464.447,0.219,0.003 (SD),48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1-methyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C16H15F3N4O5S2,,[O-]C(=O)C(F)(F)F.CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C=C3S2)S(C)(=O)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccc(S(C)(=O)=O)cc3s2)c1.O=C([O-])C(F)(F)F,464.447,0.213,0.007 (SD),48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1-methyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C16H15F3N4O5S2,,[O-]C(=O)C(F)(F)F.CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C=C3S2)S(C)(=O)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccc(S(C)(=O)=O)cc3s2)c1.O=C([O-])C(F)(F)F,464.447,0.218,0.004 (SD),48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium bromide,C14H15BrN4O3S2,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C=C3S2)S(C)(=O)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccc(S(C)(=O)=O)cc3s2)c1.[Br-],431.337,0.246,0.012 (SD),48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium bromide,C14H15BrN4O3S2,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C=C3S2)S(C)(=O)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccc(S(C)(=O)=O)cc3s2)c1.[Br-],431.337,0.229,0.008 (SD),48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium bromide,C14H15BrN4O3S2,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C=C3S2)S(C)(=O)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccc(S(C)(=O)=O)cc3s2)c1.[Br-],431.337,0.237,0.012 (SD),48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium bromide,C14H15BrN4O3S2,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C=C3S2)S(C)(=O)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccc(S(C)(=O)=O)cc3s2)c1.[Br-],431.337,0.241,0.007 (SD),48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium bromide,C14H15BF4N4O3S2,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(S(C)(=O)=O)C=C3S2)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccc(S(C)(=O)=O)cc3s2)c1.F[B-](F)(F)F,438.237,0.211,0.005 (SD),48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium hexafluorophosphate(V),C14H15F6N4O3PS2,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(S(C)(=O)=O)C=C3S2)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccc(S(C)(=O)=O)cc3s2)c1.F[P-](F)(F)(F)(F)F,496.395,0.26,0.011 (SD),48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium hexafluorophosphate(V),C14H15F6N4O3PS2,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(S(C)(=O)=O)C=C3S2)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccc(S(C)(=O)=O)cc3s2)c1.F[P-](F)(F)(F)(F)F,496.395,0.293,0.005 (SD),48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium hexafluorophosphate(V),C14H15F6N4O3PS2,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(S(C)(=O)=O)C=C3S2)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccc(S(C)(=O)=O)cc3s2)c1.F[P-](F)(F)(F)(F)F,496.395,0.287,0.01 (SD),48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium hexafluorophosphate(V),C16H15F3N4O5S2,,[O-]C(=O)C(F)(F)F.CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C=C3S2)S(C)(=O)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccc(S(C)(=O)=O)cc3s2)c1.O=C([O-])C(F)(F)F,464.447,0.21,0.009 (SD),48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium tetrafluoroborate,C14H15BF4N4O3S2,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(S(C)(=O)=O)C=C3S2)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccc(S(C)(=O)=O)cc3s2)c1.F[B-](F)(F)F,438.237,0.199,0.004 (SD),48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium tetrafluoroborate,C14H15BF4N4O3S2,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(S(C)(=O)=O)C=C3S2)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccc(S(C)(=O)=O)cc3s2)c1.F[B-](F)(F)F,438.237,0.2,0.008 (SD),48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium tetrafluoroborate,C14H15BF4N4O3S2,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(S(C)(=O)=O)C=C3S2)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccc(S(C)(=O)=O)cc3s2)c1.F[B-](F)(F)F,438.237,0.205,0.006 (SD),48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium tetrafluoroborate,C14H15F6N4O3PS2,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(S(C)(=O)=O)C=C3S2)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccc(S(C)(=O)=O)cc3s2)c1.F[P-](F)(F)(F)(F)F,496.395,0.246,0.009 (SD),48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1-methyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C16H15F3N4O3S,,[O-]C(=O)C(F)(F)F.CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C)C=C3S2)=C1,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3)sc2c1.O=C([O-])C(F)(F)F,400.382,0.19,0.011 (SD),48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1-methyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C16H15F3N4O3S,,[O-]C(=O)C(F)(F)F.CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C)C=C3S2)=C1,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3)sc2c1.O=C([O-])C(F)(F)F,400.382,0.181,0.009 (SD),48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1-methyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C16H15F3N4O3S,,[O-]C(=O)C(F)(F)F.CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C)C=C3S2)=C1,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3)sc2c1.O=C([O-])C(F)(F)F,400.382,0.187,0.009 (SD),48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"1-methyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C16H15F3N4O3S,,[O-]C(=O)C(F)(F)F.CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C)C=C3S2)=C1,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3)sc2c1.O=C([O-])C(F)(F)F,400.382,0.188,0.006 (SD),48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium bromide,C14H15BrN4OS,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C)C=C3S2)=C1,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3)sc2c1.[Br-],367.272,0.143,0.005 (SD),48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium bromide,C14H15BrN4OS,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C)C=C3S2)=C1,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3)sc2c1.[Br-],367.272,0.122,0.003 (SD),48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium bromide,C14H15BrN4OS,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C)C=C3S2)=C1,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3)sc2c1.[Br-],367.272,0.162,0.006 (SD),48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium bromide,C14H15BrN4OS,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=C(C)C=C3S2)=C1,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3)sc2c1.[Br-],367.272,0.153,0.008 (SD),48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium hexafluorophosphate(V),C14H15F6N4OPS,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(C=C3S2)C)=O)=C1,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3)sc2c1.F[P-](F)(F)(F)(F)F,432.33,0.183,0.007 (SD),48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium hexafluorophosphate(V),C14H15F6N4OPS,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(C=C3S2)C)=O)=C1,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3)sc2c1.F[P-](F)(F)(F)(F)F,432.33,0.179,0.005 (SD),48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium hexafluorophosphate(V),C14H15F6N4OPS,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(C=C3S2)C)=O)=C1,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3)sc2c1.F[P-](F)(F)(F)(F)F,432.33,0.188,0.009 (SD),48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium hexafluorophosphate(V),C14H15F6N4OPS,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(C=C3S2)C)=O)=C1,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3)sc2c1.F[P-](F)(F)(F)(F)F,432.33,0.177,0.004 (SD),48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium tetrafluoroborate,C14H15BF4N4OS,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(C=C3S2)C)=O)=C1,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3)sc2c1.F[B-](F)(F)F,374.172,0.132,0.009 (SD),48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium tetrafluoroborate,C14H15BF4N4OS,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(C=C3S2)C)=O)=C1,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3)sc2c1.F[B-](F)(F)F,374.172,0.112,0.005 (SD),48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium tetrafluoroborate,C14H15BF4N4OS,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(C=C3S2)C)=O)=C1,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3)sc2c1.F[B-](F)(F)F,374.172,0.139,0.007 (SD),48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-((6-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-1H-imidazol-3-ium tetrafluoroborate,C14H15BF4N4OS,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=C(C=C3S2)C)=O)=C1,Cc1ccc2nc(NC(=O)C[n+]3ccn(C)c3)sc2c1.F[B-](F)(F)F,374.172,0.125,0.006 (SD),48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
1-methyl-3-(2-(octyloxy)-2-oxoethyl)-1H-imidazol-3-ium chloride,C14H25ClN2O2,,[Cl-].O=C(OCCCCCCCC)C[N+]=1C=CN(C1)C,CCCCCCCCOC(=O)C[n+]1ccn(C)c1.[Cl-],288.819,0.41158,,24,Hep-2,Visual counting,"Hodyna, 2021, Biointerface Res. Appl. Chem.",10.33263/BRIAC123.29052957, IC50 of DMSO-soluble compounds
1-methyl-3-(2-(octyloxy)-2-oxoethyl)-1H-imidazol-3-ium chloride,C14H25ClN2O2,,[Cl-].O=C(OCCCCCCCC)C[N+]=1C=CN(C1)C,CCCCCCCCOC(=O)C[n+]1ccn(C)c1.[Cl-],288.819,0.26364,,48,Hep-2,Visual counting,"Hodyna, 2021, Biointerface Res. Appl. Chem.",10.33263/BRIAC123.29052957, IC50 of DMSO-soluble compounds
1-methyl-3-(2-(octyloxy)-2-oxoethyl)-1H-imidazol-3-ium chloride,C14H25ClN2O2,,[Cl-].O=C(OCCCCCCCC)C[N+]=1C=CN(C1)C,CCCCCCCCOC(=O)C[n+]1ccn(C)c1.[Cl-],288.819,0.26364,,72,Hep-2,Visual counting,"Hodyna, 2021, Biointerface Res. Appl. Chem.",10.33263/BRIAC123.29052957, IC50 of DMSO-soluble compounds
"1-methyl-3-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)-1H-imidazol-3-ium hexafluorophosphate(V)",C12H10F19N2P,313475-50-2,FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)CC[N+]=1C=CN(C1)C.F[P-](F)(F)(F)(F)F,Cn1cc[n+](CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)c1.F[P-](F)(F)(F)(F)F,574.162,>10,,4,CaCo-2,MTS,"Pereiro, 2013, ACS Sustain. Chem. Eng.",10.1021/sc300163n,Lg(EC50)=4 (uM)
"1-methyl-3-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)-1H-imidazol-3-ium hexafluorophosphate(V)",C12H10F19N2P,313475-50-2,FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)CC[N+]=1C=CN(C1)C.F[P-](F)(F)(F)(F)F,Cn1cc[n+](CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)c1.F[P-](F)(F)(F)(F)F,574.162,>10,,4,HepG2,MTS,"Pereiro, 2013, ACS Sustain. Chem. Eng.",10.1021/sc300163n,Lg(EC50)=4 (uM)
1-methyl-3-(3-oxobutyl)-1H-imidazol-3-ium bromide,C8H13BrN2O,952429-67-3,[Br-].O=C(C)CC[N+]=1C=CN(C1)C,CC(=O)CC[n+]1ccn(C)c1.[Br-],233.109,>3.020,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=3.48 (uM)
1-methyl-3-(4-(dodecanoyloxy)butyl)-1H-imidazol-3-ium chloride,C20H37ClN2O2,,CCCCCCCCCCCC(OCCCC[N+]1=CN(C)C=C1)=O.[Cl-],CCCCCCCCCCCC(=O)OCCCC[n+]1ccn(C)c1.[Cl-],372.981,0.4,0.34-0.46 (CI),24,HEK293T,MTS,"Vavina, 2024, J. Mol. Liq.",10.1016/j.molliq.2024.125483,
1-methyl-3-(4-(palmitoyloxy)butyl)-1H-imidazol-3-ium chloride,C24H45ClN2O2,,CCCCCCCCCCCCCCCC(OCCCC[N+]1=CN(C)C=C1)=O.[Cl-],CCCCCCCCCCCCCCCC(=O)OCCCC[n+]1ccn(C)c1.[Cl-],429.089,0.16,0.11-0.21 (CI),24,HEK293T,MTS,"Vavina, 2024, J. Mol. Liq.",10.1016/j.molliq.2024.125483,
1-methyl-3-(4-(stearoyloxy)butyl)-1H-imidazol-3-ium chloride,C26H49ClN2O2,,CCCCCCCCCCCCCCCCCC(OCCCC[N+]1=CN(C)C=C1)=O.[Cl-],CCCCCCCCCCCCCCCCCC(=O)OCCCC[n+]1ccn(C)c1.[Cl-],457.143,0.1,0.07-0.13 (CI),24,HEK293T,MTS,"Vavina, 2024, J. Mol. Liq.",10.1016/j.molliq.2024.125483,
1-methyl-3-(4-(tetradecanoyloxy)butyl)-1H-imidazol-3-ium chloride,C22H41ClN2O2,,CCCCCCCCCCCCCC(OCCCC[N+]1=CN(C)C=C1)=O.[Cl-],CCCCCCCCCCCCCC(=O)OCCCC[n+]1ccn(C)c1.[Cl-],401.035,0.34,0.29-0.39 (CI),24,HEK293T,MTS,"Vavina, 2024, J. Mol. Liq.",10.1016/j.molliq.2024.125483,
1-methyl-3-(4-(tridecanoyloxy)butyl)-1H-imidazol-3-ium chloride,C21H39ClN2O2,,CCCCCCCCCCCCC(OCCCC[N+]1=CN(C)C=C1)=O.[Cl-],CCCCCCCCCCCCC(=O)OCCCC[n+]1ccn(C)c1.[Cl-],387.008,0.39,0.35-0.44 (CI),24,HEK293T,MTS,"Vavina, 2024, J. Mol. Liq.",10.1016/j.molliq.2024.125483,
1-methyl-3-(4-(undecanoyloxy)butyl)-1H-imidazol-3-ium chloride,C19H35ClN2O2,,CCCCCCCCCCC(OCCCC[N+]1=CN(C)C=C1)=O.[Cl-],CCCCCCCCCCC(=O)OCCCC[n+]1ccn(C)c1.[Cl-],358.954,0.54,0.52-0.56 (CI),24,HEK293T,MTS,"Vavina, 2024, J. Mol. Liq.",10.1016/j.molliq.2024.125483,
1-methyl-3-(4-methylbenzyl)-1H-imidazol-3-ium chloride,C12H15ClN2,637348-60-8,[Cl-].C=1C=C(C=CC1C)C[N+]=2C=CN(C2)C,Cc1ccc(C[n+]2ccn(C)c2)cc1.[Cl-],222.719,0.437,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=2.64 (uM)
1-methyl-3-(4-methylbenzyl)-1H-imidazol-3-ium hexafluorophosphate(V),C12H15F6N2P,952429-66-2,F[P-](F)(F)(F)(F)F.C=1C=C(C=CC1C)C[N+]=2C=CN(C2)C,Cc1ccc(C[n+]2ccn(C)c2)cc1.F[P-](F)(F)(F)(F)F,332.228,0.457,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=2.66 (uM)
1-methyl-3-(4-methylbenzyl)-1H-imidazol-3-ium tetrafluoroborate,C12H15BF4N2,847335-66-4,F[B-](F)(F)F.C=1C=C(C=CC1C)C[N+]=2C=CN(C2)C,Cc1ccc(C[n+]2ccn(C)c2)cc1.F[B-](F)(F)F,274.07,0.468,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=2.67 (uM)
1-methyl-3-(pentyloxy)-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C11H17F6N3O5S2,1422952-74-6,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.O([N+]=1C=CN(C1)C)CCCCC,CCCCCO[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,449.395,0.26,0.04 (SD),72,CCO,WST-1,"Cvjetko Bubalo, 2015, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2014.10.029,
1-methyl-3-(prop-2-yn-1-yl)-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C9H9F6N3O4S2,800405-33-8,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C#CC[N+]=1C=CN(C1)C,C#CC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,401.31,0.41,0.07 (SD),72,CCO,WST-1,"Cvjetko Bubalo, 2015, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2014.10.029,
1-methyl-3-nonyl-1H-imidazol-3-ium chloride,C13H25ClN2,171058-20-1,[Cl-].C1=C[N+](=CN1C)CCCCCCCCC,CCCCCCCCC[n+]1ccn(C)c1.[Cl-],244.81,0.025,0.001 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=1.4, 0.04 (CI) (uM)"
1-methyl-3-nonyl-1H-imidazol-3-ium chloride,C13H25ClN2,171058-20-1,[Cl-].C1=C[N+](=CN1C)CCCCCCCCC,CCCCCCCCC[n+]1ccn(C)c1.[Cl-],244.81,0.025,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=1.4 (uM)
1-methyl-3-nonyl-1H-imidazol-3-ium hexafluorophosphate(V),C13H25F6N2P,343952-29-4,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCC,CCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,354.319,0.07,0.001 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=1.85, 0.08 (CI) (uM)"
1-methyl-3-nonyl-1H-imidazol-3-ium hexafluorophosphate(V),C13H25F6N2P,343952-29-4,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCC,CCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,354.319,0.079,0.001 (CI),72,C6,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=1.9, 0.08 (CI) (uM)"
1-methyl-3-nonyl-1H-imidazol-3-ium hexafluorophosphate(V),C13H25F6N2P,343952-29-4,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCC,CCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,354.319,0.071,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=1.85 (uM)
1-methyl-3-nonyl-1H-imidazol-3-ium tetrafluoroborate,C13H25BF4N2,244193-55-3,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCC,CCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,296.161,0.045,0.001 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=1.65, 0.05 (CI) (uM)"
1-methyl-3-nonyl-1H-imidazol-3-ium tetrafluoroborate,C13H25BF4N2,244193-55-3,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCC,CCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,296.161,0.045,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=1.65 (uM)
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.029,,?,A431,SRB,"Malhotra, 2014, MedChemComm",10.1039/c4md00161c,"lg(LC50)=-4.54 (M, concentration of the drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning)."
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,>0.1,,?,CCRF-CEM,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,>0.1,,?,HL-60 (TB),SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,>0.1,,?,K562,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,>0.1,,?,MOLT-4 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,>0.1,,?,RPMI-8226 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,>0.1,,?,SR  ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,>0.1,,?,A549,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.005758,,?,EKVX ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.009785,,?,HOP-62 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,>0.1,,?,HOP-92 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.008002,,?,NCI-H226 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.007697,,?,NCI-H23 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.006401,,?,NCI-H322M ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.00524,,?,NCI-H460 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,>0.1,,?,NCI-H522 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.00402,,?,COLO 205 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.009066,,?,HCC-2998 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,>0.1,,?,HCT-116,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.00594,,?,HCT-15 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.009131,,?,HT29,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.005455,,?,KM12 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.006484,,?,SW-620 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.006287,,?,SF-268,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.006606,,?,SF-295,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.00528,,?,SF-539,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.00495,,?,SNB-19,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.005711,,?,SNB-75,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.00397,,?,U251,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.00524,,?,LOX IMVI,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.00508,,?,MALME-3M,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.006839,,?,M14,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,>0.1,,?,SK-MEL-2,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.00651,,?,SK-MEL-28,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.004207,,?,SK-MEL-5,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,>0.1,,?,UACC-257,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.0051,,?,UACC-62,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,>0.1,,?,IGROV1,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.004712,,?,OVCAR-3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,>0.1,,?,OVCAR-4,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.009136,,?,OVCAR-5,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,>0.1,,?,OVCAR-8,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.00582,,?,SK-OV-3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,>0.1,,?,786-0 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.006221,,?,A498 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.00478,,?,ACHN ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.006716,,?,CAK-1 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.006546,,?,RXF 393 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.00572,,?,SN12C ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.004426,,?,TK-10 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,>0.1,,?,UO-31 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.005259,,?,PC3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.004691,,?,DU-145,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.00552,,?,MCF-7,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.009407,,?,NCI/ADR-RES,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.00593,,?,MDA-MB-231,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.008483,,?,HS 578T,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.006689,,?,MDA-MB-435,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,0.005948,,?,BT-549,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,>0.1,,?,T-47D,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C24H43F6N3O4S2,404001-51-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,615.747,>0.1,,?,MDA-MB-468,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.00072,,?,CCRF-CEM,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.000791,,?,HL-60 (TB),SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,>0.1,,?,K562,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.00216,,?,MOLT-4 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.00121,,?,RPMI-8226 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.003792,,?,SR  ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.01,,?,A549,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.007781,,?,EKVX ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.007796,,?,HOP-62 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.006853,,?,HOP-92 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.005994,,?,NCI-H226 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.00772,,?,NCI-H23 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.005954,,?,NCI-H322M ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.00392,,?,NCI-H460 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.006449,,?,NCI-H522 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,>0.1,,?,COLO 205 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.007773,,?,HCC-2998 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,>0.1,,?,HCT-116,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.00411,,?,HCT-15 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.005515,,?,HT29,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.00296,,?,KM12 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.00472,,?,SW-620 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.005878,,?,SF-268,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.00559,,?,SF-295,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,>0.1,,?,SNB-19,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.007405,,?,SNB-75,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.00388,,?,U251,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.00148,,?,LOX IMVI,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.005825,,?,MALME-3M,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.006628,,?,M14,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.00575,,?,SK-MEL-28,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.003966,,?,SK-MEL-5,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.006774,,?,UACC-257,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.00507,,?,UACC-62,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,>0.1,,?,IGROV1,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.00401,,?,OVCAR-3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,>0.1,,?,OVCAR-4,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.007892,,?,OVCAR-5,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.007405,,?,OVCAR-8,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,>0.1,,?,SK-OV-3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.00602,,?,786-0 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.00894,,?,A498 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.00423,,?,ACHN ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.007448,,?,CAK-1 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.004899,,?,RXF 393 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.004773,,?,SN12C ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.002773,,?,TK-10 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.005941,,?,UO-31 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.002854,,?,PC3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.0044,,?,DU-145,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.00378,,?,MCF-7,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,>0.1,,?,NCI/ADR-RES,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.004857,,?,MDA-MB-231,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.00631,,?,HS 578T,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.007961,,?,MDA-MB-435,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.005327,,?,BT-549,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,>0.1,,?,T-47D,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.007252,,?,MDA-MB-468,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium chloride,C22H43ClN2,171058-19-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],371.053,0.01,,?,A431,SRB,"Malhotra, 2014, MedChemComm",10.1039/c4md00161c,lg(LC50)=-4.99M (concentration of the drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.00098,,?,CCRF-CEM,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,>0.1,,?,HL-60 (TB),SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,>0.1,,?,K562,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,>0.1,,?,MOLT-4 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.000811,,?,RPMI-8226 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,>0.1,,?,SR  ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.009374,,?,A549,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.007644,,?,EKVX ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.007771,,?,HOP-62 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.006683,,?,HOP-92 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.005736,,?,NCI-H226 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.007983,,?,NCI-H23 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,>0.1,,?,NCI-H322M ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.00438,,?,NCI-H460 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.006773,,?,NCI-H522 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,>0.1,,?,COLO 205 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.005865,,?,HCC-2998 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,>0.1,,?,HCT-116,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.00466,,?,HCT-15 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,>0.1,,?,HT29,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.003996,,?,KM12 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.004315,,?,SW-620 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.006058,,?,SF-268,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.006023,,?,SF-295,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.007889,,?,SNB-19,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.006501,,?,SNB-75,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.0042,,?,U251,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.00384,,?,LOX IMVI,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.00769,,?,MALME-3M,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.00625,,?,M14,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.00516,,?,SK-MEL-28,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.004368,,?,SK-MEL-5,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.009657,,?,UACC-257,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.005201,,?,UACC-62,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.004393,,?,OVCAR-3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.006332,,?,OVCAR-4,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.007236,,?,OVCAR-5,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.0098,,?,OVCAR-8,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.0042,,?,SK-OV-3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.008576,,?,786-0 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.007551,,?,A498 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.00462,,?,ACHN ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.008902,,?,CAK-1 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.005978,,?,RXF 393 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.00528,,?,SN12C ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.00476,,?,TK-10 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.005354,,?,UO-31 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.003544,,?,PC3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.00468,,?,DU-145,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.0045,,?,MCF-7,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,>0.1,,?,NCI/ADR-RES,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.00511,,?,MDA-MB-231,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.006151,,?,HS 578T,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.006637,,?,MDA-MB-435,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.006909,,?,BT-549,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,>0.1,,?,T-47D,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium hexafluorophosphate(V),C22H43F6N2P,219947-96-3,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,480.562,0.00511,,?,MDA-MB-468,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,>0.1,,?,CCRF-CEM,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,>0.1,,?,HL-60 (TB),SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,>0.1,,?,K562,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,>0.1,,?,MOLT-4 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,>0.1,,?,RPMI-8226 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,>0.1,,?,SR  ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,>0.1,,?,A549,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00891,,?,EKVX ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00609,,?,HOP-62 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.022,,?,HOP-92 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00823,,?,NCI-H226 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.0127,,?,NCI-H23 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00554,,?,NCI-H322M ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00485,,?,NCI-H460 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.004316,,?,NCI-H522 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.000778,,?,COLO 205 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.0255,,?,HCC-2998 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,>0.1,,?,HCT-116,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00441,,?,HCT-15 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,>0.1,,?,HT29,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.000929,,?,KM12 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00374,,?,SW-620 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.005792,,?,SF-268,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00577,,?,SF-295,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00419,,?,SF-539,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00395,,?,SNB-19,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,>0.1,,?,SNB-75,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.0037,,?,U251,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.000678,,?,LOX IMVI,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.004251,,?,MALME-3M,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,>0.1,,?,M14,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,>0.1,,?,SK-MEL-2,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00398,,?,SK-MEL-28,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00331,,?,SK-MEL-5,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.009709,,?,UACC-257,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00466,,?,UACC-62,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.001445,,?,IGROV1,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00379,,?,OVCAR-3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,>0.1,,?,OVCAR-4,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.0327,,?,OVCAR-5,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,>0.1,,?,OVCAR-8,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00383,,?,SK-OV-3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00536,,?,786-0 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00339,,?,A498 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00355,,?,ACHN ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.007459,,?,CAK-1 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00831,,?,RXF 393 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00418,,?,SN12C ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00412,,?,TK-10 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00531,,?,UO-31 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00803,,?,PC3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.004426,,?,DU-145,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00469,,?,MCF-7,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.0125,,?,NCI/ADR-RES,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00482,,?,MDA-MB-231,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.005431,,?,HS 578T,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.00293,,?,MDA-MB-435,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.0042,,?,BT-549,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,0.0637,,?,T-47D,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
1-methyl-3-octadecyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C28H43F18N2P,945032-86-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,780.604,>0.1,,?,MDA-MB-468,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
"1-methyl-3-octyl-1H-imidazol-3-ium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate",C16H23F9N2O3S,905972-83-0,O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,494.42,6.607,,4,CaCo-2,MTS,"Pereiro, 2013, ACS Sustain. Chem. Eng.",10.1021/sc300163n,Lg(EC50)=3.83 (uM)
"1-methyl-3-octyl-1H-imidazol-3-ium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate",C16H23F9N2O3S,905972-83-0,O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,494.42,6.76,,4,HepG2,MTS,"Pereiro, 2013, ACS Sustain. Chem. Eng.",10.1021/sc300163n,Lg(EC50)=3.82 (uM)
"1-methyl-3-octyl-1H-imidazol-3-ium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate",C16H23F9N2O3S,905972-83-0,O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,494.42,2.187,,24,CaCo-2,MTS,"Vieira, 2019, Chemosphere",10.1016/j.chemosphere.2018.10.159,
"1-methyl-3-octyl-1H-imidazol-3-ium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate",C16H23F9N2O3S,905972-83-0,O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,494.42,>1.995,,24,HepG2,MTS,"Vieira, 2019, Chemosphere",10.1016/j.chemosphere.2018.10.159,
1-methyl-3-octyl-1H-imidazol-3-ium 2-(6-methoxynaphthalen-2-yl)propanoate,C26H36N2O3,,CCCCCCCC[N+]1=CN(C)C=C1.CC(C2=CC=C3C=C(OC)C=CC3=C2)C([O-])=O ,CCCCCCCC[n+]1ccn(C)c1.COc1ccc2cc(C(C)C(=O)[O-])ccc2c1,424.585,0.1735,,48,L929,MTT,"Tang, 2023, ACS Omega ",10.1021/acsomega.2c07044,
"1-methyl-3-octyl-1H-imidazol-3-ium 3-oxo-3H-benzo[d]isothiazol-2-ide 1,1-dioxide",C19H27N3O3S,958869-91-5,O=C1[N-]S(=O)(=O)C=2C=CC=CC12.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.O=C1[N-]S(=O)(=O)c2ccccc21,377.51,6.076,,4,CaCo-2,MTT,"Frade, 2009, Green Chem.",10.1039/b914284n,
1-methyl-3-octyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C14H23F6N3O4S2,178631-04-4,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,475.477,0.19,0.01 (SE),48,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
1-methyl-3-octyl-1H-imidazol-3-ium bromide,C12H23BrN2,61545-99-1,[Br-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Br-],275.234,0.17,0.02 (SE),24,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
1-methyl-3-octyl-1H-imidazol-3-ium bromide,C12H23BrN2,61545-99-1,[Br-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Br-],275.234,0.02,0.001 (SE),24,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing without FBS
1-methyl-3-octyl-1H-imidazol-3-ium bromide,C12H23BrN2,61545-99-1,[Br-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Br-],275.234,0.3,0.03 (SE),48,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
1-methyl-3-octyl-1H-imidazol-3-ium bromide,C12H23BrN2,61545-99-1,[Br-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Br-],275.234,1.51,1.310-1.710 (ND),24,MC3T3-E1,MTT,"Gindri, 2014, RSC Adv.",10.1039/C4RA09906K,
1-methyl-3-octyl-1H-imidazol-3-ium bromide,C12H23BrN2,61545-99-1,[Br-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Br-],275.234,0.0047,0.0033 (SD),48,FHC,CellTiter-Glo,"Pan, 2022, J. Hazard. Mater.",10.1016/j.jhazmat.2021.127521,"EC50=1.3 uM/mL, 0.9 (SD)."
1-methyl-3-octyl-1H-imidazol-3-ium bromide,C12H23BrN2,61545-99-1,[Br-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Br-],275.234,0.52,,24,PC12,MTT,"Li, 2012, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2012.06.013,"Exposure to this IL led to mitochondrial depolarization, cellular transmogrification, nuclear shrinkage and DNA fragmentation, and increased caspase-3 activity and ROS levels in PC12 cells, provoked cellular LDH release."
1-methyl-3-octyl-1H-imidazol-3-ium bromide,C12H23BrN2,61545-99-1,[Br-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Br-],275.234,0.2002,0.0879 (SEM),24,Sf-9,MTT,"Wu, 2018, J. Hazard. Mater.",10.1016/j.jhazmat.2018.01.028,
1-methyl-3-octyl-1H-imidazol-3-ium bromide,C12H23BrN2,61545-99-1,[Br-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Br-],275.234,0.0029,0.0004 (SEM),48,Sf-9,MTT,"Wu, 2018, J. Hazard. Mater.",10.1016/j.jhazmat.2018.01.028,
1-methyl-3-octyl-1H-imidazol-3-ium chloride,C12H23ClN2,64697-40-1,[Cl-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Cl-],230.783,0.98,,24,MCF-7,MTS,"Wang, 2012, Adv. Mater. Res. ",10.4028/www.scientific.net/AMR.610-613.721,"pEC50=3.007, 0.063 (RMSE)."
1-methyl-3-octyl-1H-imidazol-3-ium chloride,C12H23ClN2,64697-40-1,[Cl-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Cl-],230.783,0.0064,0.00072 (SD),24,B-13,MTT,"Abdelghany, 2020, Food Chem. Toxicol. ",10.1016/j.fct.2020.111593,
1-methyl-3-octyl-1H-imidazol-3-ium chloride,C12H23ClN2,64697-40-1,[Cl-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Cl-],230.783,0.0062,0.00021 (SD),48,B-13,MTT,"Abdelghany, 2020, Food Chem. Toxicol. ",10.1016/j.fct.2020.111593,
1-methyl-3-octyl-1H-imidazol-3-ium chloride,C12H23ClN2,64697-40-1,[Cl-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Cl-],230.783,0.064,0.016 (SD),24,B-13/H,MTT,"Abdelghany, 2020, Food Chem. Toxicol. ",10.1016/j.fct.2020.111593,
1-methyl-3-octyl-1H-imidazol-3-ium chloride,C12H23ClN2,64697-40-1,[Cl-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Cl-],230.783,0.022,0.00388 (SD),48,B-13/H,MTT,"Abdelghany, 2020, Food Chem. Toxicol. ",10.1016/j.fct.2020.111593,
1-methyl-3-octyl-1H-imidazol-3-ium chloride,C12H23ClN2,64697-40-1,[Cl-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Cl-],230.783,0.102,0.001 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=2.01, 0.05 (CI) (uM)"
1-methyl-3-octyl-1H-imidazol-3-ium chloride,C12H23ClN2,64697-40-1,[Cl-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Cl-],230.783,0.538,,24,A549,WST-8,"Chen, 2014, JCCS",10.1002/jccs.201300632,The incubation time is unclear.
1-methyl-3-octyl-1H-imidazol-3-ium chloride,C12H23ClN2,64697-40-1,[Cl-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Cl-],230.783,0.102,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=2.01 (uM)
1-methyl-3-octyl-1H-imidazol-3-ium chloride,C12H23ClN2,64697-40-1,[Cl-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Cl-],230.783,0.1,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
1-methyl-3-octyl-1H-imidazol-3-ium chloride,C12H23ClN2,64697-40-1,[Cl-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Cl-],230.783,~0.56,,24,PC12,WST-1,"Li, 2012, Toxicol. In Vitro",10.1016/j.tiv.2012.07.006,"Exposure to this IL induced DNA damage, sustained increase of intracellular Ca2+, overproduction of reactive oxygen species, gradually exhausted cellular ATP, and triggered mitochondrial permeability transition and apoptosis in PC12 cells."
1-methyl-3-octyl-1H-imidazol-3-ium chloride,C12H23ClN2,64697-40-1,[Cl-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Cl-],230.783,0.54,0.66 (SD),24,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
1-methyl-3-octyl-1H-imidazol-3-ium chloride,C12H23ClN2,64697-40-1,[Cl-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Cl-],230.783,0.03,0.02 (SD),48,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
1-methyl-3-octyl-1H-imidazol-3-ium chloride,C12H23ClN2,64697-40-1,[Cl-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Cl-],230.783,>1,,0.25,NCTC 2544,MTT,"McLaughlin, 2021, Chemosphere",10.1016/j.chemosphere.2020.129432,Incubation time is 15 minutes.
1-methyl-3-octyl-1H-imidazol-3-ium chloride,C12H23ClN2,64697-40-1,[Cl-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Cl-],230.783,0.255,,24,NCTC 2544,MTT,"McLaughlin, 2021, Chemosphere",10.1016/j.chemosphere.2020.129432,
1-methyl-3-octyl-1H-imidazol-3-ium chloride,C12H23ClN2,64697-40-1,[Cl-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Cl-],230.783,>1,,0.25,HaCat,MTT,"McLaughlin, 2021, Chemosphere",10.1016/j.chemosphere.2020.129432,Incubation time is 15 minutes.
1-methyl-3-octyl-1H-imidazol-3-ium chloride,C12H23ClN2,64697-40-1,[Cl-].C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.[Cl-],230.783,0.035,,24,HaCat,MTT,"McLaughlin, 2021, Chemosphere",10.1016/j.chemosphere.2020.129432,
1-methyl-3-octyl-1H-imidazol-3-ium dicyanamide,C14H23N5,905972-84-1,N#C[N-]C#N.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.N#C[N-]C#N,261.373,6.076,,4,CaCo-2,MTT,"Frade, 2009, Green Chem.",10.1039/b914284n,
1-methyl-3-octyl-1H-imidazol-3-ium dicyanamide,C14H23N5,905972-84-1,N#C[N-]C#N.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.N#C[N-]C#N,261.373,0.259,,24,MCF-7,MTT,"Guo, 2021, J. Mol. Liq.",10.1016/j.molliq.2021.116835,
1-methyl-3-octyl-1H-imidazol-3-ium hexafluorophosphate(V),C12H23F6N2P,304680-36-2,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,340.292,0.091,0.001 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=1.96, 0.07 (CI) (uM)"
1-methyl-3-octyl-1H-imidazol-3-ium hexafluorophosphate(V),C12H23F6N2P,304680-36-2,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,340.292,0.575,0.002 (CI),72,C6,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=2.76, 0.2 (CI) (uM)"
1-methyl-3-octyl-1H-imidazol-3-ium hexafluorophosphate(V),C12H23F6N2P,304680-36-2,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,340.292,0.787,,24,A549,WST-8,"Chen, 2014, JCCS",10.1002/jccs.201300632,The incubation time is unclear.
1-methyl-3-octyl-1H-imidazol-3-ium hexafluorophosphate(V),C12H23F6N2P,304680-36-2,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,340.292,>10,,4,CaCo-2,MTS,"Pereiro, 2013, ACS Sustain. Chem. Eng.",10.1021/sc300163n,Lg(EC50)=4 (uM)
1-methyl-3-octyl-1H-imidazol-3-ium hexafluorophosphate(V),C12H23F6N2P,304680-36-2,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,340.292,>10,,4,CaCo-2,MTS,"Pereiro, 2013, ACS Sustain. Chem. Eng.",10.1021/sc300163n,Lg(EC50)=4 (uM)
1-methyl-3-octyl-1H-imidazol-3-ium hexafluorophosphate(V),C12H23F6N2P,304680-36-2,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,340.292,0.091,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=1.96 (uM)
1-methyl-3-octyl-1H-imidazol-3-ium hexafluorophosphate(V),C12H23F6N2P,304680-36-2,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,340.292,3.388,0.002 (ND),24,HT29,MTT,"Frade, 2007, Green Chem.",10.1039/b617526k,"Lg(EC50)=3.53, 0.21 (uM)"
1-methyl-3-octyl-1H-imidazol-3-ium hexafluorophosphate(V),C12H23F6N2P,304680-36-2,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,340.292,1.549,0.001 (ND),24,CaCo-2,MTT,"Frade, 2007, Green Chem.",10.1039/b617526k,"Lg(EC50)=3.19, 0.01 (uM)"
1-methyl-3-octyl-1H-imidazol-3-ium hexafluorophosphate(V),C12H23F6N2P,304680-36-2,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,340.292,5.12,1.81 (SD),24,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
1-methyl-3-octyl-1H-imidazol-3-ium hexafluorophosphate(V),C12H23F6N2P,304680-36-2,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,340.292,1.46,0.29 (SD),48,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
1-methyl-3-octyl-1H-imidazol-3-ium tetrafluoroborate,C12H23BF4N2,244193-52-0,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,282.134,0.055,0.001 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=1.74, 0.06 (CI) (uM)"
1-methyl-3-octyl-1H-imidazol-3-ium tetrafluoroborate,C12H23BF4N2,244193-52-0,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,282.134,0.35,0.3-0.4 (CI),24,U937,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
1-methyl-3-octyl-1H-imidazol-3-ium tetrafluoroborate,C12H23BF4N2,244193-52-0,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,282.134,0.53,0.46-0.6 (CI),24,Jurkat,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
1-methyl-3-octyl-1H-imidazol-3-ium tetrafluoroborate,C12H23BF4N2,244193-52-0,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,282.134,0.07,0.06-0.08 (CI),24,HL60,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
1-methyl-3-octyl-1H-imidazol-3-ium tetrafluoroborate,C12H23BF4N2,244193-52-0,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,282.134,0.78,0.69-0.87 (CI),24,K562,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
1-methyl-3-octyl-1H-imidazol-3-ium tetrafluoroborate,C12H23BF4N2,244193-52-0,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,282.134,2.14,1.81-2.47 (CI),24,HEK293,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
1-methyl-3-octyl-1H-imidazol-3-ium tetrafluoroborate,C12H23BF4N2,244193-52-0,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,282.134,1.1,1.01-1.19 (CI),24,A549,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
1-methyl-3-octyl-1H-imidazol-3-ium tetrafluoroborate,C12H23BF4N2,244193-52-0,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,282.134,0.89,0.81-0.97 (CI),24,A2780,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
1-methyl-3-octyl-1H-imidazol-3-ium tetrafluoroborate,C12H23BF4N2,244193-52-0,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,282.134,0.19,0.01 (SE),24,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
1-methyl-3-octyl-1H-imidazol-3-ium tetrafluoroborate,C12H23BF4N2,244193-52-0,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,282.134,0.04,0.001 (SE),24,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing without FBS
1-methyl-3-octyl-1H-imidazol-3-ium tetrafluoroborate,C12H23BF4N2,244193-52-0,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,282.134,0.3,0.02 (SE),48,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
1-methyl-3-octyl-1H-imidazol-3-ium tetrafluoroborate,C12H23BF4N2,244193-52-0,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,282.134,0.691,,24,MCF-7,MTT,"Kumar, 2008, Environ. Toxicol.",10.1002/tox.20443,"After 24-h incubation, cells were grown for 2 more days, and then the MTT was carried out."
1-methyl-3-octyl-1H-imidazol-3-ium tetrafluoroborate,C12H23BF4N2,244193-52-0,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,282.134,0.83,,24,A549,WST-8,"Chen, 2014, JCCS",10.1002/jccs.201300632,The incubation time is unclear.
1-methyl-3-octyl-1H-imidazol-3-ium tetrafluoroborate,C12H23BF4N2,244193-52-0,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,282.134,0.039,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=1.59 (uM)
1-methyl-3-octyl-1H-imidazol-3-ium tetrafluoroborate,C12H23BF4N2,244193-52-0,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,282.134,3.981,0.002 (ND),24,HT29,MTT,"Frade, 2007, Green Chem.",10.1039/b617526k,"Lg(EC50)=3.6, 0.21 (uM)"
1-methyl-3-octyl-1H-imidazol-3-ium tetrafluoroborate,C12H23BF4N2,244193-52-0,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,282.134,2.188,0.001 (ND),24,CaCo-2,MTT,"Frade, 2007, Green Chem.",10.1039/b617526k,"Lg(EC50)=3.34, 0.13 (uM)"
1-methyl-3-octyl-1H-imidazol-3-ium trifluoromethanesulfonate,C13H23F3N2O3S,403842-84-2,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,344.399,0.021,0.007 (SD),72,HCT-116,MTS,"Kuczak, 2022, J. Hazard. Mater.",10.1016/j.jhazmat.2021.128160,
1-methyl-3-octyl-1H-imidazol-3-ium trifluoromethanesulfonate,C13H23F3N2O3S,403842-84-2,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,344.399,0.114,0.024 (SD),72,MCF-7,MTS,"Kuczak, 2022, J. Hazard. Mater.",10.1016/j.jhazmat.2021.128160,
1-methyl-3-octyl-1H-imidazol-3-ium trifluoromethanesulfonate,C13H23F3N2O3S,403842-84-2,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,344.399,0.014,0.003 (SD),72,U251,MTS,"Kuczak, 2022, J. Hazard. Mater.",10.1016/j.jhazmat.2021.128160,
1-methyl-3-octyl-1H-imidazol-3-ium trifluoromethanesulfonate,C13H23F3N2O3S,403842-84-2,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCC,CCCCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,344.399,0.17,0.02 (SD),72,NHDF,MTS,"Musiał, 2021, ACS Sustain. Chem. Eng.",10.1021/acssuschemeng.1c02277,
1-methyl-3-pentyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C11H17F6N3O4S2,280779-53-5,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCC,CCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,433.396,0.26,0.05 (SD),72,CCO,WST-1,"Cvjetko Bubalo, 2015, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2014.10.029,
1-methyl-3-pentyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C11H17F6N3O4S2,280779-53-5,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCC,CCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,433.396,0.26,0.05 (SD),72,CCO,WST-1,"Radošević, 2013, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2013.03.002,
1-methyl-3-pentyl-1H-imidazol-3-ium chloride,C9H17ClN2,171058-22-3,[Cl-].C1=C[N+](=CN1C)CCCCC,CCCCC[n+]1ccn(C)c1.[Cl-],188.702,1.45,0.001 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=3.16, 0.06 (CI) (uM)"
1-methyl-3-pentyl-1H-imidazol-3-ium chloride,C9H17ClN2,171058-22-3,[Cl-].C1=C[N+](=CN1C)CCCCC,CCCCC[n+]1ccn(C)c1.[Cl-],188.702,>1,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=3 (uM)
1-methyl-3-pentyl-1H-imidazol-3-ium hexafluorophosphate(V),C9H17F6N2P,280779-52-4,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCC,CCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,298.211,1.17,0.001 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=3.07, 0.08 (CI) (uM)"
1-methyl-3-pentyl-1H-imidazol-3-ium hexafluorophosphate(V),C9H17F6N2P,280779-52-4,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCC,CCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,298.211,>1,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,lg(EC50)=3 (uM)
1-methyl-3-pentyl-1H-imidazol-3-ium tetrafluoroborate,C9H17BF4N2,244193-49-5,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCC,CCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,240.053,1.23,0.001 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=3.09, 0.05 (CI) (uM)"
1-methyl-3-pentyl-1H-imidazol-3-ium tetrafluoroborate,C9H17BF4N2,244193-49-5,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCC,CCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,240.053,>1,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,lg(EC50)=3 (uM)
1-methyl-3-phenethyl-1H-imidazol-3-ium chloride,C12H15ClN2,187332-85-0,[Cl-].C=1C=CC(=CC1)CC[N+]=2C=CN(C2)C,Cn1cc[n+](CCc2ccccc2)c1.[Cl-],222.719,>1,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,lg(EC50)=3 (uM)
1-methyl-3-phenethyl-1H-imidazol-3-ium hexafluorophosphate(V),C12H15F6N2P,433337-12-3,F[P-](F)(F)(F)(F)F.C=1C=CC(=CC1)CC[N+]=2C=CN(C2)C,Cn1cc[n+](CCc2ccccc2)c1.F[P-](F)(F)(F)(F)F,332.228,0.851,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,lg(EC50)=2.93 (uM)
1-methyl-3-propyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C9H13F6N3O4S2,216299-72-8,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCC,CCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,405.342,6.297,,24,MCF-7,MTT,"Kumar, 2008, Environ. Toxicol.",10.1002/tox.20443,"After 24-h incubation, cells were grown for 2 more days, and then the MTT was carried out."
1-methyl-3-propyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C9H13F6N3O4S2,216299-72-8,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCC,CCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,405.342,2.85,0.15 (SD),72,NHDF,MTS,"Musiał, 2017, ACS Sustain. Chem. Eng.",10.1021/acssuschemeng.7b02918,
1-methyl-3-propyl-1H-imidazol-3-ium chloride,C7H13ClN2,79917-89-8,[Cl-].C1=C[N+](=CN1C)CCC,CCC[n+]1ccn(C)c1.[Cl-],160.648,93.37,89.57-97.17 (CI),24,U937,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
1-methyl-3-propyl-1H-imidazol-3-ium chloride,C7H13ClN2,79917-89-8,[Cl-].C1=C[N+](=CN1C)CCC,CCC[n+]1ccn(C)c1.[Cl-],160.648,62.25,59.05-65.45 (CI),24,Jurkat,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
1-methyl-3-propyl-1H-imidazol-3-ium chloride,C7H13ClN2,79917-89-8,[Cl-].C1=C[N+](=CN1C)CCC,CCC[n+]1ccn(C)c1.[Cl-],160.648,31.13,28.63-33.63 (CI),24,HL60,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
1-methyl-3-propyl-1H-imidazol-3-ium chloride,C7H13ClN2,79917-89-8,[Cl-].C1=C[N+](=CN1C)CCC,CCC[n+]1ccn(C)c1.[Cl-],160.648,124.49,118.19-130.79 (CI),24,K562,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
1-methyl-3-propyl-1H-imidazol-3-ium chloride,C7H13ClN2,79917-89-8,[Cl-].C1=C[N+](=CN1C)CCC,CCC[n+]1ccn(C)c1.[Cl-],160.648,342.23,316.43-368.03 (CI),24,HEK293,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
1-methyl-3-propyl-1H-imidazol-3-ium chloride,C7H13ClN2,79917-89-8,[Cl-].C1=C[N+](=CN1C)CCC,CCC[n+]1ccn(C)c1.[Cl-],160.648,101,89.7-112.3 (CI),24,A549,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
1-methyl-3-propyl-1H-imidazol-3-ium chloride,C7H13ClN2,79917-89-8,[Cl-].C1=C[N+](=CN1C)CCC,CCC[n+]1ccn(C)c1.[Cl-],160.648,174.4,162-186.8 (CI),24,A2780,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
1-methyl-3-propyl-1H-imidazol-3-ium chloride,C7H13ClN2,79917-89-8 ,[Cl-].C1=C[N+](=CN1C)CCC,CCC[n+]1ccn(C)c1.[Cl-],160.648,>19.953,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,lg(EC50)=4.3 (uM)
1-methyl-3-propyl-1H-imidazol-3-ium hexafluorophosphate(V),C7H13F6N2P,216300-12-8,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCC,CCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,270.157,>1,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,lg(EC50)=3 (uM)
1-methyl-3-propyl-1H-imidazol-3-ium tetrafluoroborate,C7H13BF4N2,244193-48-4,F[B-](F)(F)F.C1=C[N+](=CN1C)CCC,CCC[n+]1ccn(C)c1.F[B-](F)(F)F,211.999,>1,,48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,lg(EC50)=3 (uM)
1-methyl-3-propyl-1H-imidazol-3-ium tetrafluoroborate,C7H13BF4N2,244193-48-4,F[B-](F)(F)F.C1=C[N+](=CN1C)CCC,CCC[n+]1ccn(C)c1.F[B-](F)(F)F,211.999,2.884,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,lg(EC50)=3.46 (uM)
1-methyl-3-tetradecyl-1H-imidazol-3-ium chloride,C18H35ClN2,171058-21-2,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCC,CCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],314.945,0.0004,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
1-methyl-3-tetradecyl-1H-imidazol-3-ium chloride,C18H35ClN2,171058-21-2,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCC,CCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],314.945,0.03,,0.25,NCTC 2544,MTT,"McLaughlin, 2021, Chemosphere",10.1016/j.chemosphere.2020.129432,Incubation time is 15 minutes.
1-methyl-3-tetradecyl-1H-imidazol-3-ium chloride,C18H35ClN2,171058-21-2,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCC,CCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],314.945,0.002,,24,NCTC 2544,MTT,"McLaughlin, 2021, Chemosphere",10.1016/j.chemosphere.2020.129432,
1-methyl-3-tetradecyl-1H-imidazol-3-ium chloride,C18H35ClN2,171058-21-2,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCC,CCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],314.945,0.048,,0.25,HaCat,MTT,"McLaughlin, 2021, Chemosphere",10.1016/j.chemosphere.2020.129432,Incubation time is 15 minutes.
1-methyl-3-tetradecyl-1H-imidazol-3-ium chloride,C18H35ClN2,171058-21-2,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCC,CCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],314.945,0.005,,24,HaCat,MTT,"McLaughlin, 2021, Chemosphere",10.1016/j.chemosphere.2020.129432,
1-N-(ferrocenylmethyl)3-N-(decyl)imidazole bromide,C16H30*BrN2,1367347-53-2,CCCCCCCCCCCC[n+]1ccn(C[1*])c1.[Br-],[1*]Cn1cc[n+](CCCCCCCCCCCC)c1.[Br-],487.3,0.000164,,48,MCF-7,SRB,"Bansode, 2019, J. Mol. Liq.",10.1016/j.molliq.2019.111182,"LC50, concentration of drug resulting in a 50% reduction in themeasured protein at the end of the drug treatment as compared to that at the beginning. SMILES from SciFinder - [Br-].C1=C[N+](=CN1CCCCCCCCCC)C[C-]23[CH]4=[CH]5[CH]6=[CH]2[Fe+2]789%105643[CH]=%11[CH]%10=[CH]9[CH-]8[CH]%117"
1-N-(ferrocenylmethyl)3-N-(decyl)imidazole bromide,C16H30*BrN2,1367347-53-2,CCCCCCCCCCCC[n+]1ccn(C[1*])c1.[Br-],[1*]Cn1cc[n+](CCCCCCCCCCCC)c1.[Br-],487.3,0.02446,,48,Vero,SRB,"Bansode, 2019, J. Mol. Liq.",10.1016/j.molliq.2019.111182,"LC50, concentration of drug resulting in a 50% reduction in themeasured protein at the end of the drug treatment as compared to that at the beginning. SMILES from SciFinder - [Br-].C1=C[N+](=CN1CCCCCCCCCC)C[C-]23[CH]4=[CH]5[CH]6=[CH]2[Fe+2]789%105643[CH]=%11[CH]%10=[CH]9[CH-]8[CH]%117"
1-N-(ferrocenylmethyl)3-N-(dodecyl)imidazole bromide,C18H34*BrN2,1462911-72-3,CCCCCCCCCCCCCC[n+]1ccn(C[1*])c1.[Br-],[1*]Cn1cc[n+](CCCCCCCCCCCCCC)c1.[Br-],515.35,0.000155,,48,MCF-7,SRB,"Bansode, 2019, J. Mol. Liq.",10.1016/j.molliq.2019.111182,"LC50, concentration of drug resulting in a 50% reduction in themeasured protein at the end of the drug treatment as compared to that at the beginning. SMILES from SciFinder - [Br-].C1=C[N+](=CN1CCCCCCCCCCCC)C[C-]23[CH]4=[CH]5[CH]6=[CH]2[Fe+2]789%105643[CH]=%11[CH]%10=[CH]9[CH-]8[CH]%117"
1-N-(ferrocenylmethyl)3-N-(dodecyl)imidazole bromide,C18H34*BrN2,1462911-72-3,CCCCCCCCCCCCCC[n+]1ccn(C[1*])c1.[Br-],[1*]Cn1cc[n+](CCCCCCCCCCCCCC)c1.[Br-],515.35,<0.008,,48,Vero,SRB,"Bansode, 2019, J. Mol. Liq.",10.1016/j.molliq.2019.111182,"LC50, concentration of drug resulting in a 50% reduction in themeasured protein at the end of the drug treatment as compared to that at the beginning. SMILES from SciFinder - [Br-].C1=C[N+](=CN1CCCCCCCCCCCC)C[C-]23[CH]4=[CH]5[CH]6=[CH]2[Fe+2]789%105643[CH]=%11[CH]%10=[CH]9[CH-]8[CH]%117"
1-N-(ferrocenylmethyl)-3-N-(octyl)imidazolium bromide,C14H26*BrN2,1227909-24-1,CCCCCCCCCC[n+]1ccn(C[1*])c1.[Br-],[1*]Cn1cc[n+](CCCCCCCCCC)c1.[Br-],459.24,0.000174,,48,MCF-7,SRB,"Bansode, 2019, J. Mol. Liq.",10.1016/j.molliq.2019.111182,"LC50, concentration of drug resulting in a 50% reduction in themeasured protein at the end of the drug treatment as compared to that at the beginning. SMILES from SciFinder - [Br-].C1=C[N+](=CN1CCCCCCCC)C[C-]23[CH]4=[CH]5[CH]6=[CH]2[Fe+2]789%105643[CH]=%11[CH]%10=[CH]9[CH-]8[CH]%117"
1-N-(ferrocenylmethyl)-3-N-(octyl)imidazolium bromide,C14H26*BrN2,1227909-24-1,CCCCCCCCCC[n+]1ccn(C[1*])c1.[Br-],[1*]Cn1cc[n+](CCCCCCCCCC)c1.[Br-],459.24,0.0163,,48,Vero,SRB,"Bansode, 2019, J. Mol. Liq.",10.1016/j.molliq.2019.111182,"LC50, concentration of drug resulting in a 50% reduction in themeasured protein at the end of the drug treatment as compared to that at the beginning. SMILES from SciFinder - [Br-].C1=C[N+](=CN1CCCCCCCC)C[C-]23[CH]4=[CH]5[CH]6=[CH]2[Fe+2]789%105643[CH]=%11[CH]%10=[CH]9[CH-]8[CH]%117"
1-N-(ferrocenylmethyl)3-N-(tetradecyl)imidazole bromide,C20H38*BrN2,2460466-62-8,CCCCCCCCCCCCCCCC[n+]1ccn(C[1*])c1.[Br-],[1*]Cn1cc[n+](CCCCCCCCCCCCCCCC)c1.[Br-],543.4,0.000174,,48,MCF-7,SRB,"Bansode, 2019, J. Mol. Liq.",10.1016/j.molliq.2019.111182,"LC50, concentration of drug resulting in a 50% reduction in themeasured protein at the end of the drug treatment as compared to that at the beginning. SMILES from SciFinder - [Br-].C1=C[N+](=CN1CCCCCCCCCCCC)C[C-]23[CH]4=[CH]5[CH]6=[CH]2[Fe+2]789%105643[CH]=%11[CH]%10=[CH]9[CH-]8[CH]%117"
1-N-(ferrocenylmethyl)3-N-(tetradecyl)imidazole bromide,C20H38*BrN2,2460466-62-8,CCCCCCCCCCCCCCCC[n+]1ccn(C[1*])c1.[Br-],[1*]Cn1cc[n+](CCCCCCCCCCCCCCCC)c1.[Br-],543.4,<0.008,,48,Vero,SRB,"Bansode, 2019, J. Mol. Liq.",10.1016/j.molliq.2019.111182,"LC50, concentration of drug resulting in a 50% reduction in themeasured protein at the end of the drug treatment as compared to that at the beginning. SMILES from SciFinder - [Br-].C1=C[N+](=CN1CCCCCCCCCCCC)C[C-]23[CH]4=[CH]5[CH]6=[CH]2[Fe+2]789%105643[CH]=%11[CH]%10=[CH]9[CH-]8[CH]%117"
1-octyl-3-vinyl-1H-imidazol-3-ium chloride,C13H23ClN2,100894-54-0,[Cl-].CCCCCCCCN1C=C[N+](C=C)=C1,C=C[n+]1ccn(CCCCCCCC)c1.[Cl-],242.794,0.465,,24,A549,WST-8,"Chen, 2014, JCCS",10.1002/jccs.201300632,The incubation time is unclear.
1-propyl-3-(p-tolyl)-1H-imidazol-3-ium bromide,C13H17BrN2,1176198-73-4,[Br-].C1=CC(=CC=C1[N+]=2C=CN(C2)CCC)C,CCCn1cc[n+](-c2ccc(C)cc2)c1.[Br-],281.197,0.234,0.224-0.251 (CI),?,IPC-81,WST-1,"Stolte, 2013, ACS Sustain. Chem. Eng.",10.1021/sc300146t,
3-(10-carboxydecyl)-1-methyl-1H-imidazol-3-ium bromide,C15H27BrN2O2,953026-81-8,[Br-].O=C(O)CCCCCCCCCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCCCCCCCCCC(=O)O)c1.[Br-],347.297,>1,,24,Colo320HSR,MTS,"Kucherov, 2017, Anal. Chem.",10.1021/acs.analchem.7b03568,
3-(10-carboxydecyl)-1-methyl-1H-imidazol-3-ium bromide,C15H27BrN2O2,953026-81-8,[Br-].O=C(O)CCCCCCCCCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCCCCCCCCCC(=O)O)c1.[Br-],347.297,>1,,24,CaCo-2,MTS,"Kucherov, 2017, Anal. Chem.",10.1021/acs.analchem.7b03568,
3-(10-carboxydecyl)-1-methyl-1H-imidazol-3-ium bromide,C15H27BrN2O2,953026-81-8,[Br-].O=C(O)CCCCCCCCCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCCCCCCCCCC(=O)O)c1.[Br-],347.297,>1,,24,3215 LS,MTS,"Kucherov, 2017, Anal. Chem.",10.1021/acs.analchem.7b03568,
3-(10-carboxydecyl)-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C15H27F6N2O2P,1265530-15-1,O=C(O)CCCCCCCCCC[N+]=1C=CN(C1)C.F[P-](F)(F)(F)(F)F,Cn1cc[n+](CCCCCCCCCCC(=O)O)c1.F[P-](F)(F)(F)(F)F,412.355,>0.5,,24,Colo320HSR,MTS,"Kucherov, 2017, Anal. Chem.",10.1021/acs.analchem.7b03568,
3-(10-carboxydecyl)-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C15H27F6N2O2P,1265530-15-1,O=C(O)CCCCCCCCCC[N+]=1C=CN(C1)C.F[P-](F)(F)(F)(F)F,Cn1cc[n+](CCCCCCCCCCC(=O)O)c1.F[P-](F)(F)(F)(F)F,412.355,>1,,24,CaCo-2,MTS,"Kucherov, 2017, Anal. Chem.",10.1021/acs.analchem.7b03568,
3-(10-carboxydecyl)-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C15H27F6N2O2P,1265530-15-1,O=C(O)CCCCCCCCCC[N+]=1C=CN(C1)C.F[P-](F)(F)(F)(F)F,Cn1cc[n+](CCCCCCCCCCC(=O)O)c1.F[P-](F)(F)(F)(F)F,412.355,>0.35,,24,3215 LS,MTS,"Kucherov, 2017, Anal. Chem.",10.1021/acs.analchem.7b03568,
3-(10-carboxydecyl)-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C15H27BF4N2O2,1265530-14-0,O=C(O)CCCCCCCCCC[N+]=1C=CN(C1)C.F[B-](F)(F)F,Cn1cc[n+](CCCCCCCCCCC(=O)O)c1.F[B-](F)(F)F,354.197,>0.5,,24,Colo320HSR,MTS,"Kucherov, 2017, Anal. Chem.",10.1021/acs.analchem.7b03568,
3-(10-carboxydecyl)-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C15H27BF4N2O2,1265530-14-0,O=C(O)CCCCCCCCCC[N+]=1C=CN(C1)C.F[B-](F)(F)F,Cn1cc[n+](CCCCCCCCCCC(=O)O)c1.F[B-](F)(F)F,354.197,>0.35,,24,CaCo-2,MTS,"Kucherov, 2017, Anal. Chem.",10.1021/acs.analchem.7b03568,
3-(10-carboxydecyl)-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C15H27BF4N2O2,1265530-14-0,O=C(O)CCCCCCCCCC[N+]=1C=CN(C1)C.F[B-](F)(F)F,Cn1cc[n+](CCCCCCCCCCC(=O)O)c1.F[B-](F)(F)F,354.197,>0.35,,24,3215 LS,MTS,"Kucherov, 2017, Anal. Chem.",10.1021/acs.analchem.7b03568,
3-(2-((2-hydroxybenzoyl)oxy)ethyl)-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C20H20N2O6,1811535-48-4,O=C([O-])C=1C=CC=CC1O.O=C(OCC[N+]=1C=CN(C1)C)C=2C=CC=CC2O,Cn1cc[n+](CCOC(=O)c2ccccc2O)c1.O=C([O-])c1ccccc1O,384.388,0.71,0.58-0.84 (CI),24,3215 LS,MTS,"Egorova, 2015, ACS Med. Chem. Lett.",10.1021/acsmedchemlett.5b00258,
3-(2-((2-hydroxybenzoyl)oxy)ethyl)-1-methyl-1H-imidazol-3-ium chloride,C13H15ClN2O3,1811535-42-8,[Cl-].O=C(OCC[N+]=1C=CN(C1)C)C=2C=CC=CC2O,Cn1cc[n+](CCOC(=O)c2ccccc2O)c1.[Cl-],282.727,2.85,1.3-4.4 (CI),24,3215 LS,MTS,"Egorova, 2015, ACS Med. Chem. Lett.",10.1021/acsmedchemlett.5b00258,
3-(2-((2-hydroxybenzoyl)oxy)ethyl)-1-methyl-1H-imidazol-3-ium chloride,C13H15ClN2O3,1811535-42-8,[Cl-].O=C(OCC[N+]=1C=CN(C1)C)C=2C=CC=CC2O,Cn1cc[n+](CCOC(=O)c2ccccc2O)c1.[Cl-],282.727,3.82,3.34-4.31 (CI),24,CaCo-2,MTS,"Egorova, 2015, ACS Med. Chem. Lett.",10.1021/acsmedchemlett.5b00258,
3-(2-((2-hydroxybenzoyl)oxy)ethyl)-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C13H15BF4N2O3,1811535-41-7,O=C(OCC[N+]=1C=CN(C1)C)C=2C=CC=CC2O.F[B-](F)(F)F,Cn1cc[n+](CCOC(=O)c2ccccc2O)c1.F[B-](F)(F)F,334.078,4.12,2.51-5.73 (CI),24,3215 LS,MTS,"Egorova, 2015, ACS Med. Chem. Lett.",10.1021/acsmedchemlett.5b00258,
3-(2-((2-hydroxybenzoyl)oxy)ethyl)-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C13H15BF4N2O3,1811535-41-7,O=C(OCC[N+]=1C=CN(C1)C)C=2C=CC=CC2O.F[B-](F)(F)F,Cn1cc[n+](CCOC(=O)c2ccccc2O)c1.F[B-](F)(F)F,334.078,4.77,3.27-6.27 (CI),24,CaCo-2,MTS,"Egorova, 2015, ACS Med. Chem. Lett.",10.1021/acsmedchemlett.5b00258,
"3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1,2-dimethyl-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C16H15F3N4O3S,,[O-]C(=O)C(F)(F)F.CN1C=C[N+](CC(=O)NC2=NC3=CC=CC=C3S2)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccccc2s1.O=C([O-])C(F)(F)F,400.382,>0.5,,48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1,2-dimethyl-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C16H15F3N4O3S,,[O-]C(=O)C(F)(F)F.CN1C=C[N+](CC(=O)NC2=NC3=CC=CC=C3S2)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccccc2s1.O=C([O-])C(F)(F)F,400.382,>0.5,,48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1,2-dimethyl-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C16H15F3N4O3S,,[O-]C(=O)C(F)(F)F.CN1C=C[N+](CC(=O)NC2=NC3=CC=CC=C3S2)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccccc2s1.O=C([O-])C(F)(F)F,400.382,>0.5,,48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1,2-dimethyl-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C16H15F3N4O3S,,[O-]C(=O)C(F)(F)F.CN1C=C[N+](CC(=O)NC2=NC3=CC=CC=C3S2)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccccc2s1.O=C([O-])C(F)(F)F,400.382,>0.5,,48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1,2-dimethyl-1H-imidazol-3-ium bromide",C14H15BrN4OS,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=CC=C3S2)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccccc2s1.[Br-],367.272,>0.5,,48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1,2-dimethyl-1H-imidazol-3-ium bromide",C14H15BrN4OS,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=CC=C3S2)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccccc2s1.[Br-],367.272,>0.5,,48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1,2-dimethyl-1H-imidazol-3-ium bromide",C14H15BrN4OS,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=CC=C3S2)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccccc2s1.[Br-],367.272,>0.5,,48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1,2-dimethyl-1H-imidazol-3-ium bromide",C14H15BrN4OS,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=CC=C3S2)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccccc2s1.[Br-],367.272,>0.5,,48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1,2-dimethyl-1H-imidazol-3-ium hexafluorophosphate(V)",C14H15F6N4OPS,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=CC=C3S2)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccccc2s1.F[P-](F)(F)(F)(F)F,432.33,>0.5,,48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1,2-dimethyl-1H-imidazol-3-ium hexafluorophosphate(V)",C14H15F6N4OPS,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=CC=C3S2)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccccc2s1.F[P-](F)(F)(F)(F)F,432.33,>0.5,,48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1,2-dimethyl-1H-imidazol-3-ium hexafluorophosphate(V)",C14H15F6N4OPS,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=CC=C3S2)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccccc2s1.F[P-](F)(F)(F)(F)F,432.33,>0.5,,48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1,2-dimethyl-1H-imidazol-3-ium hexafluorophosphate(V)",C14H15F6N4OPS,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=CC=C3S2)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccccc2s1.F[P-](F)(F)(F)(F)F,432.33,>0.5,,48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1,2-dimethyl-1H-imidazol-3-ium tetrafluoroborate",C14H15BF4N4OS,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=CC=C3S2)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccccc2s1.F[B-](F)(F)F,374.172,>0.5,,48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1,2-dimethyl-1H-imidazol-3-ium tetrafluoroborate",C14H15BF4N4OS,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=CC=C3S2)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccccc2s1.F[B-](F)(F)F,374.172,>0.5,,48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1,2-dimethyl-1H-imidazol-3-ium tetrafluoroborate",C14H15BF4N4OS,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=CC=C3S2)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccccc2s1.F[B-](F)(F)F,374.172,>0.5,,48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1,2-dimethyl-1H-imidazol-3-ium tetrafluoroborate",C14H15BF4N4OS,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=CC=C3S2)=O)=C1C,Cc1n(C)cc[n+]1CC(=O)Nc1nc2ccccc2s1.F[B-](F)(F)F,374.172,>0.5,,48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C15H13F3N4O3S,,[O-]C(C(F)(F)F)=O.O=C(NC1=NC2=CC=CC=C2S1)C[N+]3=CN(C)C=C3,Cn1cc[n+](CC(=O)Nc2nc3ccccc3s2)c1.O=C([O-])C(F)(F)F,386.355,>0.5,,48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C15H13F3N4O3S,,[O-]C(C(F)(F)F)=O.O=C(NC1=NC2=CC=CC=C2S1)C[N+]3=CN(C)C=C3,Cn1cc[n+](CC(=O)Nc2nc3ccccc3s2)c1.O=C([O-])C(F)(F)F,386.355,>0.5,,48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C15H13F3N4O3S,,[O-]C(C(F)(F)F)=O.O=C(NC1=NC2=CC=CC=C2S1)C[N+]3=CN(C)C=C3,Cn1cc[n+](CC(=O)Nc2nc3ccccc3s2)c1.O=C([O-])C(F)(F)F,386.355,>0.5,,48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
"3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium 2,2,2-trifluoroacetate",C15H13F3N4O3S,,[O-]C(C(F)(F)F)=O.O=C(NC1=NC2=CC=CC=C2S1)C[N+]3=CN(C)C=C3,Cn1cc[n+](CC(=O)Nc2nc3ccccc3s2)c1.O=C([O-])C(F)(F)F,386.355,>0.5,,48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium bromide,C13H13BrN4OS,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=CC=C3S2)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccccc3s2)c1.[Br-],353.245,>0.5,,48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium bromide,C13H13BrN4OS,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=CC=C3S2)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccccc3s2)c1.[Br-],353.245,>0.5,,48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium bromide,C13H13BrN4OS,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=CC=C3S2)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccccc3s2)c1.[Br-],353.245,>0.5,,48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium bromide,C13H13BrN4OS,,[Br-].CN1C=C[N+](CC(=O)NC2=NC3=CC=CC=C3S2)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccccc3s2)c1.[Br-],353.245,>0.5,,48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C13H13F6N4OPS,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=CC=C3S2)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccccc3s2)c1.F[P-](F)(F)(F)(F)F,418.303,>0.5,,48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C13H13F6N4OPS,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=CC=C3S2)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccccc3s2)c1.F[P-](F)(F)(F)(F)F,418.303,>0.5,,48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C13H13F6N4OPS,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=CC=C3S2)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccccc3s2)c1.F[P-](F)(F)(F)(F)F,418.303,>0.5,,48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C13H13F6N4OPS,,F[P-](F)(F)(F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=CC=C3S2)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccccc3s2)c1.F[P-](F)(F)(F)(F)F,418.303,>0.5,,48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C13H13BF4N4OS,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=CC=C3S2)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccccc3s2)c1.F[B-](F)(F)F,360.145,>0.5,,48,HCT-116,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C13H13BF4N4OS,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=CC=C3S2)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccccc3s2)c1.F[B-](F)(F)F,360.145,>0.5,,48,CaCo-2,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C13H13BF4N4OS,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=CC=C3S2)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccccc3s2)c1.F[B-](F)(F)F,360.145,>0.5,,48,T-47D,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
3-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C13H13BF4N4OS,,F[B-](F)(F)F.CN1C=C[N+](CC(NC2=NC3=CC=CC=C3S2)=O)=C1,Cn1cc[n+](CC(=O)Nc2nc3ccccc3s2)c1.F[B-](F)(F)F,360.145,>0.5,,48,MCF-7,MTT,"Al-blewi, 2019, Int. J. Mol. Sci.",10.3390/ijms20122865,The exact nature of the assay - MTT or MTS - is unclear.
3-(2-(decyloxy)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium chloride,C16H29ClN2O2,1632117-47-5,[Cl-].O=C(OCCCCCCCCCC)C[N+]=1C=CN(C1)C,CCCCCCCCCCOC(=O)C[n+]1ccn(C)c1.[Cl-],316.873,0.08098,,24,Hep-2,Visual counting,"Hodyna, 2021, Biointerface Res. Appl. Chem.",10.33263/BRIAC123.29052957, IC50 of DMSO-soluble compounds
3-(2-(decyloxy)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium chloride,C16H29ClN2O2,1632117-47-5,[Cl-].O=C(OCCCCCCCCCC)C[N+]=1C=CN(C1)C,CCCCCCCCCCOC(=O)C[n+]1ccn(C)c1.[Cl-],316.873,0.06793,,48,Hep-2,Visual counting,"Hodyna, 2021, Biointerface Res. Appl. Chem.",10.33263/BRIAC123.29052957, IC50 of DMSO-soluble compounds
3-(2-(decyloxy)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium chloride,C16H29ClN2O2,1632117-47-5,[Cl-].O=C(OCCCCCCCCCC)C[N+]=1C=CN(C1)C,CCCCCCCCCCOC(=O)C[n+]1ccn(C)c1.[Cl-],316.873,0.06793,,72,Hep-2,Visual counting,"Hodyna, 2021, Biointerface Res. Appl. Chem.",10.33263/BRIAC123.29052957, IC50 of DMSO-soluble compounds
3-(2-(dodecyloxy)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium chloride,C18H33ClN2O2,1632117-46-4,[Cl-].O=C(OCCCCCCCCCCCC)C[N+]=1C=CN(C1)C,CCCCCCCCCCCCOC(=O)C[n+]1ccn(C)c1.[Cl-],344.927,0.00575,,24,Hep-2,Visual counting,"Hodyna, 2021, Biointerface Res. Appl. Chem.",10.33263/BRIAC123.29052957, IC50 of DMSO-soluble compounds
3-(2-(dodecyloxy)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium chloride,C18H33ClN2O2,1632117-46-4,[Cl-].O=C(OCCCCCCCCCCCC)C[N+]=1C=CN(C1)C,CCCCCCCCCCCCOC(=O)C[n+]1ccn(C)c1.[Cl-],344.927,0.00575,,48,Hep-2,Visual counting,"Hodyna, 2021, Biointerface Res. Appl. Chem.",10.33263/BRIAC123.29052957, IC50 of DMSO-soluble compounds
3-(2-(dodecyloxy)-2-oxoethyl)-1-methyl-1H-imidazol-3-ium chloride,C18H33ClN2O2,1632117-46-4,[Cl-].O=C(OCCCCCCCCCCCC)C[N+]=1C=CN(C1)C,CCCCCCCCCCCCOC(=O)C[n+]1ccn(C)c1.[Cl-],344.927,0.00575,,72,Hep-2,Visual counting,"Hodyna, 2021, Biointerface Res. Appl. Chem.",10.33263/BRIAC123.29052957, IC50 of DMSO-soluble compounds
3-(2-(glycyloxy)ethyl)-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H14BF4N3O2,924297-69-8,O=C(OCC[N+]=1C=CN(C1)C)CN.F[B-](F)(F)F,Cn1cc[n+](CCOC(=O)CN)c1.F[B-](F)(F)F,271.023,17.9,0.58 (SEM),24,NIH/3T3,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-(2-ethoxyethyl)-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O4,,O=C(C1=C(O)C=CC=C1)[O-].CCOCC[N+]2=CN(C)C=C2,CCOCC[n+]1ccn(C)c1.O=C([O-])c1ccccc1O,292.335,>0.1,,72,MCF-7,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
3-(2-ethoxyethyl)-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O4,,O=C(C1=C(O)C=CC=C1)[O-].CCOCC[N+]2=CN(C)C=C2,CCOCC[n+]1ccn(C)c1.O=C([O-])c1ccccc1O,292.335,>0.1,,72,MDA-MB-231,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
3-(2-ethoxyethyl)-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O4,,O=C(C1=C(O)C=CC=C1)[O-].CCOCC[N+]2=CN(C)C=C2,CCOCC[n+]1ccn(C)c1.O=C([O-])c1ccccc1O,292.335,>0.1,,72,PC3,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
3-(2-ethoxyethyl)-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O4,,O=C(C1=C(O)C=CC=C1)[O-].CCOCC[N+]2=CN(C)C=C2,CCOCC[n+]1ccn(C)c1.O=C([O-])c1ccccc1O,292.335,>0.1,,72,HeLa,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
3-(2-ethoxyethyl)-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O4,,O=C(C1=C(O)C=CC=C1)[O-].CCOCC[N+]2=CN(C)C=C2,CCOCC[n+]1ccn(C)c1.O=C([O-])c1ccccc1O,292.335,>0.1,,72,HT29,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
3-(2-ethoxyethyl)-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O4,,O=C(C1=C(O)C=CC=C1)[O-].CCOCC[N+]2=CN(C)C=C2,CCOCC[n+]1ccn(C)c1.O=C([O-])c1ccccc1O,292.335,0.05731,,72,A549,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
3-(2-ethoxyethyl)-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C10H15F6N3O5S2,778593-17-2,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.O(CC)CC[N+]=1C=CN(C1)C,CCOCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,435.368,1.5,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
3-(2-ethoxyethyl)-1-methyl-1H-imidazol-3-ium bromide,C8H15BrN2O,1012793-99-5,[Br-].O(CC)CC[N+]=1C=CN(C1)C,CCOCC[n+]1ccn(C)c1.[Br-],235.125,13.8,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
"3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium (1S,2R,4aS,6aS,6bR,8aR,10S,12aR,12bR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)-carboxylate",C36H58N2O4,,CN1C=C[N+](CCO)=C1.O=C([C@]23CC[C@@H](C)[C@H](C)[C@@]2([H])C4=CC[C@]5([H])[C@@]6(C)CC[C@H](O)C(C)(C)[C@]6([H])CC[C@@]5(C)[C@]4(C)CC3)[O-],C[C@@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2(C(=O)[O-])CC[C@H]1C.Cn1cc[n+](CCO)c1,582.87,0.00914,,48,HepG2,MTT,"Fan, 2021, J. Mol. Liq.",10.1016/j.molliq.2021.115837,
"3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium (2S,5R,6R)-6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",C22H29N5O5S,1418122-71-0,C(CO)[N+]1=CN(C)C=C1.C([O-])(=O)[C@@H]1N2[C@@]([C@H](NC([C@H](N)C3=CC=CC=C3)=O)C2=O)(SC1(C)C)[H],CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].Cn1cc[n+](CCO)c1,475.571,>0.000738,,?,MG63,MTT,"Ferraz, 2015, ChemMedChem",10.1002/cmdc.201500142,LD50=0.001240 mM
"3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium (2S,5R,6R)-6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",C22H29N5O5S,1418122-71-0,C(CO)[N+]1=CN(C)C=C1.C([O-])(=O)[C@@H]1N2[C@@]([C@H](NC([C@H](N)C3=CC=CC=C3)=O)C2=O)(SC1(C)C)[H],CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].Cn1cc[n+](CCO)c1,475.571,>0.000319,,?,HepG2,MTT,"Ferraz, 2015, ChemMedChem",10.1002/cmdc.201500142,LD50=0.000404 mM
"3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium (2S,5R,6R)-6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",C22H29N5O5S,1418122-71-0,C(CO)[N+]1=CN(C)C=C1.C([O-])(=O)[C@@H]1N2[C@@]([C@H](NC([C@H](N)C3=CC=CC=C3)=O)C2=O)(SC1(C)C)[H],CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].Cn1cc[n+](CCO)c1,475.571,>0.000146,,?,T-47D,MTT,"Ferraz, 2015, ChemMedChem",10.1002/cmdc.201500142,LD50=0.000498 mM
"3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium (2S,5R,6R)-6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",C22H29N5O5S,1418122-71-0,C(CO)[N+]1=CN(C)C=C1.C([O-])(=O)[C@@H]1N2[C@@]([C@H](NC([C@H](N)C3=CC=CC=C3)=O)C2=O)(SC1(C)C)[H],CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].Cn1cc[n+](CCO)c1,475.571,>0.000297,,?,PC3,MTT,"Ferraz, 2015, ChemMedChem",10.1002/cmdc.201500142,LD50=0.000297 mM
"3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium (2S,5R,6R)-6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",C22H29N5O5S,1418122-71-0,C(CO)[N+]1=CN(C)C=C1.C([O-])(=O)[C@@H]1N2[C@@]([C@H](NC([C@H](N)C3=CC=CC=C3)=O)C2=O)(SC1(C)C)[H],CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].Cn1cc[n+](CCO)c1,475.571,>0.000359,,?,RKO,MTT,"Ferraz, 2015, ChemMedChem",10.1002/cmdc.201500142,LD50=0.000362 mM
"3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium (2S,5R,6R)-6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",C22H29N5O5S,1418122-71-0,C(CO)[N+]1=CN(C)C=C1.C([O-])(=O)[C@@H]1N2[C@@]([C@H](NC([C@H](N)C3=CC=CC=C3)=O)C2=O)(SC1(C)C)[H],CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].Cn1cc[n+](CCO)c1,475.571,>0.005084,,?,SF,MTT,"Ferraz, 2015, ChemMedChem",10.1002/cmdc.201500142,"LD50=0.0226 mM, skin fibroblasts."
"3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium (2S,5R,6R)-6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",C22H29N5O5S,1418122-71-0,C(CO)[N+]1=CN(C)C=C1.C([O-])(=O)[C@@H]1N2[C@@]([C@H](NC([C@H](N)C3=CC=CC=C3)=O)C2=O)(SC1(C)C)[H],CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].Cn1cc[n+](CCO)c1,475.571,>0.000462,,?,GF,MTT,"Ferraz, 2015, ChemMedChem",10.1002/cmdc.201500142,"LD50=0.03047 mM, 0.000428 mM (SD), gingival fibroblasts."
"3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium (4aS,6aS,6bR,8aR,10S,12aR,12bR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)-carboxylate",C36H58N2O4,,C[C@]12[C@]3(C([C@@]4([H])[C@@](CC3)(CCC(C)(C4)C)C([O-])=O)=CC[C@]1([H])[C@@]5([C@@](C(C)([C@H](CC5)O)C)([H])CC2)C)C.CN6C=[N+](CCO)C=C6,CC1(C)CC[C@]2(C(=O)[O-])CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1.Cn1cc[n+](CCO)c1,582.87,0.03981,,48,HepG2,MTT,"Fan, 2021, J. Mol. Liq.",10.1016/j.molliq.2021.115837,
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium 2-(4-isobutylphenyl)propanoate,C19H28N2O3,1808932-91-3,O=C([O-])C(C1=CC=C(C=C1)CC(C)C)C.OCC[N+]=1C=CN(C1)C,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.Cn1cc[n+](CCO)c1,332.444,2.5,0.298 (ND),36,HaCat,MTT,"Wu, 2019, J. Hazard. Mater.",10.1016/j.molliq.2019.03.046,
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C8H11F6N3O5S2,174899-86-6,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.OCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCO)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,407.314,5.18,0.19 (SD),72,NHDF,MTS,"Musiał, 2021, ACS Sustain. Chem. Eng.",10.1021/acssuschemeng.1c02277,
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C8H11F6N3O5S2,174899-86-6,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.OCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCO)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,407.314,5.8,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium chloride,C6H11ClN2O,61755-34-8,[Cl-].OCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCO)c1.[Cl-],162.62,116.51,78.38-154.64 (CI),24,CaCo-2,MTS,"Vavina, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.118673,
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium chloride,C6H11ClN2O,61755-34-8,[Cl-].OCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCO)c1.[Cl-],162.62,5.68,0.256 (ND),36,HaCat,MTT,"Wu, 2019, J. Hazard. Mater.",10.1016/j.molliq.2019.03.046,
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium cinnamate,C15H18N2O3,,CN1C=C[N+](CCO)=C1.O=C([O-])/C=C/C2=CC=CC=C2,Cn1cc[n+](CCO)c1.O=C([O-])/C=C/c1ccccc1,274.32,17.86,12.23-23.48 (CI),24,CaCo-2,MTS,"Vavina, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.118673,
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate,C10H23N3O8P2,,CN1C=C[N+](CCO)=C1.O=P([O-])(O)C(P(O)(O)=O)(CCCN)O,Cn1cc[n+](CCO)c1.NCCCC(O)(P(=O)([O-])O)P(=O)(O)O,375.255,2.19,0.32 (ND),24,GF,MTT,"Teixeira, 2020, Pharmaceutics",10.3390/pharmaceutics12030293,"GF, human gingival fibroblasts."
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate,C10H23N3O8P2,,CN1C=C[N+](CCO)=C1.O=P([O-])(O)C(P(O)(O)=O)(CCCN)O,Cn1cc[n+](CCO)c1.NCCCC(O)(P(=O)([O-])O)P(=O)(O)O,375.255,4.54,0.66 (ND),72,GF,MTT,"Teixeira, 2020, Pharmaceutics",10.3390/pharmaceutics12030293,"GF, human gingival fibroblasts."
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate,C10H23N3O8P2,,CN1C=C[N+](CCO)=C1.O=P([O-])(O)C(P(O)(O)=O)(CCCN)O,Cn1cc[n+](CCO)c1.NCCCC(O)(P(=O)([O-])O)P(=O)(O)O,375.255,0.00592,0.00069 (ND),24,T-47D,MTT,"Teixeira, 2020, Pharmaceutics",10.3390/pharmaceutics12030293,
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate,C10H23N3O8P2,,CN1C=C[N+](CCO)=C1.O=P([O-])(O)C(P(O)(O)=O)(CCCN)O,Cn1cc[n+](CCO)c1.NCCCC(O)(P(=O)([O-])O)P(=O)(O)O,375.255,0.0114,0.0025 (ND),72,T-47D,MTT,"Teixeira, 2020, Pharmaceutics",10.3390/pharmaceutics12030293,
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate,C10H23N3O8P2,,CN1C=C[N+](CCO)=C1.O=P([O-])(O)C(P(O)(O)=O)(CCCN)O,Cn1cc[n+](CCO)c1.NCCCC(O)(P(=O)([O-])O)P(=O)(O)O,375.255,2.1e-06,0.00000037 (ND),24,A549,MTT,"Teixeira, 2020, Pharmaceutics",10.3390/pharmaceutics12030293,
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate,C10H23N3O8P2,,CN1C=C[N+](CCO)=C1.O=P([O-])(O)C(P(O)(O)=O)(CCCN)O,Cn1cc[n+](CCO)c1.NCCCC(O)(P(=O)([O-])O)P(=O)(O)O,375.255,5.65e-06,0.00000046 (ND),72,A549,MTT,"Teixeira, 2020, Pharmaceutics",10.3390/pharmaceutics12030293,
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate,C10H23N3O8P2,,CN1C=C[N+](CCO)=C1.O=P([O-])(O)C(P(O)(O)=O)(CCCN)O,Cn1cc[n+](CCO)c1.NCCCC(O)(P(=O)([O-])O)P(=O)(O)O,375.255,5.16e-05,0.0000067 (ND),24,MG63,MTT,"Teixeira, 2020, Pharmaceutics",10.3390/pharmaceutics12030293,
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate,C10H23N3O8P2,,CN1C=C[N+](CCO)=C1.O=P([O-])(O)C(P(O)(O)=O)(CCCN)O,Cn1cc[n+](CCO)c1.NCCCC(O)(P(=O)([O-])O)P(=O)(O)O,375.255,9.57e-05,0.0000091 (ND),72,MG63,MTT,"Teixeira, 2020, Pharmaceutics",10.3390/pharmaceutics12030293,
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium iodide,C6H11IN2O,1012794-00-1,[I-].OCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCO)c1.[I-],254.071,>20,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2O,374564-83-7,F[B-](F)(F)F.OCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCO)c1.F[B-](F)(F)F,213.971,25.45,0.07 (SEM),24,NIH/3T3,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2O,374564-83-7,F[B-](F)(F)F.OCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCO)c1.F[B-](F)(F)F,213.971,72.12,68.72-75.52 (CI),24,U937,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2O,374564-83-7,F[B-](F)(F)F.OCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCO)c1.F[B-](F)(F)F,213.971,51.41,48.91-53.91 (CI),24,Jurkat,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2O,374564-83-7,F[B-](F)(F)F.OCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCO)c1.F[B-](F)(F)F,213.971,64.1,61.00-67.20 (CI),24,HL60,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2O,374564-83-7,F[B-](F)(F)F.OCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCO)c1.F[B-](F)(F)F,213.971,74.78,70.68-78.88 (CI),24,K562,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2O,374564-83-7,F[B-](F)(F)F.OCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCO)c1.F[B-](F)(F)F,213.971,128.45,116.67-140.23 (CI),24,HEK293,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2O,374564-83-7,F[B-](F)(F)F.OCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCO)c1.F[B-](F)(F)F,213.971,125.39,113.85-136.93 (CI),24,A549,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2O,374564-83-7,F[B-](F)(F)F.OCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCO)c1.F[B-](F)(F)F,213.971,97.1,89.97-104.23 (CI),24,A2780,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-(2-methoxyethyl)-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C9H13F6N3O5S2,178631-01-1,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.O(C)CC[N+]=1C=CN(C1)C,COCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,421.341,1.64,0.46 (SD),72,NHDF,MTS,"Musiał, 2021, ACS Sustain. Chem. Eng.",10.1021/acssuschemeng.1c02277,
3-(2-methoxyethyl)-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C9H13F6N3O5S2,178631-01-1,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.O(C)CC[N+]=1C=CN(C1)C,COCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,421.341,1.8,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
3-(2-methoxyethyl)-1-methyl-1H-imidazol-3-ium chloride,C7H13ClN2O,474972-46-8,[Cl-].O(C)CC[N+]=1C=CN(C1)C,COCC[n+]1ccn(C)c1.[Cl-],176.647,>20,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
3-(3-((2-hydroxybenzoyl)oxy)propyl)-1-methyl-1H-imidazol-3-ium chloride,C14H17ClN2O3,1811535-45-1,[Cl-].O=C(OCCC[N+]=1C=CN(C1)C)C=2C=CC=CC2O,Cn1cc[n+](CCCOC(=O)c2ccccc2O)c1.[Cl-],296.754,3.19,0.84-5.54 (CI),24,3215 LS,MTS,"Egorova, 2015, ACS Med. Chem. Lett.",10.1021/acsmedchemlett.5b00258,
3-(3-((2-hydroxybenzoyl)oxy)propyl)-1-methyl-1H-imidazol-3-ium chloride,C14H17ClN2O3,1811535-45-1,[Cl-].O=C(OCCC[N+]=1C=CN(C1)C)C=2C=CC=CC2O,Cn1cc[n+](CCCOC(=O)c2ccccc2O)c1.[Cl-],296.754,2.55,2.08-3.13 (CI),24,CaCo-2,MTS,"Egorova, 2015, ACS Med. Chem. Lett.",10.1021/acsmedchemlett.5b00258,
3-(3-(9H-carbazol-9-yl)propyl)-1-(2-(4-bromophenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C26H23Br2N3O,1870029-70-1,[Br-].O=C(C1=CC=C(Br)C=C1)CN2C=C[N+](=C2)CCCN3C=4C=CC=CC4C=5C=CC=CC53,O=C(Cn1cc[n+](CCCn2c3ccccc3c3ccccc32)c1)c1ccc(Br)cc1.[Br-],553.298,0.00338,,48,HL60,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(2-(4-bromophenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C26H23Br2N3O,1870029-70-1,[Br-].O=C(C1=CC=C(Br)C=C1)CN2C=C[N+](=C2)CCCN3C=4C=CC=CC4C=5C=CC=CC53,O=C(Cn1cc[n+](CCCn2c3ccccc3c3ccccc32)c1)c1ccc(Br)cc1.[Br-],553.298,0.01189,,48,SMMC-7721,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(2-(4-bromophenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C26H23Br2N3O,1870029-70-1,[Br-].O=C(C1=CC=C(Br)C=C1)CN2C=C[N+](=C2)CCCN3C=4C=CC=CC4C=5C=CC=CC53,O=C(Cn1cc[n+](CCCn2c3ccccc3c3ccccc32)c1)c1ccc(Br)cc1.[Br-],553.298,0.01962,,48,A549,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(2-(4-bromophenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C26H23Br2N3O,1870029-70-1,[Br-].O=C(C1=CC=C(Br)C=C1)CN2C=C[N+](=C2)CCCN3C=4C=CC=CC4C=5C=CC=CC53,O=C(Cn1cc[n+](CCCn2c3ccccc3c3ccccc32)c1)c1ccc(Br)cc1.[Br-],553.298,0.00874,,48,MCF-7,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(2-(4-bromophenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C26H23Br2N3O,1870029-70-1,[Br-].O=C(C1=CC=C(Br)C=C1)CN2C=C[N+](=C2)CCCN3C=4C=CC=CC4C=5C=CC=CC53,O=C(Cn1cc[n+](CCCn2c3ccccc3c3ccccc32)c1)c1ccc(Br)cc1.[Br-],553.298,0.01249,,48,SW480,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C27H26BrN3O2,1870029-66-5,[Br-].O=C(C1=CC=C(OC)C=C1)CN2C=C[N+](=C2)CCCN3C=4C=CC=CC4C=5C=CC=CC53,COc1ccc(C(=O)Cn2cc[n+](CCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],504.428,0.00244,,48,HL60,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C27H26BrN3O2,1870029-66-5,[Br-].O=C(C1=CC=C(OC)C=C1)CN2C=C[N+](=C2)CCCN3C=4C=CC=CC4C=5C=CC=CC53,COc1ccc(C(=O)Cn2cc[n+](CCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],504.428,0.01383,,48,SMMC-7721,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C27H26BrN3O2,1870029-66-5,[Br-].O=C(C1=CC=C(OC)C=C1)CN2C=C[N+](=C2)CCCN3C=4C=CC=CC4C=5C=CC=CC53,COc1ccc(C(=O)Cn2cc[n+](CCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],504.428,0.02511,,48,A549,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C27H26BrN3O2,1870029-66-5,[Br-].O=C(C1=CC=C(OC)C=C1)CN2C=C[N+](=C2)CCCN3C=4C=CC=CC4C=5C=CC=CC53,COc1ccc(C(=O)Cn2cc[n+](CCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],504.428,0.00878,,48,MCF-7,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C27H26BrN3O2,1870029-66-5,[Br-].O=C(C1=CC=C(OC)C=C1)CN2C=C[N+](=C2)CCCN3C=4C=CC=CC4C=5C=CC=CC53,COc1ccc(C(=O)Cn2cc[n+](CCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],504.428,0.01961,,48,SW480,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(2-(naphthalen-2-yl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C30H26BrN3O,1870029-68-7,[Br-].O=C(C=1C=CC=2C=CC=CC2C1)CN3C=C[N+](=C3)CCCN4C=5C=CC=CC5C=6C=CC=CC64,O=C(Cn1cc[n+](CCCn2c3ccccc3c3ccccc32)c1)c1ccc2ccccc2c1.[Br-],524.462,0.00279,,48,HL60,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(2-(naphthalen-2-yl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C30H26BrN3O,1870029-68-7,[Br-].O=C(C=1C=CC=2C=CC=CC2C1)CN3C=C[N+](=C3)CCCN4C=5C=CC=CC5C=6C=CC=CC64,O=C(Cn1cc[n+](CCCn2c3ccccc3c3ccccc32)c1)c1ccc2ccccc2c1.[Br-],524.462,0.00699,,48,SMMC-7721,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(2-(naphthalen-2-yl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C30H26BrN3O,1870029-68-7,[Br-].O=C(C=1C=CC=2C=CC=CC2C1)CN3C=C[N+](=C3)CCCN4C=5C=CC=CC5C=6C=CC=CC64,O=C(Cn1cc[n+](CCCn2c3ccccc3c3ccccc32)c1)c1ccc2ccccc2c1.[Br-],524.462,0.01544,,48,A549,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(2-(naphthalen-2-yl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C30H26BrN3O,1870029-68-7,[Br-].O=C(C=1C=CC=2C=CC=CC2C1)CN3C=C[N+](=C3)CCCN4C=5C=CC=CC5C=6C=CC=CC64,O=C(Cn1cc[n+](CCCn2c3ccccc3c3ccccc32)c1)c1ccc2ccccc2c1.[Br-],524.462,0.0046,,48,MCF-7,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(2-(naphthalen-2-yl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C30H26BrN3O,1870029-68-7,[Br-].O=C(C=1C=CC=2C=CC=CC2C1)CN3C=C[N+](=C3)CCCN4C=5C=CC=CC5C=6C=CC=CC64,O=C(Cn1cc[n+](CCCn2c3ccccc3c3ccccc32)c1)c1ccc2ccccc2c1.[Br-],524.462,0.00953,,48,SW480,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(2-oxo-2-phenylethyl)-1H-imidazol-3-ium bromide,C26H24BrN3O,1870029-64-3,[Br-].O=C(C=1C=CC=CC1)CN2C=C[N+](=C2)CCCN3C=4C=CC=CC4C=5C=CC=CC53,O=C(Cn1cc[n+](CCCn2c3ccccc3c3ccccc32)c1)c1ccccc1.[Br-],474.402,0.00623,,48,HL60,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(2-oxo-2-phenylethyl)-1H-imidazol-3-ium bromide,C26H24BrN3O,1870029-64-3,[Br-].O=C(C=1C=CC=CC1)CN2C=C[N+](=C2)CCCN3C=4C=CC=CC4C=5C=CC=CC53,O=C(Cn1cc[n+](CCCn2c3ccccc3c3ccccc32)c1)c1ccccc1.[Br-],474.402,0.02462,,48,SMMC-7721,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(2-oxo-2-phenylethyl)-1H-imidazol-3-ium bromide,C26H24BrN3O,1870029-64-3,[Br-].O=C(C=1C=CC=CC1)CN2C=C[N+](=C2)CCCN3C=4C=CC=CC4C=5C=CC=CC53,O=C(Cn1cc[n+](CCCn2c3ccccc3c3ccccc32)c1)c1ccccc1.[Br-],474.402,>0.040,,48,A549,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(2-oxo-2-phenylethyl)-1H-imidazol-3-ium bromide,C26H24BrN3O,1870029-64-3,[Br-].O=C(C=1C=CC=CC1)CN2C=C[N+](=C2)CCCN3C=4C=CC=CC4C=5C=CC=CC53,O=C(Cn1cc[n+](CCCn2c3ccccc3c3ccccc32)c1)c1ccccc1.[Br-],474.402,0.01239,,48,MCF-7,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(2-oxo-2-phenylethyl)-1H-imidazol-3-ium bromide,C26H24BrN3O,1870029-64-3,[Br-].O=C(C=1C=CC=CC1)CN2C=C[N+](=C2)CCCN3C=4C=CC=CC4C=5C=CC=CC53,O=C(Cn1cc[n+](CCCn2c3ccccc3c3ccccc32)c1)c1ccccc1.[Br-],474.402,>0.040,,48,SW480,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(4-bromobenzyl)-1H-imidazol-3-ium bromide,C25H23Br2N3,1870029-72-3,[Br-].BrC1=CC=C(C=C1)CN2C=C[N+](=C2)CCCN3C=4C=CC=CC4C=5C=CC=CC53,Brc1ccc(Cn2cc[n+](CCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],525.288,0.00309,,48,HL60,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(4-bromobenzyl)-1H-imidazol-3-ium bromide,C25H23Br2N3,1870029-72-3,[Br-].BrC1=CC=C(C=C1)CN2C=C[N+](=C2)CCCN3C=4C=CC=CC4C=5C=CC=CC53,Brc1ccc(Cn2cc[n+](CCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],525.288,0.01348,,48,SMMC-7721,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(4-bromobenzyl)-1H-imidazol-3-ium bromide,C25H23Br2N3,1870029-72-3,[Br-].BrC1=CC=C(C=C1)CN2C=C[N+](=C2)CCCN3C=4C=CC=CC4C=5C=CC=CC53,Brc1ccc(Cn2cc[n+](CCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],525.288,0.02478,,48,A549,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(4-bromobenzyl)-1H-imidazol-3-ium bromide,C25H23Br2N3,1870029-72-3,[Br-].BrC1=CC=C(C=C1)CN2C=C[N+](=C2)CCCN3C=4C=CC=CC4C=5C=CC=CC53,Brc1ccc(Cn2cc[n+](CCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],525.288,0.00825,,48,MCF-7,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(4-bromobenzyl)-1H-imidazol-3-ium bromide,C25H23Br2N3,1870029-72-3,[Br-].BrC1=CC=C(C=C1)CN2C=C[N+](=C2)CCCN3C=4C=CC=CC4C=5C=CC=CC53,Brc1ccc(Cn2cc[n+](CCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],525.288,0.0122,,48,SW480,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(4-methylbenzyl)-1H-imidazol-3-ium bromide,C26H26BrN3,1870029-74-5,[Br-].C=1C=CC2=C(C1)C=3C=CC=CC3N2CCC[N+]=4C=CN(C4)CC5=CC=C(C=C5)C,Cc1ccc(Cn2cc[n+](CCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],460.419,0.00215,,48,HL60,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(4-methylbenzyl)-1H-imidazol-3-ium bromide,C26H26BrN3,1870029-74-5,[Br-].C=1C=CC2=C(C1)C=3C=CC=CC3N2CCC[N+]=4C=CN(C4)CC5=CC=C(C=C5)C,Cc1ccc(Cn2cc[n+](CCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],460.419,0.01365,,48,SMMC-7721,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(4-methylbenzyl)-1H-imidazol-3-ium bromide,C26H26BrN3,1870029-74-5,[Br-].C=1C=CC2=C(C1)C=3C=CC=CC3N2CCC[N+]=4C=CN(C4)CC5=CC=C(C=C5)C,Cc1ccc(Cn2cc[n+](CCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],460.419,0.01982,,48,A549,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(4-methylbenzyl)-1H-imidazol-3-ium bromide,C26H26BrN3,1870029-74-5,[Br-].C=1C=CC2=C(C1)C=3C=CC=CC3N2CCC[N+]=4C=CN(C4)CC5=CC=C(C=C5)C,Cc1ccc(Cn2cc[n+](CCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],460.419,0.0069,,48,MCF-7,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(9H-carbazol-9-yl)propyl)-1-(4-methylbenzyl)-1H-imidazol-3-ium bromide,C26H26BrN3,1870029-74-5,[Br-].C=1C=CC2=C(C1)C=3C=CC=CC3N2CCC[N+]=4C=CN(C4)CC5=CC=C(C=C5)C,Cc1ccc(Cn2cc[n+](CCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],460.419,0.01498,,48,SW480,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(3-(dimethylamino)propyl)-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C11H18F6N4O4S2,1376707-92-4,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCN(C)C,CN(C)CCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,448.411,1.1,0.21 (SD),72,CCO,WST-1,"Cvjetko Bubalo, 2015, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2014.10.029,
3-(3-carboxypropyl)-1-methyl-1H-imidazol-3-ium chloride,C8H13ClN2O2,805228-35-7,[Cl-].CN1C=[N+](CCCC(O)=O)C=C1,Cn1cc[n+](CCCC(=O)O)c1.[Cl-],204.657,>3.020,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=3.48 (uM)
3-(3-hydroxypropyl)-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C14H18N2O4,2097306-48-2,O=C([O-])C=1C=CC=CC1O.OCCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCCO)c1.O=C([O-])c1ccccc1O,278.308,>0.1,,72,MCF-7,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
3-(3-hydroxypropyl)-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C14H18N2O4,2097306-48-2,O=C([O-])C=1C=CC=CC1O.OCCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCCO)c1.O=C([O-])c1ccccc1O,278.308,>0.1,,72,MDA-MB-231,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
3-(3-hydroxypropyl)-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C14H18N2O4,2097306-48-2,O=C([O-])C=1C=CC=CC1O.OCCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCCO)c1.O=C([O-])c1ccccc1O,278.308,>0.1,,72,PC3,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
3-(3-hydroxypropyl)-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C14H18N2O4,2097306-48-2,O=C([O-])C=1C=CC=CC1O.OCCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCCO)c1.O=C([O-])c1ccccc1O,278.308,>0.1,,72,HeLa,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
3-(3-hydroxypropyl)-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C14H18N2O4,2097306-48-2,O=C([O-])C=1C=CC=CC1O.OCCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCCO)c1.O=C([O-])c1ccccc1O,278.308,>0.1,,72,HT29,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
3-(3-hydroxypropyl)-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C14H18N2O4,2097306-48-2,O=C([O-])C=1C=CC=CC1O.OCCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCCO)c1.O=C([O-])c1ccccc1O,278.308,>0.1,,72,A549,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
3-(3-hydroxypropyl)-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C9H13F6N3O5S2,827027-30-5,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.OCCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCCO)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,421.341,4.6,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
3-(3-hydroxypropyl)-1-methyl-1H-imidazol-3-ium chloride,C7H13ClN2O,355011-34-6,[Cl-].OCCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCCO)c1.[Cl-],176.647,>20,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
3-(3-methoxypropyl)-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C10H15F6N3O5S2,1015254-36-0,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.O(C)CCC[N+]=1C=CN(C1)C,COCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,435.368,2.2,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
3-(3-methoxypropyl)-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2O,1012794-06-7,[Cl-].O(C)CCC[N+]=1C=CN(C1)C,COCCC[n+]1ccn(C)c1.[Cl-],190.674,>20,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
3-(4-(9H-carbazol-9-yl)butyl)-1-(2-(4-bromophenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C27H25Br2N3O,1870029-98-3,[Br-].O=C(C1=CC=C(Br)C=C1)CN2C=C[N+](=C2)CCCCN3C=4C=CC=CC4C=5C=CC=CC53,O=C(Cn1cc[n+](CCCCn2c3ccccc3c3ccccc32)c1)c1ccc(Br)cc1.[Br-],567.325,0.00242,,48,HL60,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(2-(4-bromophenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C27H25Br2N3O,1870029-98-3,[Br-].O=C(C1=CC=C(Br)C=C1)CN2C=C[N+](=C2)CCCCN3C=4C=CC=CC4C=5C=CC=CC53,O=C(Cn1cc[n+](CCCCn2c3ccccc3c3ccccc32)c1)c1ccc(Br)cc1.[Br-],567.325,0.01022,,48,SMMC-7721,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(2-(4-bromophenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C27H25Br2N3O,1870029-98-3,[Br-].O=C(C1=CC=C(Br)C=C1)CN2C=C[N+](=C2)CCCCN3C=4C=CC=CC4C=5C=CC=CC53,O=C(Cn1cc[n+](CCCCn2c3ccccc3c3ccccc32)c1)c1ccc(Br)cc1.[Br-],567.325,0.0157,,48,A549,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(2-(4-bromophenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C27H25Br2N3O,1870029-98-3,[Br-].O=C(C1=CC=C(Br)C=C1)CN2C=C[N+](=C2)CCCCN3C=4C=CC=CC4C=5C=CC=CC53,O=C(Cn1cc[n+](CCCCn2c3ccccc3c3ccccc32)c1)c1ccc(Br)cc1.[Br-],567.325,0.00395,,48,MCF-7,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(2-(4-bromophenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C27H25Br2N3O,1870029-98-3,[Br-].O=C(C1=CC=C(Br)C=C1)CN2C=C[N+](=C2)CCCCN3C=4C=CC=CC4C=5C=CC=CC53,O=C(Cn1cc[n+](CCCCn2c3ccccc3c3ccccc32)c1)c1ccc(Br)cc1.[Br-],567.325,0.01416,,48,SW480,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C28H28BrN3O2,1870029-96-1,[Br-].O=C(C1=CC=C(OC)C=C1)CN2C=C[N+](=C2)CCCCN3C=4C=CC=CC4C=5C=CC=CC53,COc1ccc(C(=O)Cn2cc[n+](CCCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],518.455,0.00134,,48,HL60,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C28H28BrN3O2,1870029-96-1,[Br-].O=C(C1=CC=C(OC)C=C1)CN2C=C[N+](=C2)CCCCN3C=4C=CC=CC4C=5C=CC=CC53,COc1ccc(C(=O)Cn2cc[n+](CCCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],518.455,0.00841,,48,SMMC-7721,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C28H28BrN3O2,1870029-96-1,[Br-].O=C(C1=CC=C(OC)C=C1)CN2C=C[N+](=C2)CCCCN3C=4C=CC=CC4C=5C=CC=CC53,COc1ccc(C(=O)Cn2cc[n+](CCCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],518.455,0.01107,,48,A549,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C28H28BrN3O2,1870029-96-1,[Br-].O=C(C1=CC=C(OC)C=C1)CN2C=C[N+](=C2)CCCCN3C=4C=CC=CC4C=5C=CC=CC53,COc1ccc(C(=O)Cn2cc[n+](CCCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],518.455,0.00254,,48,MCF-7,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C28H28BrN3O2,1870029-96-1,[Br-].O=C(C1=CC=C(OC)C=C1)CN2C=C[N+](=C2)CCCCN3C=4C=CC=CC4C=5C=CC=CC53,COc1ccc(C(=O)Cn2cc[n+](CCCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],518.455,0.01174,,48,SW480,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(2-bromobenzyl)-1H-imidazol-3-ium bromide,C26H25Br2N3,1870030-04-8,[Br-].BrC=1C=CC=CC1CN2C=C[N+](=C2)CCCCN3C=4C=CC=CC4C=5C=CC=CC53,Brc1ccccc1Cn1cc[n+](CCCCn2c3ccccc3c3ccccc32)c1.[Br-],539.315,0.00049,,48,HL60,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(2-bromobenzyl)-1H-imidazol-3-ium bromide,C26H25Br2N3,1870030-04-8,[Br-].BrC=1C=CC=CC1CN2C=C[N+](=C2)CCCCN3C=4C=CC=CC4C=5C=CC=CC53,Brc1ccccc1Cn1cc[n+](CCCCn2c3ccccc3c3ccccc32)c1.[Br-],539.315,0.00304,,48,SMMC-7721,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(2-bromobenzyl)-1H-imidazol-3-ium bromide,C26H25Br2N3,1870030-04-8,[Br-].BrC=1C=CC=CC1CN2C=C[N+](=C2)CCCCN3C=4C=CC=CC4C=5C=CC=CC53,Brc1ccccc1Cn1cc[n+](CCCCn2c3ccccc3c3ccccc32)c1.[Br-],539.315,0.00292,,48,A549,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(2-bromobenzyl)-1H-imidazol-3-ium bromide,C26H25Br2N3,1870030-04-8,[Br-].BrC=1C=CC=CC1CN2C=C[N+](=C2)CCCCN3C=4C=CC=CC4C=5C=CC=CC53,Brc1ccccc1Cn1cc[n+](CCCCn2c3ccccc3c3ccccc32)c1.[Br-],539.315,0.00195,,48,MCF-7,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(2-bromobenzyl)-1H-imidazol-3-ium bromide,C26H25Br2N3,1870030-04-8,[Br-].BrC=1C=CC=CC1CN2C=C[N+](=C2)CCCCN3C=4C=CC=CC4C=5C=CC=CC53,Brc1ccccc1Cn1cc[n+](CCCCn2c3ccccc3c3ccccc32)c1.[Br-],539.315,0.00433,,48,SW480,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(2-oxo-2-phenylethyl)-1H-imidazol-3-ium bromide,C27H26BrN3O,1870030-00-4,[Br-].O=C(C=1C=CC=CC1)CN2C=C[N+](=C2)CCCCN3C=4C=CC=CC4C=5C=CC=CC53,O=C(Cn1cc[n+](CCCCn2c3ccccc3c3ccccc32)c1)c1ccccc1.[Br-],488.429,0.00298,,48,NHDF,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(2-oxo-2-phenylethyl)-1H-imidazol-3-ium bromide,C27H26BrN3O,1870030-00-4,[Br-].O=C(C=1C=CC=CC1)CN2C=C[N+](=C2)CCCCN3C=4C=CC=CC4C=5C=CC=CC53,O=C(Cn1cc[n+](CCCCn2c3ccccc3c3ccccc32)c1)c1ccccc1.[Br-],488.429,0.01169,,48,SMMC-7721,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(2-oxo-2-phenylethyl)-1H-imidazol-3-ium bromide,C27H26BrN3O,1870030-00-4,[Br-].O=C(C=1C=CC=CC1)CN2C=C[N+](=C2)CCCCN3C=4C=CC=CC4C=5C=CC=CC53,O=C(Cn1cc[n+](CCCCn2c3ccccc3c3ccccc32)c1)c1ccccc1.[Br-],488.429,0.01904,,48,A549,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(2-oxo-2-phenylethyl)-1H-imidazol-3-ium bromide,C27H26BrN3O,1870030-00-4,[Br-].O=C(C=1C=CC=CC1)CN2C=C[N+](=C2)CCCCN3C=4C=CC=CC4C=5C=CC=CC53,O=C(Cn1cc[n+](CCCCn2c3ccccc3c3ccccc32)c1)c1ccccc1.[Br-],488.429,0.01998,,48,MCF-7,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(2-oxo-2-phenylethyl)-1H-imidazol-3-ium bromide,C27H26BrN3O,1870030-00-4,[Br-].O=C(C=1C=CC=CC1)CN2C=C[N+](=C2)CCCCN3C=4C=CC=CC4C=5C=CC=CC53,O=C(Cn1cc[n+](CCCCn2c3ccccc3c3ccccc32)c1)c1ccccc1.[Br-],488.429,0.01639,,48,SW480,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(4-methylbenzyl)-1H-imidazol-3-ium bromide,C27H28BrN3,1870030-02-6,[Br-].C=1C=CC2=C(C1)C=3C=CC=CC3N2CCCC[N+]=4C=CN(C4)CC5=CC=C(C=C5)C,Cc1ccc(Cn2cc[n+](CCCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],474.446,0.00084,,48,HL60,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(4-methylbenzyl)-1H-imidazol-3-ium bromide,C27H28BrN3,1870030-02-6,[Br-].C=1C=CC2=C(C1)C=3C=CC=CC3N2CCCC[N+]=4C=CN(C4)CC5=CC=C(C=C5)C,Cc1ccc(Cn2cc[n+](CCCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],474.446,0.00574,,48,SMMC-7721,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(4-methylbenzyl)-1H-imidazol-3-ium bromide,C27H28BrN3,1870030-02-6,[Br-].C=1C=CC2=C(C1)C=3C=CC=CC3N2CCCC[N+]=4C=CN(C4)CC5=CC=C(C=C5)C,Cc1ccc(Cn2cc[n+](CCCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],474.446,0.00392,,48,A549,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(4-methylbenzyl)-1H-imidazol-3-ium bromide,C27H28BrN3,1870030-02-6,[Br-].C=1C=CC2=C(C1)C=3C=CC=CC3N2CCCC[N+]=4C=CN(C4)CC5=CC=C(C=C5)C,Cc1ccc(Cn2cc[n+](CCCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],474.446,0.00224,,48,MCF-7,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(9H-carbazol-9-yl)butyl)-1-(4-methylbenzyl)-1H-imidazol-3-ium bromide,C27H28BrN3,1870030-02-6,[Br-].C=1C=CC2=C(C1)C=3C=CC=CC3N2CCCC[N+]=4C=CN(C4)CC5=CC=C(C=C5)C,Cc1ccc(Cn2cc[n+](CCCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],474.446,0.00956,,48,SW480,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(4-(ethoxycarbonyl)phenyl)-1-hexyl-1H-imidazol-3-ium bromide,C18H25BrN2O2,1176198-66-5,[Br-].O=C(OCC)C=1C=CC(=CC1)[N+]=2C=CN(C2)CCCCCC,CCCCCCn1cc[n+](-c2ccc(C(=O)OCC)cc2)c1.[Br-],381.314,0.095,0.091-0.100 (CI),?,IPC-81,WST-1,"Stolte, 2013, ACS Sustain. Chem. Eng.",10.1021/sc300146t,
3-(4-chlorobenzyl)-1-methyl-1H-imidazol-3-ium chloride,C11H12Cl2N2,1010707-48-8,[Cl-].ClC1=CC=C(C=C1)C[N+]=2C=CN(C2)C,Cn1cc[n+](Cc2ccc(Cl)cc2)c1.[Cl-],243.137,4.58,0.51 (SD),24,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-(4-chlorobenzyl)-1-methyl-1H-imidazol-3-ium chloride,C11H12Cl2N2,1010707-48-8,[Cl-].ClC1=CC=C(C=C1)C[N+]=2C=CN(C2)C,Cn1cc[n+](Cc2ccc(Cl)cc2)c1.[Cl-],243.137,1.07,0.12 (SD),48,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-(4-ethoxyphenyl)-1-pentyl-1H-imidazol-3-ium bromide,C16H23BrN2O,1421755-21-6,[Br-].O(C=1C=CC(=CC1)[N+]=2C=CN(C2)CCCCC)CC,CCCCCn1cc[n+](-c2ccc(OCC)cc2)c1.[Br-],339.277,0.036,0.033-0.040 (CI),?,IPC-81,WST-1,"Stolte, 2013, ACS Sustain. Chem. Eng.",10.1021/sc300146t,
3-(4-fluorobenzyl)-1-methyl-1H-imidazol-3-ium chloride,C11H12ClFN2,1010707-49-9,[Cl-].FC1=CC=C(C=C1)C[N+]=2C=CN(C2)C,Cn1cc[n+](Cc2ccc(F)cc2)c1.[Cl-],226.682,20.37,7.28 (SD),24,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-(4-fluorobenzyl)-1-methyl-1H-imidazol-3-ium chloride,C11H12ClFN2,1010707-49-9,[Cl-].FC1=CC=C(C=C1)C[N+]=2C=CN(C2)C,Cn1cc[n+](Cc2ccc(F)cc2)c1.[Cl-],226.682,2.78,0.99 (SD),48,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-(4-hydroxybutyl)-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2O,864665-30-5,[Cl-].OCCCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCCCO)c1.[Cl-],190.674,195.32,165.61 -225.03 (CI),24,CaCo-2,MTS,"Vavina, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.118673,
3-(4-hydroxybutyl)-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2O,864665-30-5,[Cl-].OCCCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCCCO)c1.[Cl-],190.674,>3.020,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=3.48 (uM)
3-(4-hydroxybutyl)-1-methyl-1H-imidazol-3-ium cinnamate,C17H22N2O3,,CN1C=C[N+](CCCCO)=C1.O=C([O-])/C=C/C2=CC=CC=C2,Cn1cc[n+](CCCCO)c1.O=C([O-])/C=C/c1ccccc1,302.374,9.27,6.51 -12.04 (CI),24,CaCo-2,MTS,"Vavina, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.118673,
3-(5-(9H-carbazol-9-yl)pentyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C29H30BrN3O2,1870030-31-1,[Br-].O=C(C1=CC=C(OC)C=C1)CN2C=C[N+](=C2)CCCCCN3C=4C=CC=CC4C=5C=CC=CC53,COc1ccc(C(=O)Cn2cc[n+](CCCCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],532.482,0.00068,,48,HL60,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(5-(9H-carbazol-9-yl)pentyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C29H30BrN3O2,1870030-31-1,[Br-].O=C(C1=CC=C(OC)C=C1)CN2C=C[N+](=C2)CCCCCN3C=4C=CC=CC4C=5C=CC=CC53,COc1ccc(C(=O)Cn2cc[n+](CCCCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],532.482,0.00634,,48,SMMC-7721,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(5-(9H-carbazol-9-yl)pentyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C29H30BrN3O2,1870030-31-1,[Br-].O=C(C1=CC=C(OC)C=C1)CN2C=C[N+](=C2)CCCCCN3C=4C=CC=CC4C=5C=CC=CC53,COc1ccc(C(=O)Cn2cc[n+](CCCCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],532.482,0.00483,,48,A549,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(5-(9H-carbazol-9-yl)pentyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C29H30BrN3O2,1870030-31-1,[Br-].O=C(C1=CC=C(OC)C=C1)CN2C=C[N+](=C2)CCCCCN3C=4C=CC=CC4C=5C=CC=CC53,COc1ccc(C(=O)Cn2cc[n+](CCCCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],532.482,0.00304,,48,MCF-7,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(5-(9H-carbazol-9-yl)pentyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C29H30BrN3O2,1870030-31-1,[Br-].O=C(C1=CC=C(OC)C=C1)CN2C=C[N+](=C2)CCCCCN3C=4C=CC=CC4C=5C=CC=CC53,COc1ccc(C(=O)Cn2cc[n+](CCCCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],532.482,0.00869,,48,SW480,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(5-(9H-carbazol-9-yl)pentyl)-1-(2-(naphthalen-2-yl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C32H30BrN3O,1870030-33-3,[Br-].O=C(C=1C=CC=2C=CC=CC2C1)CN3C=C[N+](=C3)CCCCCN4C=5C=CC=CC5C=6C=CC=CC64,O=C(Cn1cc[n+](CCCCCn2c3ccccc3c3ccccc32)c1)c1ccc2ccccc2c1.[Br-],552.516,0.00087,,48,HL60,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(5-(9H-carbazol-9-yl)pentyl)-1-(2-(naphthalen-2-yl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C32H30BrN3O,1870030-33-3,[Br-].O=C(C=1C=CC=2C=CC=CC2C1)CN3C=C[N+](=C3)CCCCCN4C=5C=CC=CC5C=6C=CC=CC64,O=C(Cn1cc[n+](CCCCCn2c3ccccc3c3ccccc32)c1)c1ccc2ccccc2c1.[Br-],552.516,0.00293,,48,SMMC-7721,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(5-(9H-carbazol-9-yl)pentyl)-1-(2-(naphthalen-2-yl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C32H30BrN3O,1870030-33-3,[Br-].O=C(C=1C=CC=2C=CC=CC2C1)CN3C=C[N+](=C3)CCCCCN4C=5C=CC=CC5C=6C=CC=CC64,O=C(Cn1cc[n+](CCCCCn2c3ccccc3c3ccccc32)c1)c1ccc2ccccc2c1.[Br-],552.516,0.00299,,48,A549,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(5-(9H-carbazol-9-yl)pentyl)-1-(2-(naphthalen-2-yl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C32H30BrN3O,1870030-33-3,[Br-].O=C(C=1C=CC=2C=CC=CC2C1)CN3C=C[N+](=C3)CCCCCN4C=5C=CC=CC5C=6C=CC=CC64,O=C(Cn1cc[n+](CCCCCn2c3ccccc3c3ccccc32)c1)c1ccc2ccccc2c1.[Br-],552.516,0.00259,,48,MCF-7,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(5-(9H-carbazol-9-yl)pentyl)-1-(2-(naphthalen-2-yl)-2-oxoethyl)-1H-imidazol-3-ium bromide,C32H30BrN3O,1870030-33-3,[Br-].O=C(C=1C=CC=2C=CC=CC2C1)CN3C=C[N+](=C3)CCCCCN4C=5C=CC=CC5C=6C=CC=CC64,O=C(Cn1cc[n+](CCCCCn2c3ccccc3c3ccccc32)c1)c1ccc2ccccc2c1.[Br-],552.516,0.0045,,48,SW480,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(5-(9H-carbazol-9-yl)pentyl)-1-(4-methylbenzyl)-1H-imidazol-3-ium bromide,C28H30BrN3,1870030-35-5,[Br-].C=1C=CC2=C(C1)C=3C=CC=CC3N2CCCCC[N+]=4C=CN(C4)CC5=CC=C(C=C5)C,Cc1ccc(Cn2cc[n+](CCCCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],488.473,0.00055,,48,HL60,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(5-(9H-carbazol-9-yl)pentyl)-1-(4-methylbenzyl)-1H-imidazol-3-ium bromide,C28H30BrN3,1870030-35-5,[Br-].C=1C=CC2=C(C1)C=3C=CC=CC3N2CCCCC[N+]=4C=CN(C4)CC5=CC=C(C=C5)C,Cc1ccc(Cn2cc[n+](CCCCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],488.473,0.00305,,48,SMMC-7721,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(5-(9H-carbazol-9-yl)pentyl)-1-(4-methylbenzyl)-1H-imidazol-3-ium bromide,C28H30BrN3,1870030-35-5,[Br-].C=1C=CC2=C(C1)C=3C=CC=CC3N2CCCCC[N+]=4C=CN(C4)CC5=CC=C(C=C5)C,Cc1ccc(Cn2cc[n+](CCCCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],488.473,0.00229,,48,A549,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(5-(9H-carbazol-9-yl)pentyl)-1-(4-methylbenzyl)-1H-imidazol-3-ium bromide,C28H30BrN3,1870030-35-5,[Br-].C=1C=CC2=C(C1)C=3C=CC=CC3N2CCCCC[N+]=4C=CN(C4)CC5=CC=C(C=C5)C,Cc1ccc(Cn2cc[n+](CCCCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],488.473,0.00191,,48,MCF-7,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(5-(9H-carbazol-9-yl)pentyl)-1-(4-methylbenzyl)-1H-imidazol-3-ium bromide,C28H30BrN3,1870030-35-5,[Br-].C=1C=CC2=C(C1)C=3C=CC=CC3N2CCCCC[N+]=4C=CN(C4)CC5=CC=C(C=C5)C,Cc1ccc(Cn2cc[n+](CCCCCn3c4ccccc4c4ccccc43)c2)cc1.[Br-],488.473,0.00445,,48,SW480,MTS,"Liu, 2015, Sci. Rep.",10.1038/srep13101,
3-(7-carboxyheptyl)-1-methyl-1H-imidazol-3-ium bromide,C12H21BrN2O2,952429-64-0,[Br-].O=C(O)CCCCCCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCCCCCCC(=O)O)c1.[Br-],305.216,>3.020,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=3.48 (uM)
3-(8-hydroxyoctyl)-1-methyl-1H-imidazol-3-ium bromide,C12H23BrN2O,952429-65-1,[Br-].OCCCCCCCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCCCCCCCO)c1.[Br-],291.233,0.229,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=2.36 (uM)
3-(8-hydroxyoctyl)-1-methyl-1H-imidazol-3-ium chloride,C12H23ClN2O,875574-09-7,[Cl-].OCCCCCCCC[N+]=1C=CN(C1)C,Cn1cc[n+](CCCCCCCCO)c1.[Cl-],246.782,0.194,,24,B-13,MTT,"Hedya, 2023, Toxicol. In Vitro",10.1016/j.tiv.2022.105550,
3-(cyanomethyl)-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C8H8F6N4O4S2,937720-90-6,N#CC[N+]=1C=CN(C1)C.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,Cn1cc[n+](CC#N)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,402.298,8,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
3-(cyanomethyl)-1-methyl-1H-imidazol-3-ium chloride,C6H8ClN3,154312-63-7,[Cl-].N#CC[N+]=1C=CN(C1)C,Cn1cc[n+](CC#N)c1.[Cl-],157.604,>20,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
3-(ethoxymethyl)-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C9H13F6N3O5S2,945996-13-4,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.O(C[N+]=1C=CN(C1)C)CC,CCOC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,421.341,1.6,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
3-(ethoxymethyl)-1-methyl-1H-imidazol-3-ium chloride,C7H13ClN2O,945996-02-1,[Cl-].O(C[N+]=1C=CN(C1)C)CC,CCOC[n+]1ccn(C)c1.[Cl-],176.647,4,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
3-allyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C9H11F6N3O4S2,655249-87-9,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C=CC[N+]=1C=CN(C1)C,C=CC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,403.326,0.55,0.08 (SD),72,CCO,WST-1,"Cvjetko Bubalo, 2015, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2014.10.029,
3-allyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C9H11F6N3O4S2,655249-87-9,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C=CC[N+]=1C=CN(C1)C,C=CC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,403.326,1.63,0.28 (SE),48,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
3-allyl-1-methyl-1H-imidazol-3-ium bromide,C7H11BrN2,31410-07-8,[Br-].C=CC[N+]=1C=CN(C1)C,C=CC[n+]1ccn(C)c1.[Br-],203.083,15,,24,L929,CellQuanti-Blue,"Reiß, 2020, RSC Adv.",10.1039/d0ra01370f,
3-allyl-1-methyl-1H-imidazol-3-ium chloride,C7H11ClN2,65039-10-3,[Cl-].C=CC[N+]=1C=CN(C1)C,C=CC[n+]1ccn(C)c1.[Cl-],158.632,7.04,1.12 (SE),48,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
3-allyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C7H11BF4N2,851606-63-8,F[B-](F)(F)F.C=CC[N+]=1C=CN(C1)C,C=CC[n+]1ccn(C)c1.F[B-](F)(F)F,209.983,7.85,0.88 (SE),48,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
3-benzyl-1-ethyl-1H-imidazol-3-ium bromide,C12H15BrN2,65039-13-6,[Br-].C=1C=CC(=CC1)C[N+]=2C=CN(C2)CC,CCn1cc[n+](Cc2ccccc2)c1.[Br-],267.17,0.22247,,48,K562,SRB,"Starling, 2022, J. Mol. Struct.",10.1016/j.molstruc.2021.132062,
3-benzyl-1-ethyl-1H-imidazol-3-ium bromide,C12H15BrN2,65039-13-6,[Br-].C=1C=CC(=CC1)C[N+]=2C=CN(C2)CC,CCn1cc[n+](Cc2ccccc2)c1.[Br-],267.17,>0.3,,48,SK-OV-3,SRB,"Starling, 2022, J. Mol. Struct.",10.1016/j.molstruc.2021.132062,
3-benzyl-1-ethyl-1H-imidazol-3-ium bromide,C12H15BrN2,65039-13-6,[Br-].C=1C=CC(=CC1)C[N+]=2C=CN(C2)CC,CCn1cc[n+](Cc2ccccc2)c1.[Br-],267.17,>0.3,,48,DU-145,SRB,"Starling, 2022, J. Mol. Struct.",10.1016/j.molstruc.2021.132062,
3-benzyl-1-ethyl-1H-imidazol-3-ium bromide,C12H15BrN2,65039-13-6,[Br-].C=1C=CC(=CC1)C[N+]=2C=CN(C2)CC,CCn1cc[n+](Cc2ccccc2)c1.[Br-],267.17,>0.3,,48,MRC-5,SRB,"Starling, 2022, J. Mol. Struct.",10.1016/j.molstruc.2021.132062,
3-benzyl-1-ethyl-1H-imidazol-3-ium ethyl sulfate,C14H20N2O4S,1106947-27-6,O=S(=O)([O-])OCC.C=1C=CC(=CC1)C[N+]=2C=CN(C2)CC,CCOS(=O)(=O)[O-].CCn1cc[n+](Cc2ccccc2)c1,312.391,14.08,5.00 (SD),24,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-benzyl-1-ethyl-1H-imidazol-3-ium ethyl sulfate,C14H20N2O4S,1106947-27-6,O=S(=O)([O-])OCC.C=1C=CC(=CC1)C[N+]=2C=CN(C2)CC,CCOS(=O)(=O)[O-].CCn1cc[n+](Cc2ccccc2)c1,312.391,10.37,0.61 (SD),48,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-benzyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C13H13F6N3O4S2,433337-24-7,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C=1C=CC(=CC1)C[N+]=2C=CN(C2)C,Cn1cc[n+](Cc2ccccc2)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,453.386,0.31,0.1 (SD),72,CCO,WST-1,"Cvjetko Bubalo, 2015, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2014.10.029,
3-benzyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C13H13F6N3O4S2,433337-24-7,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C=1C=CC(=CC1)C[N+]=2C=CN(C2)C,Cn1cc[n+](Cc2ccccc2)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,453.386,0.33,0.03 (SE),48,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
3-benzyl-1-methyl-1H-imidazol-3-ium bromide,C11H13BrN2,65039-11-4,[Br-].C=1C=CC(=CC1)C[N+]=2C=CN(C2)C,Cn1cc[n+](Cc2ccccc2)c1.[Br-],253.143,1.82,0.26 (SE),24,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
3-benzyl-1-methyl-1H-imidazol-3-ium bromide,C11H13BrN2,65039-11-4,[Br-].C=1C=CC(=CC1)C[N+]=2C=CN(C2)C,Cn1cc[n+](Cc2ccccc2)c1.[Br-],253.143,0.55,0.03 (SE),24,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing without FBS
3-benzyl-1-methyl-1H-imidazol-3-ium bromide,C11H13BrN2,65039-11-4,[Br-].C=1C=CC(=CC1)C[N+]=2C=CN(C2)C,Cn1cc[n+](Cc2ccccc2)c1.[Br-],253.143,0.53,0.05 (SE),48,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
3-benzyl-1-methyl-1H-imidazol-3-ium chloride,C11H13ClN2,36443-80-8,[Cl-].C=1C=CC(=CC1)C[N+]=2C=CN(C2)C,Cn1cc[n+](Cc2ccccc2)c1.[Cl-],208.692,>1,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=3 (uM)
3-benzyl-1-methyl-1H-imidazol-3-ium chloride,C11H13ClN2,36443-80-8,[Cl-].C[N+]1=CN(C=C1)CC2=CC=CC=C2,C[n+]1ccn(Cc2ccccc2)c1.[Cl-],208.692,30.76,6.41 (SD),24,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-benzyl-1-methyl-1H-imidazol-3-ium chloride,C11H13ClN2,36443-80-8,[Cl-].C[N+]1=CN(C=C1)CC2=CC=CC=C2,C[n+]1ccn(Cc2ccccc2)c1.[Cl-],208.692,11.09,0.67 (SD),48,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-benzyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C11H13F6N2P,433337-11-2,F[P-](F)(F)(F)(F)F.C=1C=CC(=CC1)C[N+]=2C=CN(C2)C,Cn1cc[n+](Cc2ccccc2)c1.F[P-](F)(F)(F)(F)F,318.201,>1,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=3 (uM)
3-benzyl-1-methyl-1H-imidazol-3-ium methyl sulfate,C12H16N2O4S,1005735-56-7,O=S(=O)([O-])OC.C=1C=CC(=CC1)C[N+]=2C=CN(C2)C,COS(=O)(=O)[O-].Cn1cc[n+](Cc2ccccc2)c1,284.337,16.96,6.71 (SD),24,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-benzyl-1-methyl-1H-imidazol-3-ium methyl sulfate,C12H16N2O4S,1005735-56-7,O=S(=O)([O-])OC.C=1C=CC(=CC1)C[N+]=2C=CN(C2)C,COS(=O)(=O)[O-].Cn1cc[n+](Cc2ccccc2)c1,284.337,14.13,4.75 (SD),48,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-benzyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C11H13BF4N2,500996-04-3,F[B-](F)(F)F.C=1C=CC(=CC1)C[N+]=2C=CN(C2)C,Cn1cc[n+](Cc2ccccc2)c1.F[B-](F)(F)F,260.043,1.4,0.13 (SE),24,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
3-benzyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C11H13BF4N2,500996-04-3,F[B-](F)(F)F.C=1C=CC(=CC1)C[N+]=2C=CN(C2)C,Cn1cc[n+](Cc2ccccc2)c1.F[B-](F)(F)F,260.043,0.46,0.02 (SE),24,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing without FBS
3-benzyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C11H13BF4N2,500996-04-3,F[B-](F)(F)F.C=1C=CC(=CC1)C[N+]=2C=CN(C2)C,Cn1cc[n+](Cc2ccccc2)c1.F[B-](F)(F)F,260.043,1.78,0.44 (SE),48,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
3-benzyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C11H13BF4N2,500996-04-3,F[B-](F)(F)F.C=1C=CC(=CC1)C[N+]=2C=CN(C2)C,Cn1cc[n+](Cc2ccccc2)c1.F[B-](F)(F)F,260.043,>1,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=3 (uM)
3-butyl-1-((methylthio)methyl)-1H-imidazol-3-ium chloride,C9H17ClN2S,1371548-36-5,[Cl-].S(C)CN1C=C[N+](=C1)CCCC,CCCC[n+]1ccn(CSC)c1.[Cl-],220.769,>0.5,,24,HeLa,MTT,"Bachowska, 2012, ChemistryOPEN",10.1002/open.201100003,
3-butyl-1-((methylthio)methyl)-1H-imidazol-3-ium chloride,C9H17ClN2S,1371548-36-5,[Cl-].S(C)CN1C=C[N+](=C1)CCCC,CCCC[n+]1ccn(CSC)c1.[Cl-],220.769,>0.5,,48,HeLa,MTT,"Bachowska, 2012, ChemistryOPEN",10.1002/open.201100003,
3-butyl-1-((methylthio)methyl)-1H-imidazol-3-ium chloride,C9H17ClN2S,1371548-36-5,[Cl-].S(C)CN1C=C[N+](=C1)CCCC,CCCC[n+]1ccn(CSC)c1.[Cl-],220.769,>0.5,,24,K562,MTT,"Bachowska, 2012, ChemistryOPEN",10.1002/open.201100003,
3-butyl-1-((methylthio)methyl)-1H-imidazol-3-ium chloride,C9H17ClN2S,1371548-36-5,[Cl-].S(C)CN1C=C[N+](=C1)CCCC,CCCC[n+]1ccn(CSC)c1.[Cl-],220.769,>0.5,,48,K562,MTT,"Bachowska, 2012, ChemistryOPEN",10.1002/open.201100003,
3-butyl-1-((methylthio)methyl)-1H-imidazol-3-ium chloride,C9H17ClN2S,1371548-36-5,[Cl-].S(C)CN1C=C[N+](=C1)CCCC,CCCC[n+]1ccn(CSC)c1.[Cl-],220.769,>0.5,,24,HUVEC,MTT,"Bachowska, 2012, ChemistryOPEN",10.1002/open.201100003,
3-butyl-1-((methylthio)methyl)-1H-imidazol-3-ium chloride,C9H17ClN2S,1371548-36-5,[Cl-].S(C)CN1C=C[N+](=C1)CCCC,CCCC[n+]1ccn(CSC)c1.[Cl-],220.769,>0.5,,48,HUVEC,MTT,"Bachowska, 2012, ChemistryOPEN",10.1002/open.201100003,
3-butyl-1-(methoxymethyl)-1H-imidazol-3-ium chloride,C9H17ClN2O,1427172-69-7,[Cl-].O(C)CN1C=C[N+](=C1)CCCC,CCCC[n+]1ccn(COC)c1.[Cl-],204.701,>0.5,,24,HeLa,MTT,"Bachowska, 2012, ChemistryOPEN",10.1002/open.201100003,
3-butyl-1-(methoxymethyl)-1H-imidazol-3-ium chloride,C9H17ClN2O,1427172-69-7,[Cl-].O(C)CN1C=C[N+](=C1)CCCC,CCCC[n+]1ccn(COC)c1.[Cl-],204.701,>0.5,,48,HeLa,MTT,"Bachowska, 2012, ChemistryOPEN",10.1002/open.201100003,
3-butyl-1-(methoxymethyl)-1H-imidazol-3-ium chloride,C9H17ClN2O,1427172-69-7,[Cl-].O(C)CN1C=C[N+](=C1)CCCC,CCCC[n+]1ccn(COC)c1.[Cl-],204.701,>0.5,,24,K562,MTT,"Bachowska, 2012, ChemistryOPEN",10.1002/open.201100003,
3-butyl-1-(methoxymethyl)-1H-imidazol-3-ium chloride,C9H17ClN2O,1427172-69-7,[Cl-].O(C)CN1C=C[N+](=C1)CCCC,CCCC[n+]1ccn(COC)c1.[Cl-],204.701,>0.5,,48,K562,MTT,"Bachowska, 2012, ChemistryOPEN",10.1002/open.201100003,
3-butyl-1-(methoxymethyl)-1H-imidazol-3-ium chloride,C9H17ClN2O,1427172-69-7,[Cl-].O(C)CN1C=C[N+](=C1)CCCC,CCCC[n+]1ccn(COC)c1.[Cl-],204.701,>0.5,,24,HUVEC,MTT,"Bachowska, 2012, ChemistryOPEN",10.1002/open.201100003,
3-butyl-1-(methoxymethyl)-1H-imidazol-3-ium chloride,C9H17ClN2O,1427172-69-7,[Cl-].O(C)CN1C=C[N+](=C1)CCCC,CCCC[n+]1ccn(COC)c1.[Cl-],204.701,>0.5,,48,HUVEC,MTT,"Bachowska, 2012, ChemistryOPEN",10.1002/open.201100003,
"3-butyl-1,2-dimethyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide",C11H17F6N3O4S2,350493-08-2,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=C(N1C)C)CCCC,CCCC[n+]1ccn(C)c1C.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,433.396,0.85,0.34 (SD),72,NHDF,MTS,"Musiał, 2018, ACS Sustain. Chem. Eng.",10.1021/acssuschemeng.8b01317,
"3-butyl-1,2-dimethyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide",C11H17F6N3O4S2,350493-08-2,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.CN1C(C)=[N+](CCCC)C=C1,CCCC[n+]1ccn(C)c1C.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,433.396,0.92,0.86-0.98 (CI),24,Jurkat,Flow cytometry (7AAD),"Dzhemileva, 2024, Chemosphere",10.1016/j.chemosphere.2024.142964,
"3-butyl-1,2-dimethyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide",C11H17F6N3O4S2,350493-08-2,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.CN1C(C)=[N+](CCCC)C=C1,CCCC[n+]1ccn(C)c1C.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,433.396,2.76,2.51-3.01 (CI),24,U937,Flow cytometry (7AAD),"Dzhemileva, 2024, Chemosphere",10.1016/j.chemosphere.2024.142964,
"3-butyl-1,2-dimethyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide",C11H17F6N3O4S2,350493-08-2,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.CN1C(C)=[N+](CCCC)C=C1,CCCC[n+]1ccn(C)c1C.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,433.396,5.64,5.11-6.17 (CI),24,K562,Flow cytometry (7AAD),"Dzhemileva, 2024, Chemosphere",10.1016/j.chemosphere.2024.142964,
"3-butyl-1,2-dimethyl-1H-imidazol-3-ium hexafluorophosphate(V)",C9H17F6N2P,227617-70-1,F[P-](F)(F)(F)(F)F.CN1C(C)=[N+](CCCC)C=C1,CCCC[n+]1ccn(C)c1C.F[P-](F)(F)(F)(F)F,298.211,6.04,5.37-6.71 (CI),24,Jurkat,Flow cytometry (7AAD),"Dzhemileva, 2024, Chemosphere",10.1016/j.chemosphere.2024.142964,
"3-butyl-1,2-dimethyl-1H-imidazol-3-ium hexafluorophosphate(V)",C9H17F6N2P,227617-70-1,F[P-](F)(F)(F)(F)F.CN1C(C)=[N+](CCCC)C=C1,CCCC[n+]1ccn(C)c1C.F[P-](F)(F)(F)(F)F,298.211,14.08,13.06-15.10 (CI),24,U937,Flow cytometry (7AAD),"Dzhemileva, 2024, Chemosphere",10.1016/j.chemosphere.2024.142964,
"3-butyl-1,2-dimethyl-1H-imidazol-3-ium hexafluorophosphate(V)",C9H17F6N2P,227617-70-1,F[P-](F)(F)(F)(F)F.CN1C(C)=[N+](CCCC)C=C1,CCCC[n+]1ccn(C)c1C.F[P-](F)(F)(F)(F)F,298.211,25.14,23.25-27.04 (CI),24,K562,Flow cytometry (7AAD),"Dzhemileva, 2024, Chemosphere",10.1016/j.chemosphere.2024.142964,
"3-butyl-1,2-dimethyl-1H-imidazol-3-ium tetrafluoroborate",C9H17BF4N2,402846-78-0,F[B-](F)(F)F.C1=C[N+](=C(N1C)C)CCCC,CCCC[n+]1ccn(C)c1C.F[B-](F)(F)F,240.053,>6.026,,24,HT29,MTT,"Frade, 2007, Green Chem.",10.1039/b617526k,Lg(EC50)=3.78 (uM)
"3-butyl-1,2-dimethyl-1H-imidazol-3-ium tetrafluoroborate",C9H17BF4N2,402846-78-0,F[B-](F)(F)F.CN1C(C)=[N+](CCCC)C=C1,CCCC[n+]1ccn(C)c1C.F[B-](F)(F)F,240.053,20.83,19.57-22.09 (CI),24,Jurkat,Flow cytometry (7AAD),"Dzhemileva, 2024, Chemosphere",10.1016/j.chemosphere.2024.142964,
"3-butyl-1,2-dimethyl-1H-imidazol-3-ium tetrafluoroborate",C9H17BF4N2,402846-78-0,F[B-](F)(F)F.CN1C(C)=[N+](CCCC)C=C1,CCCC[n+]1ccn(C)c1C.F[B-](F)(F)F,240.053,27.08,23.95-30.21 (CI),24,U937,Flow cytometry (7AAD),"Dzhemileva, 2024, Chemosphere",10.1016/j.chemosphere.2024.142964,
"3-butyl-1,2-dimethyl-1H-imidazol-3-ium tetrafluoroborate",C9H17BF4N2,402846-78-0,F[B-](F)(F)F.CN1C(C)=[N+](CCCC)C=C1,CCCC[n+]1ccn(C)c1C.F[B-](F)(F)F,240.053,62.49,56.82-68.16 (CI),24,K562,Flow cytometry (7AAD),"Dzhemileva, 2024, Chemosphere",10.1016/j.chemosphere.2024.142964,
3-butyl-1-ethyl-1H-imidazol-3-ium ethyl sulfate,C11H22N2O4S,516474-07-0,O=S(=O)([O-])OCC.C1=C[N+](=CN1CC)CCCC,CCCC[n+]1ccn(CC)c1.CCOS(=O)(=O)[O-],278.374,8.5,11.29 (SD),24,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-butyl-1-ethyl-1H-imidazol-3-ium ethyl sulfate,C11H22N2O4S,516474-07-0,O=S(=O)([O-])OCC.C1=C[N+](=CN1CC)CCCC,CCCC[n+]1ccn(CC)c1.CCOS(=O)(=O)[O-],278.374,13.08,1.99 (SD),48,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-butyl-1-ethyl-1H-imidazol-3-ium tetrafluoroborate,C9H17BF4N2,581101-91-9,F[B-](F)(F)F.C1=C[N+](=CN1CC)CCCC,CCCC[n+]1ccn(CC)c1.F[B-](F)(F)F,240.053,>1,,48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,lg(EC50)=3 (uM)
3-butyl-1-ethyl-1H-imidazol-3-ium tetrafluoroborate,C9H17BF4N2,581101-91-9,F[B-](F)(F)F.C1=C[N+](=CN1CC)CCCC,CCCC[n+]1ccn(CC)c1.F[B-](F)(F)F,240.053,1.82,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=3.26 (uM)
3-butyl-1-ethyl-1H-imidazol-3-ium tetrafluoroborate,C9H17BF4N2,581101-91-9,F[B-](F)(F)F.C1=C[N+](=CN1CC)CCCC,CCCC[n+]1ccn(CC)c1.F[B-](F)(F)F,240.053,3.4,1.07 (SD),24,HeLa,WST-1,"Stepnowski, 2004, Hum. Exp. Toxicol.",10.1191/0960327104ht480oa,
3-butyl-1-ethyl-1H-imidazol-3-ium tetrafluoroborate,C9H17BF4N2,581101-91-9,F[B-](F)(F)F.C1=C[N+](=CN1CC)CCCC,CCCC[n+]1ccn(CC)c1.F[B-](F)(F)F,240.053,22.9,1.23 (SD),44,HeLa,WST-1,"Stepnowski, 2004, Hum. Exp. Toxicol.",10.1191/0960327104ht480oa,
3-butyl-1-methyl-1H-imidazol-3-ium (T-4)-tetracarbonylcobaltate,C8H15*4CoN2,385384-39-4,[1*][Co-]([1*])([1*])[1*].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[1*][Co-]([1*])([1*])[1*],310.19,0.28,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,SMILES from SciFinder - O#C[Co-](C#O)(C#O)C#O.C1=C[N+](=CN1C)CCCC
3-butyl-1-methyl-1H-imidazol-3-ium 2-(2-methoxyethoxy)ethyl sulfate,C13H26N2O6S,595565-54-1,O=S(=O)([O-])OCCOCCOC.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.COCCOCCOS(=O)(=O)[O-],338.426,1.4,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-butyl-1-methyl-1H-imidazol-3-ium 2-(4-isobutylphenyl)propanoate,C21H32N2O2,1289675-16-6,O=C([O-])C(C1=CC=C(C=C1)CC(C)C)C.C1=C[N+](=CN1C)CCCC,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CCCC[n+]1ccn(C)c1,344.499,2.071,0.145 (ND),36,HaCat,MTT,"Wu, 2019, J. Hazard. Mater.",10.1016/j.molliq.2019.03.046,
3-butyl-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O3,868671-35-6,O=C([O-])C=1C=CC=CC1O.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=C([O-])c1ccccc1O,276.336,0.64,0.19-1.09 (CI),24,3215 LS,MTS,"Egorova, 2015, ACS Med. Chem. Lett.",10.1021/acsmedchemlett.5b00258,
3-butyl-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O3,868671-35-6,O=C([O-])C=1C=CC=CC1O.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=C([O-])c1ccccc1O,276.336,4.34,2.48-7.61 (CI),24,CaCo-2,MTS,"Egorova, 2015, ACS Med. Chem. Lett.",10.1021/acsmedchemlett.5b00258,
3-butyl-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O3,868671-35-6,O=C([O-])C=1C=CC=CC1O.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=C([O-])c1ccccc1O,276.336,0.02754,,72,MRC-5,MTT,"Vraneš, 2016, RSC Adv.",10.1039/c6ra16182k,
3-butyl-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O3,868671-35-6,O=C([O-])C=1C=CC=CC1O.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=C([O-])c1ccccc1O,276.336,>0.1,,72,MCF-7,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
3-butyl-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O3,868671-35-6,O=C([O-])C=1C=CC=CC1O.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=C([O-])c1ccccc1O,276.336,>0.1,,72,MDA-MB-231,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
3-butyl-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O3,868671-35-6,O=C([O-])C=1C=CC=CC1O.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=C([O-])c1ccccc1O,276.336,>0.1,,72,PC3,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
3-butyl-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O3,868671-35-6,O=C([O-])C=1C=CC=CC1O.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=C([O-])c1ccccc1O,276.336,0.07546,,72,HeLa,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
3-butyl-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O3,868671-35-6,O=C([O-])C=1C=CC=CC1O.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=C([O-])c1ccccc1O,276.336,0.01489,,72,HT29,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
3-butyl-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C15H20N2O3,868671-35-6,O=C([O-])C=1C=CC=CC1O.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=C([O-])c1ccccc1O,276.336,>0.1,,72,A549,MTT,"Jovanovic-Santa, 2020, J. Serb. Chem. Soc.",10.2298/JSC190717098J,
3-butyl-1-methyl-1H-imidazol-3-ium 2-hydroxypropanoate,C11H20N2O3,878132-20-8,[C@@H](C([O-])=O)(C)O.C(CCC)[N+]1=CN(C)C=C1,CCCC[n+]1ccn(C)c1.C[C@H](O)C(=O)[O-],228.292,19.16,0.31 (SEM),24,CaCo-2,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-butyl-1-methyl-1H-imidazol-3-ium 2-hydroxypropanoate,C11H20N2O3,878132-20-8,[C@@H](C([O-])=O)(C)O.C(CCC)[N+]1=CN(C)C=C1,CCCC[n+]1ccn(C)c1.C[C@H](O)C(=O)[O-],228.292,33.65,0.53 (SEM),24,NIH/3T3,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-butyl-1-methyl-1H-imidazol-3-ium 4-methylbenzenesulfonate,C15H22N2O3S,410522-18-8,O=S(=O)([O-])C1=CC=C(C=C1)C.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.Cc1ccc(S(=O)(=O)[O-])cc1,310.419,1.55,0.002 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=3.19, 0.2 (CI) (uM)"
3-butyl-1-methyl-1H-imidazol-3-ium 4-methylbenzenesulfonate,C15H22N2O3S,410522-18-8,O=S(=O)([O-])C1=CC=C(C=C1)C.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.Cc1ccc(S(=O)(=O)[O-])cc1,310.419,1.9,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-butyl-1-methyl-1H-imidazol-3-ium acetate,C10H18N2O2,284049-75-8,O=C([O-])C.C1=C[N+](=CN1C)CCCC,CC(=O)[O-].CCCC[n+]1ccn(C)c1,198.266,32.78,30.08-35.48  (CI),24,U937,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium acetate,C10H18N2O2,284049-75-8,O=C([O-])C.C1=C[N+](=CN1C)CCCC,CC(=O)[O-].CCCC[n+]1ccn(C)c1,198.266,37.82,36.42-39.22  (CI),24,Jurkat,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium acetate,C10H18N2O2,284049-75-8,O=C([O-])C.C1=C[N+](=CN1C)CCCC,CC(=O)[O-].CCCC[n+]1ccn(C)c1,198.266,20.17,19.07-21.27 (CI),24,HL60,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium acetate,C10H18N2O2,284049-75-8,O=C([O-])C.C1=C[N+](=CN1C)CCCC,CC(=O)[O-].CCCC[n+]1ccn(C)c1,198.266,80.69,77.29-84.09 (CI),24,K562,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium acetate,C10H18N2O2,284049-75-8,O=C([O-])C.C1=C[N+](=CN1C)CCCC,CC(=O)[O-].CCCC[n+]1ccn(C)c1,198.266,284.11,264.21-304.01 (CI),24,HEK293,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium acetate,C10H18N2O2,284049-75-8,O=C([O-])C.C1=C[N+](=CN1C)CCCC,CC(=O)[O-].CCCC[n+]1ccn(C)c1,198.266,130.05,117.95-142.15 (CI),24,A549,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium acetate,C10H18N2O2,284049-75-8,O=C([O-])C.C1=C[N+](=CN1C)CCCC,CC(=O)[O-].CCCC[n+]1ccn(C)c1,198.266,123.58,111.28-135.88 (CI),24,A2780,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium acetate,C10H18N2O2,284049-75-8,O=C([O-])C.C1=C[N+](=CN1C)CCCC,CC(=O)[O-].CCCC[n+]1ccn(C)c1,198.266,9.721,9.103-10.38 (CI),24,Colo320HSR,MTS,"Egorova, 2020, J. Mol. Liq.",10.1016/j.molliq.2019.111751,
3-butyl-1-methyl-1H-imidazol-3-ium acetate,C10H18N2O2,284049-75-8,O=C([O-])C.C1=C[N+](=CN1C)CCCC,CC(=O)[O-].CCCC[n+]1ccn(C)c1,198.266,0.555,0.020-1.090 (CI),24,CaCo-2,MTS,"Egorova, 2021, J. Mol. Liq.",10.1016/j.molliq.2020.114870,
3-butyl-1-methyl-1H-imidazol-3-ium acetate,C10H18N2O2,284049-75-8,O=C([O-])C.C1=C[N+](=CN1C)CCCC,CC(=O)[O-].CCCC[n+]1ccn(C)c1,198.266,5.2,1.5 (SD),72,NHDF,MTS,"Musiał, 2021, ACS Sustain. Chem. Eng.",10.1021/acssuschemeng.1c02277,
3-butyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C10H15F6N3O4S2,174899-83-3,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,419.369,3.81,3.01-4.61 (CI),24,U937,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C10H15F6N3O4S2,174899-83-3,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,419.369,2.38,1.78-2.98 (CI),24,Jurkat,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C10H15F6N3O4S2,174899-83-3,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,419.369,1.9,1.7-2.1 (CI),24,HL60,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C10H15F6N3O4S2,174899-83-3,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,419.369,5.24,4.64-5.84 (CI),24,K562,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C10H15F6N3O4S2,174899-83-3,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,419.369,21.7,19.3-24.1 (CI),24,HEK293,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C10H15F6N3O4S2,174899-83-3,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,419.369,13.1,11.6-14.6 (CI),24,A549,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C10H15F6N3O4S2,174899-83-3,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,419.369,12.16,11.06-13.26  (CI),24,A2780,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C10H15F6N3O4S2,174899-83-3,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,419.369,2.88,0.43 (SD),72,CCO,WST-1,"Cvjetko Bubalo, 2015, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2014.10.029,
3-butyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C10H15F6N3O4S2,174899-83-3,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,419.369,2.88,0.43 (SD),72,CCO,WST-1,"Radošević, 2013, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2013.03.002,EC50
3-butyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C10H15F6N3O4S2,174899-83-3,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,419.369,1.17,0.21 (SE),48,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
3-butyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C10H15F6N3O4S2,174899-83-3,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,419.369,2.366,,24,A549,WST-8,"Chen, 2014, JCCS",10.1002/jccs.201300632,The incubation time is unclear.
3-butyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C10H15F6N3O4S2,174899-83-3,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,419.369,5.25,1.03 (SD),72,NHDF,MTS,"Musiał, 2017, ACS Sustain. Chem. Eng.",10.1021/acssuschemeng.7b02918,
3-butyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C10H15F6N3O4S2,174899-83-3,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,419.369,0.5,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
3-butyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C10H15F6N3O4S2,174899-83-3,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,419.369,3.26,0.18 (SEM),72,CCO,MTT,"Cvjetko, 2012, Arh Hig Rada Toksikol",10.2478/10004-1254-63-2012-2132,EC50
3-butyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C10H15F6N3O4S2,174899-83-3,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,419.369,3.11,0.11 (SEM),48,HeLa,MTT,"Cvjetko, 2012, Arh Hig Rada Toksikol",10.2478/10004-1254-63-2012-2132,EC50
3-butyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C10H15F6N3O4S2,174899-83-3,CN1C=[N+](CCCC)C=C1.O=S([N-]S(=O)(C(F)(F)F)=O)(C(F)(F)F)=O,CCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,419.369,0.48,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-butyl-1-methyl-1H-imidazol-3-ium bis(trifluoromethyl)imide,C10H15F6N3,710336-91-7,FC(F)(F)[N-]C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.FC(F)(F)[N-]C(F)(F)F,291.239,0.15,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-butyl-1-methyl-1H-imidazol-3-ium bromide,C8H15BrN2,85100-77-2,[Br-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Br-],219.126,3.81,0.36 (SD),72,CCO,WST-1,"Cvjetko Bubalo, 2015, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2014.10.029,
3-butyl-1-methyl-1H-imidazol-3-ium bromide,C8H15BrN2,85100-77-2,[Br-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Br-],219.126,3.81,0.36 (SD),72,CCO,WST-1,"Radošević, 2013, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2013.03.002,EC50
3-butyl-1-methyl-1H-imidazol-3-ium bromide,C8H15BrN2,85100-77-2,[Br-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Br-],219.126,>1,,48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,lg(EC50)=3 (uM)
3-butyl-1-methyl-1H-imidazol-3-ium bromide,C8H15BrN2,85100-77-2,[Br-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Br-],219.126,1.35,0.002 (CI),72,C6,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=3.13, 0.2 (CI) (uM)"
3-butyl-1-methyl-1H-imidazol-3-ium bromide,C8H15BrN2,85100-77-2,[Br-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Br-],219.126,3.24,0.46 (SE),24,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
3-butyl-1-methyl-1H-imidazol-3-ium bromide,C8H15BrN2,85100-77-2,[Br-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Br-],219.126,2.16,0.22 (SE),24,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing without FBS
3-butyl-1-methyl-1H-imidazol-3-ium bromide,C8H15BrN2,85100-77-2,[Br-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Br-],219.126,2.75,0.69 (SE),48,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
3-butyl-1-methyl-1H-imidazol-3-ium bromide,C8H15BrN2,85100-77-2,[Br-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Br-],219.126,2.692,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=3.43 (uM)
3-butyl-1-methyl-1H-imidazol-3-ium bromide,C8H15BrN2,85100-77-2,[Br-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Br-],219.126,>9.123,,24,PC12,MTT,"Li, 2012, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2012.06.013,
3-butyl-1-methyl-1H-imidazol-3-ium bromide,C8H15BrN2,85100-77-2,[Br-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Br-],219.126,0.5791,0.4509 (SEM),24,Sf-9,MTT,"Wu, 2018, J. Hazard. Mater.",10.1016/j.jhazmat.2018.01.028,
3-butyl-1-methyl-1H-imidazol-3-ium bromide,C8H15BrN2,85100-77-2,[Br-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Br-],219.126,0.0014,0.0005 (SEM),48,Sf-9,MTT,"Wu, 2018, J. Hazard. Mater.",10.1016/j.jhazmat.2018.01.028,
3-butyl-1-methyl-1H-imidazol-3-ium bromide,C8H15BrN2,85100-77-2,[Br-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Br-],219.126,2.7,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,17.46,15.69-19.22 (CI),24,HEK293T,MTS,"Egorova, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120450,pH at CC50: 7.0
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,30.08,19.47-40.70 (CI),24,3215 LS,MTS,"Egorova, 2015, ACS Med. Chem. Lett.",10.1021/acsmedchemlett.5b00258,
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,38.69,35.03-42.73 (CI),24,Colo320HSR,MTS,"Egorova, 2020, J. Mol. Liq.",10.1016/j.molliq.2019.111751,
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,18.85,1.27(SEM),24,CaCo-2,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,25.93,0.07 (SEM),24,NIH/3T3,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,57.25,53.45-61.05 (CI),24,U937,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,28.62,24.92-32.32 (CI),24,Jurkat,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,14.31,13.11-15.51 (CI),24,HL60,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,85.87,82.17-89.57 (CI),24,K562,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,322.38,303.68-341.08 (CI),24,HEK293,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,185.61,173.71-197.51 (CI),24,A549,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,101.62,91.52-111.72 (CI),24,A2780,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,1.5,0.189 (SD),24,B-13,MTT,"Abdelghany, 2020, Food Chem. Toxicol. ",10.1016/j.fct.2020.111593,
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,0.49,0.0748 (SD),48,B-13,MTT,"Abdelghany, 2020, Food Chem. Toxicol. ",10.1016/j.fct.2020.111593,
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,31.2,22.27-40.13 (CI),24,CaCo-2,MTS,"Vavina, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.118673,
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,2.354,1.728-2.981 (CI),24,CaCo-2,MTS,"Egorova, 2021, J. Mol. Liq.",10.1016/j.molliq.2020.114870,
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,10,,24,L929,CellQuanti-Blue,"Reiß, 2020, RSC Adv.",10.1039/d0ra01370f,
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,11.784,,24,A549,WST-8,"Chen, 2014, JCCS",10.1002/jccs.201300632,The incubation time is unclear.
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,3.548,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=3.55(uM)
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,3.6,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,12.3,1.41 (SD),24,HeLa,WST-1,"Stepnowski, 2004, Hum. Exp. Toxicol.",10.1191/0960327104ht480oa,
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,0.7122,0.2525 (SEM),24,Sf-9,MTT,"Wu, 2018, J. Hazard. Mater.",10.1016/j.jhazmat.2018.01.028,
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,0.2571,0.0218 (SEM),48,Sf-9,MTT,"Wu, 2018, J. Hazard. Mater.",10.1016/j.jhazmat.2018.01.028,
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,5.638,0.309 (ND),36,HaCat,MTT,"Wu, 2019, J. Hazard. Mater.",10.1016/j.molliq.2019.03.046,
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,5,,120,MDA-MB-231,MTT,"Kumari, 2020, J. Phys. Chem. Lett",10.1021/acs.jpclett.0c02149,
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,28.69,10.24 (SD),24,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,3.8,0.66 (SD),48,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-butyl-1-methyl-1H-imidazol-3-ium chloride,C8H15ClN2,79917-90-1,[Cl-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[Cl-],174.675,3.6,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-butyl-1-methyl-1H-imidazol-3-ium cinnamate,C17H22N2O2,2370819-41-1,O=C([O-])C=CC=1C=CC=CC1.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=C([O-])C=Cc1ccccc1,286.375,10.32,7.19-13.45 (CI),24,CaCo-2,MTS,"Vavina, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.118673,
3-butyl-1-methyl-1H-imidazol-3-ium dicyanamide,C10H15N5,448245-52-1,N#C[N-]C#N.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.N#C[N-]C#N,205.265,>6.026,,24,HT29,MTT,"Frade, 2007, Green Chem.",10.1039/b617526k,Lg(EC50)=3.78 (uM)
3-butyl-1-methyl-1H-imidazol-3-ium dicyanamide,C10H15N5,448245-52-1,N#C[N-]C#N.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.N#C[N-]C#N,205.265,17.3,,24,MCF-7,MTT,"Guo, 2021, J. Mol. Liq.",10.1016/j.molliq.2021.116835,
3-butyl-1-methyl-1H-imidazol-3-ium dicyanamide,C10H15N5,448245-52-1,N#C[N-]C#N.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.N#C[N-]C#N,205.265,1.4,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-butyl-1-methyl-1H-imidazol-3-ium glycinate,C10H19N3O2,1028361-04-7,O=C([O-])CN.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.NCC(=O)[O-],213.281,16.31,0.42 (SEM),24,CaCo-2,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-butyl-1-methyl-1H-imidazol-3-ium glycinate,C10H19N3O2,1028361-04-7,O=C([O-])CN.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.NCC(=O)[O-],213.281,22.34,0.93(SEM),24,NIH/3T3,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-butyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C8H15F6N2P,174501-64-5,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,284.184,11.5,1.08 (SEM),24,CaCo-2,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-butyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C8H15F6N2P,174501-64-5,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,284.184,16.65,0.11 (SEM),24,NIH/3T3,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,Tm - oil
3-butyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C8H15F6N2P,174501-64-5,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,284.184,>10,,72,CCO,WST-1,"Cvjetko Bubalo, 2015, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2014.10.029,
3-butyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C8H15F6N2P,174501-64-5,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,284.184,>10,,72,CCO,WST-1,"Radošević, 2013, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2013.03.002,EC50
3-butyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C8H15F6N2P,174501-64-5,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,284.184,>1,,48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,lg(EC50)=3 (uM)
3-butyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C8H15F6N2P,174501-64-5,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,284.184,>1,,72,C6,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,lg(EC50)=3 (uM)
3-butyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C8H15F6N2P,174501-64-5,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,284.184,7,,24,L929,CellQuanti-Blue,"Reiß, 2020, RSC Adv.",10.1039/d0ra01370f,
3-butyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C8H15F6N2P,174501-64-5,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,284.184,19.409,,24,A549,WST-8,"Chen, 2014, JCCS",10.1002/jccs.201300632,The incubation time is unclear.
3-butyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C8H15F6N2P,174501-64-5,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,284.184,1.259,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=3.1 (uM)
3-butyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C8H15F6N2P,174501-64-5,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,284.184,10.32,0.28 (SEM),72,CCO,MTT,"Cvjetko, 2012, Arh Hig Rada Toksikol",10.2478/10004-1254-63-2012-2132,EC50
3-butyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C8H15F6N2P,174501-64-5,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,284.184,11.2,0.15 (SEM),48,HeLa,MTT,"Cvjetko, 2012, Arh Hig Rada Toksikol",10.2478/10004-1254-63-2012-2132,EC50
3-butyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C8H15F6N2P,174501-64-5,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,284.184,13.9,1.66 (SD),24,HeLa,WST-1,"Stepnowski, 2004, Hum. Exp. Toxicol.",10.1191/0960327104ht480oa,
3-butyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C8H15F6N2P,174501-64-5,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,284.184,13.9,1.66 (SD),44,HeLa,WST-1,"Stepnowski, 2004, Hum. Exp. Toxicol.",10.1191/0960327104ht480oa,
3-butyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C8H15F6N2P,174501-64-5,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,284.184,1.3,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-butyl-1-methyl-1H-imidazol-3-ium hexafluorostibate(V),C8H15F6N2Sb,174645-81-9,CN1C=C[N+](CCCC)=C1.F[Sb-](F)(F)(F)(F)F,CCCC[n+]1ccn(C)c1.F[Sb-](F)(F)(F)(F)F,374.97,0.18,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-butyl-1-methyl-1H-imidazol-3-ium hydrogen sulfate,C8H16N2O4S,262297-13-2,O=S(=O)([O-])O.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([O-])O,236.293,13.7,0.78 (SEM),24,CaCo-2,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-butyl-1-methyl-1H-imidazol-3-ium hydrogen sulfate,C8H16N2O4S,262297-13-2,O=S(=O)([O-])O.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([O-])O,236.293,18.66,0.2 (SEM),24,NIH/3T3,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-butyl-1-methyl-1H-imidazol-3-ium hydrogen sulfate,C8H16N2O4S,262297-13-2,O=S(=O)([O-])O.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([O-])O,236.293,10.38,8.453-12.74 (CI),24,Colo320HSR,MTS,"Egorova, 2020, J. Mol. Liq.",10.1016/j.molliq.2019.111751,
3-butyl-1-methyl-1H-imidazol-3-ium hydrogen sulfate,C8H16N2O4S,262297-13-2,O=S(=O)([O-])O.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([O-])O,236.293,1.9,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-butyl-1-methyl-1H-imidazol-3-ium iodide,C8H15IN2,65039-05-6,[I-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[I-],266.126,25.599,,24,A549,WST-8,"Chen, 2014, JCCS",10.1002/jccs.201300632,The incubation time is unclear.
3-butyl-1-methyl-1H-imidazol-3-ium iodide,C8H15IN2,65039-05-6,[I-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.[I-],266.126,3,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-butyl-1-methyl-1H-imidazol-3-ium L-alaninate,C11H21N3O2,915712-88-8,[C@@H](C([O-])=O)(C)N.C(CCC)[N+]1=CN(C)C=C1,CCCC[n+]1ccn(C)c1.C[C@H](N)C(=O)[O-],227.308,19.35,1.03 (SEM),24,CaCo-2,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-butyl-1-methyl-1H-imidazol-3-ium L-alaninate,C11H21N3O2,915712-88-8,[C@@H](C([O-])=O)(C)N.C(CCC)[N+]1=CN(C)C=C1,CCCC[n+]1ccn(C)c1.C[C@H](N)C(=O)[O-],227.308,30.23,0.53 (SEM),24,NIH/3T3,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-butyl-1-methyl-1H-imidazol-3-ium L-valinate,C13H25N3O2,1084610-55-8,[C@H](C(C)C)(C([O-])=O)N.C(CCC)[N+]1=CN(C)C=C1,CC(C)[C@H](N)C(=O)[O-].CCCC[n+]1ccn(C)c1,255.362,16.86,0.58 (SEM),24,CaCo-2,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-butyl-1-methyl-1H-imidazol-3-ium L-valinate,C13H25N3O2,1084610-55-8,[C@H](C(C)C)(C([O-])=O)N.C(CCC)[N+]1=CN(C)C=C1,CC(C)[C@H](N)C(=O)[O-].CCCC[n+]1ccn(C)c1,255.362,25.18,0.64 (SEM),24,NIH/3T3,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-butyl-1-methyl-1H-imidazol-3-ium methanesulfonate,C9H18N2O3S,342789-81-5,O=S(=O)([O-])C.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.CS(=O)(=O)[O-],234.321,3.2,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-butyl-1-methyl-1H-imidazol-3-ium methyl sulfate,C9H18N2O4S,401788-98-5,O=S(=O)([O-])OC.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.COS(=O)(=O)[O-],250.32,20.46,7.88 (SD),24,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-butyl-1-methyl-1H-imidazol-3-ium methyl sulfate,C9H18N2O4S,401788-98-5,O=S(=O)([O-])OC.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.COS(=O)(=O)[O-],250.32,23.34,13.03 (SD),48,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-butyl-1-methyl-1H-imidazol-3-ium methyl sulfate,C9H18N2O4S,401788-98-5,O=S(=O)([O-])OC.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.COS(=O)(=O)[O-],250.32,1.7,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
"3-butyl-1-methyl-1H-imidazol-3-ium methyl-poly(oxy-1,2-ethanediyl) sulfate",C11H22*2N2O5S,845835-02-1,CN1C=C[N+](CCCC)=C1.O=S([O-])([*]OCC[*]OC)=O,CCCC[n+]1ccn(C)c1.CO*CCO*S(=O)(=O)[O-],294.373,1.1,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,Polymeric ionic liquid. Empirical formula C8H15N2(C2H4O)nCH3O4S.
3-butyl-1-methyl-1H-imidazol-3-ium octyl sulfate,C16H32N2O4S,445473-58-5,O=S(=O)([O-])OCCCCCCCC.C1=C[N+](=CN1C)CCCC,CCCCCCCCOS(=O)(=O)[O-].CCCC[n+]1ccn(C)c1,348.509,1.7,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-butyl-1-methyl-1H-imidazol-3-ium tetrachloroferrate(III),C8H15Cl4FeN2,359845-21-9,CN1C=C[N+](CCCC)=C1.Cl[Fe-](Cl)(Cl)Cl,CCCC[n+]1ccn(C)c1.Cl[Fe-](Cl)(Cl)Cl,336.879,7.384,,24,A549,WST-8,"Chen, 2014, JCCS",10.1002/jccs.201300632,The incubation time is unclear.
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,4.88,4.27-5.50 (CI),24,3215 LS,MTS,"Egorova, 2015, ACS Med. Chem. Lett.",10.1021/acsmedchemlett.5b00258,
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,3.037,1.052-5.022 (CI),24,CaCo-2,MTS,"Egorova, 2021, J. Mol. Liq.",10.1016/j.molliq.2020.114870,
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,11.19,0.63 (SEM),24,CaCo-2,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,11.3,1.15 (SEM),24,NIH/3T3,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,31.18,29.38-32.98 (CI),24,U937,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,23.11,21.61-24.61 (CI),24,Jurkat,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,7.04,5.84-8.24 (CI),24,HL60,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,41.24,38.84-43.64 (CI),24,K562,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,148.15,126.55-169.75 (CI),24,HEK293,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,16.92,14.72-19.45 (CI),24,Colo320HSR,MTS,"Egorova, 2020, J. Mol. Liq.",10.1016/j.molliq.2019.111751,
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,136.6,125.00-148.2 (CI),24,A549,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,114.47,103.57-125.37 (CI),24,A2780,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,4.46,0.39 (SD),72,CCO,WST-1,"Cvjetko Bubalo, 2015, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2014.10.029,
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,4.46,0.39 (SD),72,CCO,WST-1,"Radošević, 2013, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2013.03.002,EC50
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,1.38,0.001 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=3.14, 0.02 (CI) (uM)"
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,>1,,72,C6,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,lg(EC50)=3 (uM)
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,3.14,0.35 (SE),24,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,1.59,0.23 (SE),24,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing without FBS
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,4.55,0.85 (SE),48,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,73.776,,24,A549,WST-8,"Chen, 2014, JCCS",10.1002/jccs.201300632,The incubation time is unclear.
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,1.318,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=3.12 (uM)
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,1.06,0.07 (SE),16,PC12,MTT,"Samorì, 2010, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2010.07.020,
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,1.66,0.22 (SE),16,PC12,LDH release,"Samorì, 2010, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2010.07.020,
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,0.54,0.13 (SE),16,PC12,AChE inhibition,"Samorì, 2010, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2010.07.020,
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,1.3,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,5.01,0.32 (SEM),72,CCO,MTT,"Cvjetko, 2012, Arh Hig Rada Toksikol",10.2478/10004-1254-63-2012-2132,EC50
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,4.42,0.18 (SEM),48,HeLa,MTT,"Cvjetko, 2012, Arh Hig Rada Toksikol",10.2478/10004-1254-63-2012-2132,EC50
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,>6.026,,24,HT29,MTT,"Frade, 2007, Green Chem.",10.1039/b617526k,Lg(EC50)=3.78 (uM)
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,>3.020,,24,CaCo-2,MTT,"Frade, 2007, Green Chem.",10.1039/b617526k,Lg(EC50)=3.48 (uM)
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,0.6,1.12 (SD),24,HeLa,WST-1,"Stepnowski, 2004, Hum. Exp. Toxicol.",10.1191/0960327104ht480oa,
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,5.3,1.12 (SD),44,HeLa,WST-1,"Stepnowski, 2004, Hum. Exp. Toxicol.",10.1191/0960327104ht480oa,
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,0.108,0.0111 (SEM),24,Sf-9,MTT,"Wu, 2018, J. Hazard. Mater.",10.1016/j.jhazmat.2018.01.028,
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,0.058,0.0044 (SEM),48,Sf-9,MTT,"Wu, 2018, J. Hazard. Mater.",10.1016/j.jhazmat.2018.01.028,
3-butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C8H15BF4N2,174501-65-6,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.F[B-](F)(F)F,226.026,1.7,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-butyl-1-methyl-1H-imidazol-3-ium thiocyanate,C9H15N3S,344790-87-0,N#C[S-].C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.N#C[S-],197.307,2.6,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-butyl-1-methyl-1H-imidazol-3-ium trifluoromethanesulfonate,C9H15F3N2O3S,174899-66-2,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,288.291,2.64,0.45 (SD),72,HCT-116,MTS,"Kuczak, 2022, J. Hazard. Mater.",10.1016/j.jhazmat.2021.128160,
3-butyl-1-methyl-1H-imidazol-3-ium trifluoromethanesulfonate,C9H15F3N2O3S,174899-66-2,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,288.291,2.2,0.78 (SD),72,MCF-7,MTS,"Kuczak, 2022, J. Hazard. Mater.",10.1016/j.jhazmat.2021.128160,
3-butyl-1-methyl-1H-imidazol-3-ium trifluoromethanesulfonate,C9H15F3N2O3S,174899-66-2,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,288.291,0.274,0.036 (SD),72,U251,MTS,"Kuczak, 2022, J. Hazard. Mater.",10.1016/j.jhazmat.2021.128160,
3-butyl-1-methyl-1H-imidazol-3-ium trifluoromethanesulfonate,C9H15F3N2O3S,174899-66-2,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,288.291,4.22,0.68 (SD),72,NHDF,MTS,"Musiał, 2021, ACS Sustain. Chem. Eng.",10.1021/acssuschemeng.1c02277,
3-butyl-1-methyl-1H-imidazol-3-ium trifluoromethanesulfonate,C9H15F3N2O3S,174899-66-2,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,288.291,1,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-butyl-1-methyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C14H15F18N2P,917762-91-5 ,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCC,CCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,584.226,<0.1,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
"3-decyl-1-(3,4-dihydroxybenzoyl)-1H-imidazol-3-ium bromide",C20H29BrN2O3,,O=C(C1=CC=C(O)C(O)=C1)N2C=C[N+](CCCCCCCCCC)=C2.[Br-],CCCCCCCCCC[n+]1ccn(C(=O)c2ccc(O)c(O)c2)c1.[Br-],425.367,>0.032,,24,HaCat,MTT,"Forero-Doria, 2022, Bioorg. Chem.",10.1016/j.bioorg.2022.105914,
3-decyl-1-ethyl-1H-imidazol-3-ium bromide,C15H29BrN2,581101-93-1,[Br-].C1=C[N+](=CN1CC)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(CC)c1.[Br-],317.315,0.0034,0.0012 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=0.533, 0.07 (CI) (uM)"
3-decyl-1-ethyl-1H-imidazol-3-ium bromide,C15H29BrN2,581101-93-1,[Br-].C1=C[N+](=CN1CC)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(CC)c1.[Br-],317.315,0.0034,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=0.53 (uM)
3-decyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C16H27F6N3O4S2,433337-23-6,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,503.531,<0.1,,72,CCO,WST-1,"Cvjetko Bubalo, 2015, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2014.10.029,
3-decyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C16H27F6N3O4S2,433337-23-6,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,503.531,<0.1,,72,CCO,WST-1,"Radošević, 2013, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2013.03.002,EC50
3-decyl-1-methyl-1H-imidazol-3-ium bromide,C14H27BrN2,188589-32-4,[Br-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Br-],303.288,0.05,,24,PC12,MTT,"Li, 2012, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2012.06.013,
3-decyl-1-methyl-1H-imidazol-3-ium bromide,C14H27BrN2,188589-32-4,[Br-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Br-],303.288,0.0122,0.0043 (SEM),24,Sf-9,MTT,"Wu, 2018, J. Hazard. Mater.",10.1016/j.jhazmat.2018.01.028,
3-decyl-1-methyl-1H-imidazol-3-ium bromide,C14H27BrN2,188589-32-4,[Br-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Br-],303.288,0.0003,0.00003 (SEM),48,Sf-9,MTT,"Wu, 2018, J. Hazard. Mater.",10.1016/j.jhazmat.2018.01.028,
3-decyl-1-methyl-1H-imidazol-3-ium chloride,C14H27ClN2,171058-18-7,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Cl-],258.837,0.022,0.001 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=1.34, 0.04 (CI) (uM)"
3-decyl-1-methyl-1H-imidazol-3-ium chloride,C14H27ClN2,171058-18-7,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Cl-],258.837,0.24,0.21-0.28 (CI),24,HEK293T,MTS,"Egorova, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120450,pH at CC50: 5.6
3-decyl-1-methyl-1H-imidazol-3-ium chloride,C14H27ClN2,171058-18-7,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Cl-],258.837,0.04,0.031-0.049 (CI),24,U937,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-decyl-1-methyl-1H-imidazol-3-ium chloride,C14H27ClN2,171058-18-7,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Cl-],258.837,0.08,0.075-0.085 (CI),24,Jurkat,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-decyl-1-methyl-1H-imidazol-3-ium chloride,C14H27ClN2,171058-18-7,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Cl-],258.837,0.007,0.006-0.008 (CI),24,HL60,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-decyl-1-methyl-1H-imidazol-3-ium chloride,C14H27ClN2,171058-18-7,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Cl-],258.837,0.081,0.073-0.089 (CI),24,K562,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-decyl-1-methyl-1H-imidazol-3-ium chloride,C14H27ClN2,171058-18-7,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Cl-],258.837,0.19,0.174-0.206 (CI),24,HEK293,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-decyl-1-methyl-1H-imidazol-3-ium chloride,C14H27ClN2,171058-18-7,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Cl-],258.837,0.12,0.109-0.131 (CI),24,A549,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-decyl-1-methyl-1H-imidazol-3-ium chloride,C14H27ClN2,171058-18-7,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Cl-],258.837,0.93,0.858-1.002 (CI),24,A2780,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-decyl-1-methyl-1H-imidazol-3-ium chloride,C14H27ClN2,171058-18-7,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Cl-],258.837,0.0022,0.00066 (SD),24,B-13,MTT,"Abdelghany, 2020, Food Chem. Toxicol. ",10.1016/j.fct.2020.111593,
3-decyl-1-methyl-1H-imidazol-3-ium chloride,C14H27ClN2,171058-18-7,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Cl-],258.837,0.00071,0.00444 (SD),48,B-13,MTT,"Abdelghany, 2020, Food Chem. Toxicol. ",10.1016/j.fct.2020.111593,
3-decyl-1-methyl-1H-imidazol-3-ium chloride,C14H27ClN2,171058-18-7,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Cl-],258.837,0.046,0.0037 (SD),24,B-13/H,MTT,"Abdelghany, 2020, Food Chem. Toxicol. ",10.1016/j.fct.2020.111593,
3-decyl-1-methyl-1H-imidazol-3-ium chloride,C14H27ClN2,171058-18-7,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Cl-],258.837,0.0058,0.0005 (SD),48,B-13/H,MTT,"Abdelghany, 2020, Food Chem. Toxicol. ",10.1016/j.fct.2020.111593,
3-decyl-1-methyl-1H-imidazol-3-ium chloride,C14H27ClN2,171058-18-7,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Cl-],258.837,0.035,,24,L929,CellQuanti-Blue,"Reiß, 2020, RSC Adv.",10.1039/d0ra01370f,
3-decyl-1-methyl-1H-imidazol-3-ium chloride,C14H27ClN2,171058-18-7,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Cl-],258.837,1.91,,4,CaCo-2,MTT,"Frade, 2009, Green Chem.",10.1039/b914284n,
3-decyl-1-methyl-1H-imidazol-3-ium chloride,C14H27ClN2,171058-18-7,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Cl-],258.837,0.022,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=1.34 (uM)
3-decyl-1-methyl-1H-imidazol-3-ium chloride,C14H27ClN2,171058-18-7,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Cl-],258.837,0.0025,,120,MDA-MB-231,MTT,"Kumari, 2020, J. Phys. Chem. Lett",10.1021/acs.jpclett.0c02149,
3-decyl-1-methyl-1H-imidazol-3-ium chloride,C14H27ClN2,171058-18-7,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Cl-],258.837,0.03,0.02 (SD),24,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-decyl-1-methyl-1H-imidazol-3-ium chloride,C14H27ClN2,171058-18-7,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.[Cl-],258.837,0.01,0.01 (SD),48,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-decyl-1-methyl-1H-imidazol-3-ium dicyanamide,C16H27N5,958869-93-7,N#C[N-]C#N.C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.N#C[N-]C#N,289.427,0.0919,,24,MCF-7,MTT,"Guo, 2021, J. Mol. Liq.",10.1016/j.molliq.2021.116835,
3-decyl-1-methyl-1H-imidazol-3-ium glycinate,C16H31N3O2,1357292-55-7,O=C([O-])CN.C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.NCC(=O)[O-],297.443,0.19,,24,PBMC,MTT,"Beck, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120054,
3-decyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C14H27F6N2P,362043-46-7,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,368.346,0.031,0.001 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=1.5, 0.04 (CI) (uM)"
3-decyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C14H27F6N2P,362043-46-7,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,368.346,0.049,0.001 (CI),72,C6,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=1.69, 0.07 (CI) (uM)"
3-decyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C14H27F6N2P,362043-46-7,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,368.346,0.032,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=1.5 (uM)
3-decyl-1-methyl-1H-imidazol-3-ium L-lysinate,C20H40N4O2,,CCCCCCCCCC[N+]1=CN(C=C1)C.NCCCC[C@H](N)C([O-])=O,CCCCCCCCCC[n+]1ccn(C)c1.NCCCC[C@H](N)C(=O)[O-],368.566,1.9,,24,PBMC,MTT,"Beck, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120054,
3-decyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C14H27BF4N2,244193-56-4,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,310.188,0.0059,0.0012 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=0.77, 0.08 (CI) (uM)"
3-decyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C14H27BF4N2,244193-56-4,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,310.188,0.0059,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=0.77 (uM)
3-decyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C14H27BF4N2,244193-56-4,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,310.188,0.288,0.001 (ND),24,HT29,MTT,"Frade, 2007, Green Chem.",10.1039/b617526k,"Lg(EC50)=2.46, 0.06 (uM)"
3-decyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C14H27BF4N2,244193-56-4,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,310.188,0.603,0.001 (ND),24,CaCo-2,MTT,"Frade, 2007, Green Chem.",10.1039/b617526k,"Lg(EC50)=2.78, 0.02 (uM)"
3-decyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C14H27BF4N2,244193-56-4,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,310.188,0.07,1.23 (SD),24,HeLa,WST-1,"Stepnowski, 2004, Hum. Exp. Toxicol.",10.1191/0960327104ht480oa,
3-decyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C14H27BF4N2,244193-56-4,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,310.188,0.0626,,24,LoVo,MTT,"Guo, 2021, J. Mol. Liq.",10.1016/j.molliq.2021.116835,
3-decyl-1-methyl-1H-imidazol-3-ium trifluoromethanesulfonate,C15H27F3N2O3S,412009-62-2,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,372.453,0.015,0.003 (SD),72,HCT-116,MTS,"Kuczak, 2022, J. Hazard. Mater.",10.1016/j.jhazmat.2021.128160,
3-decyl-1-methyl-1H-imidazol-3-ium trifluoromethanesulfonate,C15H27F3N2O3S,412009-62-2,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,372.453,0.006,0.003 (SD),72,MCF-7,MTS,"Kuczak, 2022, J. Hazard. Mater.",10.1016/j.jhazmat.2021.128160,
3-decyl-1-methyl-1H-imidazol-3-ium trifluoromethanesulfonate,C15H27F3N2O3S,412009-62-2,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,372.453,0.04,0.006 (SD),72,U251,MTS,"Kuczak, 2022, J. Hazard. Mater.",10.1016/j.jhazmat.2021.128160,
3-decyl-1-methyl-1H-imidazol-3-ium trifluoromethanesulfonate,C15H27F3N2O3S,412009-62-2,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCC,CCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,372.453,0.025,0.001 (SD),72,NHDF,MTS,"Musiał, 2021, ACS Sustain. Chem. Eng.",10.1021/acssuschemeng.1c02277,
"3-dodecyl-1-methyl-1H-imidazol-3-ium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate",C20H31F9N2O3S,1797402-57-3,O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,550.528,0.1633,,24,CaCo-2,MTS,"Vieira, 2019, Chemosphere",10.1016/j.chemosphere.2018.10.159,
"3-dodecyl-1-methyl-1H-imidazol-3-ium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate",C20H31F9N2O3S,1797402-57-3,O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,550.528,0.2388,,24,HepG2,MTS,"Vieira, 2019, Chemosphere",10.1016/j.chemosphere.2018.10.159,
3-dodecyl-1-methyl-1H-imidazol-3-ium bromide,C16H31BrN2,61546-00-7,[Br-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Br-],331.342,0.024,,24,PC12,MTT,"Li, 2012, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2012.06.013,
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.074,,48,A431,SRB,"Malhotra, 2014, MedChemComm",10.1039/c4md00161c,"lg(LC50) = -4.13 (M, concentration of the drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning)."
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.03061,,?,CCRF-CEM,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.00778,,?,HL-60 (TB),SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,K562,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,MOLT-4 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.00613,,?,RPMI-8226 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.0976,,?,SR  ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,A549,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,EKVX ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,HOP-62 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,HOP-92 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,NCI-H226 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,NCI-H23 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,NCI-H322M ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,NCI-H460 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,NCI-H522 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,COLO 205 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,HCC-2998 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,HCT-116,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,HCT-15 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,HT29,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.0858,,?,KM12 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,SW-620 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,SF-268,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,SF-295,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,SF-539,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,SNB-19,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.0568,,?,SNB-75,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,U251,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.0453,,?,LOX IMVI,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,MALME-3M,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,M14,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.0716,,?,SK-MEL-28,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.0078,,?,SK-MEL-5,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.0921,,?,UACC-257,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.0375,,?,UACC-62,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.0598,,?,OVCAR-3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,OVCAR-4,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,OVCAR-5,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,OVCAR-8,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,SK-OV-3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,786-0 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,A498 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,ACHN ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,CAK-1 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,RXF 393 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.0349,,?,SN12C ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.0616,,?,TK-10 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,UO-31 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,PC3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,DU-145,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.0906,,?,MCF-7,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,NCI/ADR-RES,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.0636,,?,MDA-MB-231,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,HS 578T,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.0691,,?,MDA-MB-435,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.0508,,?,BT-549,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,>0.1,,?,T-47D,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.0153,,?,MDA-MB-468,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium chloride,C16H31ClN2,114569-84-5,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],286.891,0.0328,,24,MCF-7,MTS,"Wang, 2012, Adv. Mater. Res. ",10.4028/www.scientific.net/AMR.610-613.721,"pEC50=4.484, 0.06 (RMSE)."
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,0.0565,,?,CCRF-CEM,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,0.00993,,?,HL-60 (TB),SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,K562,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,0.0775,,?,MOLT-4 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,0.00948,,?,RPMI-8226 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,SR  ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,A549,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,EKVX ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,HOP-62 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,HOP-92 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,NCI-H226 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,NCI-H23 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,NCI-H322M ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,NCI-H460 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,NCI-H522 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,COLO 205 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>10,,?,HCC-2998 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,HCT-116,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,HCT-15 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,HT29,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,0.023,,?,KM12 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,SW-620 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,SF-268,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,SF-295,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,SF-539,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,SNB-19,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,0.0903,,?,SNB-75,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,U251,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,0.0349,,?,LOX IMVI,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,0.0997,,?,MALME-3M,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,M14,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,0.021,,?,SK-MEL-28,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,0.0545,,?,SK-MEL-5,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,0.0423,,?,UACC-257,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,IGROV1,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,0.0562,,?,OVCAR-3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,OVCAR-4,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,OVCAR-5,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,OVCAR-8,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,SK-OV-3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,786-0 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,A498 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,ACHN ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,CAK-1 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,RXF 393 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,0.0428,,?,SN12C ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,0.0581,,?,TK-10 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,UO-31 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,PC3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,DU-145,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,MCF-7,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,NCI/ADR-RES,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,0.0642,,?,MDA-MB-231,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,HS 578T,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,0.0775,,?,MDA-MB-435,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,0.0519,,?,BT-549,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,T-47D,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C16H31BF4N2,244193-59-7,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,338.242,>0.1,,?,MDA-MB-468,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
"3-ethyl-1,2-dimethyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide",C9H13F6N3O4S2,174899-90-2,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=C(N1C)C)CC,CC[n+]1ccn(C)c1C.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,405.342,1.87,0.39 (SD),72,NHDF,MTS,"Musiał, 2018, ACS Sustain. Chem. Eng.",10.1021/acssuschemeng.8b01317,
"3-ethyl-1-methyl-1H-imidazol-3-ium (2S,5R,6R)-6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",C22H29N5O4S,1418122-70-9,C(C)[N+]1=CN(C)C=C1.C([O-])(=O)[C@@H]1N2[C@@]([C@H](NC([C@H](N)C3=CC=CC=C3)=O)C2=O)(SC1(C)C)[H],CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].CC[n+]1ccn(C)c1,459.572,>0.001122,,?,MG63,MTT,"Ferraz, 2015, ChemMedChem",10.1002/cmdc.201500142,LD50=0.00112 mM.
"3-ethyl-1-methyl-1H-imidazol-3-ium (2S,5R,6R)-6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",C22H29N5O4S,1418122-70-9,C(C)[N+]1=CN(C)C=C1.C([O-])(=O)[C@@H]1N2[C@@]([C@H](NC([C@H](N)C3=CC=CC=C3)=O)C2=O)(SC1(C)C)[H],CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].CC[n+]1ccn(C)c1,459.572,>0.02427,,?,HepG2,MTT,"Ferraz, 2015, ChemMedChem",10.1002/cmdc.201500142,LD50=0.024270 mM.
"3-ethyl-1-methyl-1H-imidazol-3-ium (2S,5R,6R)-6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",C22H29N5O4S,1418122-70-9,C(C)[N+]1=CN(C)C=C1.C([O-])(=O)[C@@H]1N2[C@@]([C@H](NC([C@H](N)C3=CC=CC=C3)=O)C2=O)(SC1(C)C)[H],CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].CC[n+]1ccn(C)c1,459.572,>0.02999,,?,PC3,MTT,"Ferraz, 2015, ChemMedChem",10.1002/cmdc.201500142,LD50=0.03102 mM.
"3-ethyl-1-methyl-1H-imidazol-3-ium (2S,5R,6R)-6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",C22H29N5O4S,1418122-70-9,C(C)[N+]1=CN(C)C=C1.C([O-])(=O)[C@@H]1N2[C@@]([C@H](NC([C@H](N)C3=CC=CC=C3)=O)C2=O)(SC1(C)C)[H],CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].CC[n+]1ccn(C)c1,459.572,>0.000269,,?,RKO,MTT,"Ferraz, 2015, ChemMedChem",10.1002/cmdc.201500142,LD50=0.2097 mM.
"3-ethyl-1-methyl-1H-imidazol-3-ium (2S,5R,6R)-6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",C22H29N5O4S,1418122-70-9,C(C)[N+]1=CN(C)C=C1.C([O-])(=O)[C@@H]1N2[C@@]([C@H](NC([C@H](N)C3=CC=CC=C3)=O)C2=O)(SC1(C)C)[H],CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].CC[n+]1ccn(C)c1,459.572,>0.006366,,?,SF,MTT,"Ferraz, 2015, ChemMedChem",10.1002/cmdc.201500142,"LD50=0.006366 mM, skin fibroblasts."
"3-ethyl-1-methyl-1H-imidazol-3-ium (2S,5R,6R)-6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",C22H29N5O4S,1418122-70-9,C(C)[N+]1=CN(C)C=C1.C([O-])(=O)[C@@H]1N2[C@@]([C@H](NC([C@H](N)C3=CC=CC=C3)=O)C2=O)(SC1(C)C)[H],CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].CC[n+]1ccn(C)c1,459.572,>0.000853,,?,GF,MTT,"Ferraz, 2015, ChemMedChem",10.1002/cmdc.201500142,"LD50=0.009357 mM, gingival fibroblasts."
"3-ethyl-1-methyl-1H-imidazol-3-ium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate",C10H11F9N2O3S,174899-79-7,O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,410.258,>10,,24,CaCo-2,MTS,"Vieira, 2019, Chemosphere",10.1016/j.chemosphere.2018.10.159,
"3-ethyl-1-methyl-1H-imidazol-3-ium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate",C10H11F9N2O3S,174899-79-7,O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,410.258,>10,,24,HepG2,MTS,"Vieira, 2019, Chemosphere",10.1016/j.chemosphere.2018.10.159,
"3-ethyl-1-methyl-1H-imidazol-3-ium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate",C10H11F9N2O3S,174899-79-7,O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,410.258,>10,,24,EA.hy926,MTS,"Vieira, 2019, Chemosphere",10.1016/j.chemosphere.2018.10.159,
"3-ethyl-1-methyl-1H-imidazol-3-ium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate",C10H11F9N2O3S,174899-79-7,O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,410.258,6.166,,24,HaCat,MTS,"Vieira, 2019, Chemosphere",10.1016/j.chemosphere.2018.10.159,
"3-ethyl-1-methyl-1H-imidazol-3-ium 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonate",C14H11F17N2O3S,1648691-53-5,O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,610.286,0.3548,,24,CaCo-2,MTS,"Vieira, 2019, Chemosphere",10.1016/j.chemosphere.2018.10.159,
"3-ethyl-1-methyl-1H-imidazol-3-ium 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonate",C14H11F17N2O3S,1648691-53-5,O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,610.286,0.07834,,24,HepG2,MTS,"Vieira, 2019, Chemosphere",10.1016/j.chemosphere.2018.10.159,
"3-ethyl-1-methyl-1H-imidazol-3-ium 2,2'-spirobi[benzo[d][1,3,2]dioxaborol]-2-uide",C18H19BN2O4,376650-04-3,CN1C=C[N+](CC)=C1.C23=CC=CC=C2O[B-]4(OC5=CC=CC=C5O4)O3,CC[n+]1ccn(C)c1.c1ccc2c(c1)O[B-]1(O2)Oc2ccccc2O1,338.172,0.01,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
"3-ethyl-1-methyl-1H-imidazol-3-ium 2,2'-spirobi[benzo[d][1,3,2]dioxaborol]-2-uide",C18H19BN2O4,376650-04-3,CN1C=C[N+](CC)=C1.C23=CC=CC=C2O[B-]4(OC5=CC=CC=C5O4)O3,CC[n+]1ccn(C)c1.c1ccc2c(c1)O[B-]1(O2)Oc2ccccc2O1,338.172,0.01,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
"3-ethyl-1-methyl-1H-imidazol-3-ium 2,3,7,8-tetraoxo-1,4,6,9-tetraoxa-5-boraspiro[4.4]nonan-5-uide",C10H11BN2O8,376650-06-5,CN1C=C[N+](CC)=C1.O=C(O2)C(O[B-]2(OC3=O)OC3=O)=O,CC[n+]1ccn(C)c1.O=C1O[B-]2(OC1=O)OC(=O)C(=O)O2,298.016,0.86,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-ethyl-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C13H16N2O3,945611-28-9,O=C([O-])C=1C=CC=CC1O.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=C([O-])c1ccccc1O,248.282,1.39,0.64-2.14 (CI),24,3215 LS,MTS,"Egorova, 2015, ACS Med. Chem. Lett.",10.1021/acsmedchemlett.5b00258,pH at CC50: 7.0
3-ethyl-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C13H16N2O3,945611-28-9,O=C([O-])C=1C=CC=CC1O.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=C([O-])c1ccccc1O,248.282,5.97,4.51-7.91 (CI),24,CaCo-2,MTS,"Egorova, 2015, ACS Med. Chem. Lett.",10.1021/acsmedchemlett.5b00258,
3-ethyl-1-methyl-1H-imidazol-3-ium acetate,C8H14N2O2,143314-17-4,O=C([O-])C.C1=C[N+](=CN1C)CC,CC(=O)[O-].CC[n+]1ccn(C)c1,170.212,150.88,143.48-158.28 (CI),24,U937,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium acetate,C8H14N2O2,143314-17-4,O=C([O-])C.C1=C[N+](=CN1C)CC,CC(=O)[O-].CC[n+]1ccn(C)c1,170.212,146.76,141.06-152.46 (CI),24,Jurkat,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium acetate,C8H14N2O2,143314-17-4,O=C([O-])C.C1=C[N+](=CN1C)CC,CC(=O)[O-].CC[n+]1ccn(C)c1,170.212,72.5,70.00-75.00 (CI),24,HL60,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium acetate,C8H14N2O2,143314-17-4,O=C([O-])C.C1=C[N+](=CN1C)CC,CC(=O)[O-].CC[n+]1ccn(C)c1,170.212,178.25,170.15-186.35 (CI),24,K562,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium acetate,C8H14N2O2,143314-17-4,O=C([O-])C.C1=C[N+](=CN1C)CC,CC(=O)[O-].CC[n+]1ccn(C)c1,170.212,651.6,605-698.2 (CI),24,HEK293,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium acetate,C8H14N2O2,143314-17-4,O=C([O-])C.C1=C[N+](=CN1C)CC,CC(=O)[O-].CC[n+]1ccn(C)c1,170.212,271.01,249.61-292.41 (CI),24,A549,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium acetate,C8H14N2O2,143314-17-4,O=C([O-])C.C1=C[N+](=CN1C)CC,CC(=O)[O-].CC[n+]1ccn(C)c1,170.212,174.6,159.1-190.1 (CI),24,A2780,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium acetate,C8H14N2O2,143314-17-4,O=C([O-])C.C1=C[N+](=CN1C)CC,CC(=O)[O-].CC[n+]1ccn(C)c1,170.212,46,9.3 (SD),24,HCE,AlamarBlue,"Ruokonen, 2018, Chem. Eur. J.",10.1002/chem.201704924,
3-ethyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C8H11F6N3O4S2,174899-82-2,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,391.315,2.22,0.62-3.82 (CI),24,HEK293T,MTS,"Egorova, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120450,pH at CC50: 6.4
3-ethyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C8H11F6N3O4S2,174899-82-2,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,391.315,6.13,5.63-6.63 (CI),24,U937,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C8H11F6N3O4S2,174899-82-2,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,391.315,4.64,4.34-4.94 (CI),24,Jurkat,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C8H11F6N3O4S2,174899-82-2,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,391.315,3.07,2.77-3.37 (CI),24,HL60,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C8H11F6N3O4S2,174899-82-2,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,391.315,6.64,6.04-7.24 (CI),24,K562,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C8H11F6N3O4S2,174899-82-2,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,391.315,13.19,12.59-13.79 (CI),24,HEK293,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C8H11F6N3O4S2,174899-82-2,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,391.315,4.3,4.1-4.5 (CI),24,A549,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C8H11F6N3O4S2,174899-82-2,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,391.315,13.39,12.49-14.29 (CI),24,A2780,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C8H11F6N3O4S2,174899-82-2,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,391.315,1.82,0.16 (SE),48,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
3-ethyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C8H11F6N3O4S2,174899-82-2,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,391.315,2.1,,48,IPC-81,WST-1,"Steudte, 2012, ChemComm",10.1039/c2cc34955h,
3-ethyl-1-methyl-1H-imidazol-3-ium bis(perfluoroethyl)phosphinate,C10H11F10N2O2P,852616-00-3,O=P([O-])(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=P([O-])(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,412.164,0.68,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-ethyl-1-methyl-1H-imidazol-3-ium bromide,C6H11BrN2,65039-08-9,[Br-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Br-],191.072,6.72,0.68 (SE),24,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
3-ethyl-1-methyl-1H-imidazol-3-ium bromide,C6H11BrN2,65039-08-9,[Br-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Br-],191.072,9.61,0.32 (SE),24,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing without FBS
3-ethyl-1-methyl-1H-imidazol-3-ium bromide,C6H11BrN2,65039-08-9,[Br-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Br-],191.072,8.35,1 (SE),48,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
3-ethyl-1-methyl-1H-imidazol-3-ium bromide,C6H11BrN2,65039-08-9,[Br-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Br-],191.072,65.707,,24,A549,WST-8,"Chen, 2014, JCCS",10.1002/jccs.201300632,The incubation time is unclear.
3-ethyl-1-methyl-1H-imidazol-3-ium bromide,C6H11BrN2,65039-08-9,[Br-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Br-],191.072,8.9339,1.9789 (SEM),24,Sf-9,MTT,"Wu, 2018, J. Hazard. Mater.",10.1016/j.jhazmat.2018.01.028,
3-ethyl-1-methyl-1H-imidazol-3-ium bromide,C6H11BrN2,65039-08-9,[Br-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Br-],191.072,1.4612,0.1685 (SEM),48,Sf-9,MTT,"Wu, 2018, J. Hazard. Mater.",10.1016/j.jhazmat.2018.01.028,
3-ethyl-1-methyl-1H-imidazol-3-ium chloride,C6H11ClN2,65039-09-0,[Cl-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Cl-],146.621,20.89,18.20-23.5 (CI),24,HEK293T,MTS,"Egorova, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120450,pH at CC50: 5.5
3-ethyl-1-methyl-1H-imidazol-3-ium chloride,C6H11ClN2,65039-09-0,[Cl-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Cl-],146.621,46.15,45.70-46.59 (CI),24,3215 LS,MTS,"Egorova, 2015, ACS Med. Chem. Lett.",10.1021/acsmedchemlett.5b00258,
3-ethyl-1-methyl-1H-imidazol-3-ium chloride,C6H11ClN2,65039-09-0,[Cl-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Cl-],146.621,68.77,63.21-74.82 (CI),24,Colo320HSR,MTS,"Egorova, 2020, J. Mol. Liq.",10.1016/j.molliq.2019.111751,
3-ethyl-1-methyl-1H-imidazol-3-ium chloride,C6H11ClN2,65039-09-0,[Cl-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Cl-],146.621,27.512,2.345-52.681 (CI),24,CaCo-2,MTS,"Egorova, 2021, J. Mol. Liq.",10.1016/j.molliq.2020.114870,
3-ethyl-1-methyl-1H-imidazol-3-ium chloride,C6H11ClN2,65039-09-0,[Cl-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Cl-],146.621,32.1,1.84 (SEM),24,CaCo-2,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-ethyl-1-methyl-1H-imidazol-3-ium chloride,C6H11ClN2,65039-09-0,[Cl-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Cl-],146.621,51.82,0.45 (SEM),24,NIH/3T3,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-ethyl-1-methyl-1H-imidazol-3-ium chloride,C6H11ClN2,65039-09-0,[Cl-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Cl-],146.621,110.31,104.51-116.11  (CI),24,U937,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium chloride,C6H11ClN2,65039-09-0,[Cl-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Cl-],146.621,102.14,95.94-108.34 (CI),24,Jurkat,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium chloride,C6H11ClN2,65039-09-0,[Cl-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Cl-],146.621,33.17,31.27-35.07 (CI),24,HL60,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium chloride,C6H11ClN2,65039-09-0,[Cl-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Cl-],146.621,143.22,137.82-148.62 (CI),24,K562,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium chloride,C6H11ClN2,65039-09-0,[Cl-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Cl-],146.621,393.37,372.07-414.67 (CI),24,HEK293,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium chloride,C6H11ClN2,65039-09-0,[Cl-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Cl-],146.621,188.18,175.78-200.58 (CI),24,A549,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium chloride,C6H11ClN2,65039-09-0,[Cl-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Cl-],146.621,187.41,173.31-201.51 (CI),24,A2780,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium chloride,C6H11ClN2,65039-09-0,[Cl-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Cl-],146.621,70.62,53.25-88 (CI),24,CaCo-2,MTS,"Vavina, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.118673,
3-ethyl-1-methyl-1H-imidazol-3-ium chloride,C6H11ClN2,65039-09-0,[Cl-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.[Cl-],146.621,9.9,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-ethyl-1-methyl-1H-imidazol-3-ium cinnamate,C15H18N2O2,,CN1C=C[N+](CC)=C1.O=C([O-])/C=C/C2=CC=CC=C2,CC[n+]1ccn(C)c1.O=C([O-])/C=C/c1ccccc1,258.321,12.16,5.67-18.64 (CI),24,CaCo-2,MTS,"Vavina, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.118673,
3-ethyl-1-methyl-1H-imidazol-3-ium dicyanamide,C8H11N5,370865-89-7,N#C[N-]C#N.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.N#C[N-]C#N,177.211,14.08,0.62 (SD),72,NHDF,MTS,"Musiał, 2021, ACS Sustain. Chem. Eng.",10.1021/acssuschemeng.1c02277,
3-ethyl-1-methyl-1H-imidazol-3-ium dicyanamide,C8H11N5,370865-89-7,N#C[N-]C#N.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.N#C[N-]C#N,177.211,6.6,,48,IPC-81,WST-1,"Steudte, 2012, ChemComm",10.1039/c2cc34955h,
3-ethyl-1-methyl-1H-imidazol-3-ium dicyanamide,C8H11N5,370865-89-7,N#C[N-]C#N.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.N#C[N-]C#N,177.211,26.9,,24,MCF-7,MTT,"Guo, 2021, J. Mol. Liq.",10.1016/j.molliq.2021.116835,
3-ethyl-1-methyl-1H-imidazol-3-ium diethyl phosphate,C10H21N2O4P,848641-69-0,O=P([O-])(OCC)OCC.C1=C[N+](=CN1C)CC,CCOP(=O)([O-])OCC.CC[n+]1ccn(C)c1,264.262,25.6,1.4 (SD),72,NHDF,MTS,"Musiał, 2021, ACS Sustain. Chem. Eng.",10.1021/acssuschemeng.1c02277,
3-ethyl-1-methyl-1H-imidazol-3-ium diethyl phosphate,C10H21N2O4P,848641-69-0,O=P([O-])(OCC)OCC.C1=C[N+](=CN1C)CC,CCOP(=O)([O-])OCC.CC[n+]1ccn(C)c1,264.262,47.55,,24,MC3T3-E1,MTT,"Zhu, 2020, Int. J. Biol. Macromol.",10.1016/j.ijbiomac.2020.04.267,3D scaffold.
3-ethyl-1-methyl-1H-imidazol-3-ium diethyl phosphate,C10H21N2O4P,848641-69-0,O=P([O-])(OCC)OCC.C1=C[N+](=CN1C)CC,CCOP(=O)([O-])OCC.CC[n+]1ccn(C)c1,264.262,34.11,,48,MC3T3-E1,MTT,"Zhu, 2020, Int. J. Biol. Macromol.",10.1016/j.ijbiomac.2020.04.267,3D scaffold.
3-ethyl-1-methyl-1H-imidazol-3-ium diethyl phosphate,C10H21N2O4P,848641-69-0,O=P([O-])(OCC)OCC.C1=C[N+](=CN1C)CC,CCOP(=O)([O-])OCC.CC[n+]1ccn(C)c1,264.262,29.88,,72,MC3T3-E1,MTT,"Zhu, 2020, Int. J. Biol. Macromol.",10.1016/j.ijbiomac.2020.04.267,3D scaffold.
3-ethyl-1-methyl-1H-imidazol-3-ium diethyl phosphate,C10H21N2O4P,848641-69-0,O=P([O-])(OCC)OCC.C1=C[N+](=CN1C)CC,CCOP(=O)([O-])OCC.CC[n+]1ccn(C)c1,264.262,14.98,,24,MC3T3-E1,MTT,"Zhu, 2020, Int. J. Biol. Macromol.",10.1016/j.ijbiomac.2020.04.267,2D scaffold.
3-ethyl-1-methyl-1H-imidazol-3-ium diethyl phosphate,C10H21N2O4P,848641-69-0,O=P([O-])(OCC)OCC.C1=C[N+](=CN1C)CC,CCOP(=O)([O-])OCC.CC[n+]1ccn(C)c1,264.262,8.42,,48,MC3T3-E1,MTT,"Zhu, 2020, Int. J. Biol. Macromol.",10.1016/j.ijbiomac.2020.04.267,2D scaffold.
3-ethyl-1-methyl-1H-imidazol-3-ium diethyl phosphate,C10H21N2O4P,848641-69-0,O=P([O-])(OCC)OCC.C1=C[N+](=CN1C)CC,CCOP(=O)([O-])OCC.CC[n+]1ccn(C)c1,264.262,7.13,,72,MC3T3-E1,MTT,"Zhu, 2020, Int. J. Biol. Macromol.",10.1016/j.ijbiomac.2020.04.267,2D scaffold.
3-ethyl-1-methyl-1H-imidazol-3-ium dimethyl phosphate,C8H17N2O4P,945611-27-8,O=P([O-])(OC)OC.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.COP(=O)([O-])OC,236.208,30.5,2.5 (SD),72,NHDF,MTS,"Musiał, 2021, ACS Sustain. Chem. Eng.",10.1021/acssuschemeng.1c02277,
3-ethyl-1-methyl-1H-imidazol-3-ium ethyl sulfate,C8H16N2O4S,342573-75-5,O=S(=O)([O-])OCC.C1=C[N+](=CN1C)CC,CCOS(=O)(=O)[O-].CC[n+]1ccn(C)c1,236.293,20.82,0.89 (SD),24,NHDF,MTS,"Dzida, 2018, ACS Sustain Chem Eng.",10.1021/acssuschemeng.8b02318,
3-ethyl-1-methyl-1H-imidazol-3-ium ethyl sulfate,C8H16N2O4S,342573-75-5,O=S(=O)([O-])OCC.C1=C[N+](=CN1C)CC,CCOS(=O)(=O)[O-].CC[n+]1ccn(C)c1,236.293,8.5,,72,IPC-81,WST-1,"Stolte, 2007, Green Chem.",10.1039/b615326g,
3-ethyl-1-methyl-1H-imidazol-3-ium ethyl sulfate,C8H16N2O4S,342573-75-5,O=S(=O)([O-])OCC.C1=C[N+](=CN1C)CC,CCOS(=O)(=O)[O-].CC[n+]1ccn(C)c1,236.293,44.11,26.48 (SD),24,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-ethyl-1-methyl-1H-imidazol-3-ium ethyl sulfate,C8H16N2O4S,342573-75-5,O=S(=O)([O-])OCC.C1=C[N+](=CN1C)CC,CCOS(=O)(=O)[O-].CC[n+]1ccn(C)c1,236.293,13.6,5.94 (SD),48,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-ethyl-1-methyl-1H-imidazol-3-ium ethyl sulfate,C8H16N2O4S,342573-75-5,O=S(=O)([O-])OCC.C1=C[N+](=CN1C)CC,CCOS(=O)(=O)[O-].CC[n+]1ccn(C)c1,236.293,8.5,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-ethyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C6H11F6N2P,155371-19-0,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,256.13,8.4,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-ethyl-1-methyl-1H-imidazol-3-ium hydrogen sulfate,C6H12N2O4S,412009-61-1,O=S(=O)([O-])O.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([O-])O,208.239,16.63,10.85-22.41 (CI),24,HEK293T,MTS,"Egorova, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120450,pH at CC50: 2.6
3-ethyl-1-methyl-1H-imidazol-3-ium hydrogen sulfate,C6H12N2O4S,412009-61-1,O=S(=O)([O-])O.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([O-])O,208.239,23.06,0.33 (SEM),24,NIH/3T3,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-ethyl-1-methyl-1H-imidazol-3-ium hydrogen sulfate,C6H12N2O4S,412009-61-1,O=S(=O)([O-])O.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([O-])O,208.239,17.64,1.51 (SEM),24,CaCo-2,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-ethyl-1-methyl-1H-imidazol-3-ium tetracyanoborate,C10H11BN6,742099-80-5,CN1C=C[N+](CC)=C1.N#C[B-](C#N)(C#N)C#N,CC[n+]1ccn(C)c1.N#C[B-](C#N)(C#N)C#N,226.052,3.2,,48,IPC-81,WST-1,"Steudte, 2012, ChemComm",10.1039/c2cc34955h,
3-ethyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2,143314-16-3,F[B-](F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.F[B-](F)(F)F,197.972,2.2,,24,MCF-7,MTS,"Wang, 2012, Adv. Mater. Res. ",10.4028/www.scientific.net/AMR.610-613.721,"pEC50=2.658, 0.03 (RMSE)."
3-ethyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2,143314-16-3,F[B-](F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.F[B-](F)(F)F,197.972,73.24,69.84-76.64 (CI),24,U937,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2,143314-16-3,F[B-](F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.F[B-](F)(F)F,197.972,75.77,72.97-78.57 (CI),24,Jurkat,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2,143314-16-3,F[B-](F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.F[B-](F)(F)F,197.972,25.26,23.76-26.76 (CI),24,HL60,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2,143314-16-3,F[B-](F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.F[B-](F)(F)F,197.972,106.07,101.47-110.67 (CI),24,K562,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2,143314-16-3,F[B-](F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.F[B-](F)(F)F,197.972,478.12,444.92-511.32 (CI),24,HEK293,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2,143314-16-3,F[B-](F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.F[B-](F)(F)F,197.972,151.23,139.08-163.38 (CI),24,A549,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2,143314-16-3,F[B-](F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.F[B-](F)(F)F,197.972,241.76,239.54-243.98 (CI),24,A2780,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-ethyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2,143314-16-3,F[B-](F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.F[B-](F)(F)F,197.972,3.69,0.51 (SE),24,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
3-ethyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2,143314-16-3,F[B-](F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.F[B-](F)(F)F,197.972,8.87,1.01 (SE),24,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing without FBS
3-ethyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2,143314-16-3,F[B-](F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.F[B-](F)(F)F,197.972,9.94,0.72 (SE),48,HeLa,MTT,"Wang, 2007, Green Chem.",10.1039/b704503d,Culturing with FBS
3-ethyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2,143314-16-3,F[B-](F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.F[B-](F)(F)F,197.972,4,,24,L929,CellQuanti-Blue,"Reiß, 2020, RSC Adv.",10.1039/d0ra01370f,
3-ethyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2,143314-16-3,F[B-](F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.F[B-](F)(F)F,197.972,111.569,,24,A549,WST-8,"Chen, 2014, JCCS",10.1002/jccs.201300632,The incubation time is unclear.
3-ethyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2,143314-16-3,F[B-](F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.F[B-](F)(F)F,197.972,3.42,,24,LoVo,MTT,"Guo, 2021, J. Mol. Liq.",10.1016/j.molliq.2021.116835,
3-ethyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C6H11BF4N2,143314-16-3,F[B-](F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.F[B-](F)(F)F,197.972,3.4,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,Incubation time = 44+4
3-ethyl-1-methyl-1H-imidazol-3-ium thiocyanate,C7H11N3S,331717-63-6,N#C[S-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.N#C[S-],169.253,8,,24,L929,CellQuanti-Blue,"Reiß, 2020, RSC Adv.",10.1039/d0ra01370f,
3-ethyl-1-methyl-1H-imidazol-3-ium thiocyanate,C7H11N3S,331717-63-6,N#C[S-].C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.N#C[S-],169.253,11.27,0.28 (SD),72,NHDF,MTS,"Musiał, 2021, ACS Sustain. Chem. Eng.",10.1021/acssuschemeng.1c02277,
3-ethyl-1-methyl-1H-imidazol-3-ium tricyanomethanide,C10H11N5,666823-18-3,N#C[C-](C#N)C#N.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.N#C[C-](C#N)C#N,201.233,8.01,0.32 (SD),72,NHDF,MTS,"Musiał, 2021, ACS Sustain. Chem. Eng.",10.1021/acssuschemeng.1c02277,
3-ethyl-1-methyl-1H-imidazol-3-ium tricyanomethanide,C10H11N5,666823-18-3,N#C[C-](C#N)C#N.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.N#C[C-](C#N)C#N,201.233,2,,48,IPC-81,WST-1,"Steudte, 2012, ChemComm",10.1039/c2cc34955h,
3-ethyl-1-methyl-1H-imidazol-3-ium trifluoromethanesulfonate,C7H11F3N2O3S,145022-44-2,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,260.237,8.8,1.2 (SD),72,HCT-116,MTS,"Kuczak, 2022, J. Hazard. Mater.",10.1016/j.jhazmat.2021.128160,
3-ethyl-1-methyl-1H-imidazol-3-ium trifluoromethanesulfonate,C7H11F3N2O3S,145022-44-2,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,260.237,5.28,0.57 (SD),72,MCF-7,MTS,"Kuczak, 2022, J. Hazard. Mater.",10.1016/j.jhazmat.2021.128160,
3-ethyl-1-methyl-1H-imidazol-3-ium trifluoromethanesulfonate,C7H11F3N2O3S,145022-44-2,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,260.237,0.149,0.064 (SD),72,U251,MTS,"Kuczak, 2022, J. Hazard. Mater.",10.1016/j.jhazmat.2021.128160,
3-ethyl-1-methyl-1H-imidazol-3-ium trifluoromethanesulfonate,C7H11F3N2O3S,145022-44-2,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,260.237,11.8,1.2 (SD),72,NHDF,MTS,"Musiał, 2021, ACS Sustain. Chem. Eng.",10.1021/acssuschemeng.1c02277,
3-ethyl-1-methyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C12H11F18N2P,377739-43-0,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,556.172,>0.010,,48,IPC-81,WST-1,"Steudte, 2012, ChemComm",10.1039/c2cc34955h,
3-ethyl-1-methyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C12H11F18N2P,377739-43-0 ,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CC,CC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,556.172,<0.1,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
"3-heptyl-1,2-dimethyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide",C14H23F6N3O4S2,1422952-71-3,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=C(N1C)C)CCCCCCC,CCCCCCC[n+]1ccn(C)c1C.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,475.477,<0.1,,72,CCO,WST-1,"Cvjetko Bubalo, 2015, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2014.10.029,
3-heptyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C13H21F6N3O4S2,425382-14-5,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCC,CCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,461.45,<0.1,,72,CCO,WST-1,"Cvjetko Bubalo, 2015, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2014.10.029,
3-heptyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C13H21F6N3O4S2,425382-14-5,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCC,CCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,461.45,<0.1,,72,CCO,WST-1,"Radošević, 2013, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2013.03.002,EC50
3-heptyl-1-methyl-1H-imidazol-3-ium chloride,C11H21ClN2,581101-92-0,[Cl-].C1=C[N+](=CN1C)CCCCCCC,CCCCCCC[n+]1ccn(C)c1.[Cl-],216.756,0.338,0.001 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=2.53, 0.05 (CI) (uM)"
3-heptyl-1-methyl-1H-imidazol-3-ium chloride,C11H21ClN2,581101-92-0,[Cl-].C1=C[N+](=CN1C)CCCCCCC,CCCCCCC[n+]1ccn(C)c1.[Cl-],216.756,0.339,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=2.53 (uM)
3-heptyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C11H21F6N2P,357915-04-9,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCC,CCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,326.265,0.2,0.001 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=2.30, 0.06 (CI) (uM)"
3-heptyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C11H21F6N2P,357915-04-9,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCC,CCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,326.265,1.2,0.002 (CI),72,C6,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=3.08, 0.2 (CI) (uM)"
3-heptyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C11H21F6N2P,357915-04-9,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCCC,CCCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,326.265,0.2,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=2.3 (uM)
3-heptyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C11H21BF4N2,244193-51-9,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCC,CCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,268.107,0.38,0.001 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=2.58, 0.07 (CI) (uM)"
3-heptyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C11H21BF4N2,244193-51-9,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCCC,CCCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,268.107,0.38,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=2.58 (uM)
3-hexadecyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C22H39F6N3O4S2,404001-50-9,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,587.693,0.017,,24,HaCat,MTT,"McLaughlin, 2021, Chemosphere",10.1016/j.chemosphere.2020.129432,
3-hexadecyl-1-methyl-1H-imidazol-3-ium bromide,C20H39BrN2,132361-22-9,[Br-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Br-],387.45,0.00627,0.00102 (SEM),24,HaCat,AlamarBlue,"Gomes, 2022, Microbiol. Spectr.",10.1128/spectrum.02291-21,
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00245,,?,CCRF-CEM,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.000816,,?,HL-60 (TB),SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00349,,?,K562,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00386,,?,MOLT-4 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.000764,,?,RPMI-8226 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00438,,?,SR  ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00831,,?,A549,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00677,,?,EKVX ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.006893,,?,HOP-62 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.007298,,?,HOP-92 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.005045,,?,NCI-H226 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,>0.1,,?,NCI-H23 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.007054,,?,NCI-H322M ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00538,,?,NCI-H460 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.006834,,?,NCI-H522 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,>0.1,,?,COLO 205 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.007294,,?,HCC-2998 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.006215,,?,HCT-116,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00465,,?,HCT-15 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.005059,,?,HT29,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00357,,?,KM12 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00423,,?,SW-620 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00493,,?,SF-268,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00502,,?,SF-295,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.005467,,?,SF-539,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.009593,,?,SNB-19,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.005651,,?,SNB-75,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00387,,?,U251,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00378,,?,LOX IMVI,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.005682,,?,MALME-3M,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.005519,,?,M14,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.0054,,?,SK-MEL-28,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.004188,,?,SK-MEL-5,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.008337,,?,UACC-257,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.004941,,?,UACC-62,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,>0.1,,?,IGROV1,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00429,,?,OVCAR-3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.007196,,?,OVCAR-4,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.007238,,?,OVCAR-5,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.009128,,?,OVCAR-8,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,>0.1,,?,SK-OV-3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.007215,,?,786-0 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00739,,?,A498 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00457,,?,ACHN ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,>0.1,,?,CAK-1 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.005925,,?,RXF 393 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00464,,?,SN12C ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00373,,?,TK-10 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.006515,,?,UO-31 ,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.003856,,?,PC3,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00448,,?,DU-145,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00477,,?,MCF-7,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,>0.1,,?,NCI/ADR-RES,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00455,,?,MDA-MB-231,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00611,,?,HS 578T,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.006978,,?,MDA-MB-435,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.005925,,?,BT-549,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,>0.1,,?,T-47D,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00298,,?,MDA-MB-468,SRB,"Malhotra, 2010, Bioorg. Med. Chem. Lett.",10.1016/j.bmcl.2009.11.085,LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning).
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.012,0.01-0.014 (CI),24,U937,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.015,0.013-0.017 (CI),24,Jurkat,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.003,0.002-0.004 (CI),24,HL60,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.007,0.006-0.008 (CI),24,K562,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.045,0.042-0.048 (CI),24,HEK293,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.022,0.02-0.024 (CI),24,A549,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.012,0.011-0.013 (CI),24,A2780,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.0078,,48,A431,SRB,"Malhotra, 2014, MedChemComm",10.1039/c4md00161c,"lg(LC50)=-5.11 (M, concentration of the drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning)."
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00463,,12,HeLa,MTT,"Xia, 2018, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2018.07.022,
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00253,,24,HeLa,MTT,"Xia, 2018, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2018.07.022,
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.00166,,48,HeLa,MTT,"Xia, 2018, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2018.07.022,
3-hexadecyl-1-methyl-1H-imidazol-3-ium chloride,C20H39ClN2,61546-01-8,[Cl-].C1=C[N+](=CN1C)CCCCCCCCCCCCCCCC,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.[Cl-],342.999,0.004,,24,HaCat,MTT,"McLaughlin, 2021, Chemosphere",10.1016/j.chemosphere.2020.129432,
3-hexadecyl-1-methyl-1H-imidazol-3-ium dibromoargentate(I),C20H39AgBr2N2,1190713-66-6,CN1C=C[N+](CCCCCCCCCCCCCCCC)=C1.Br[Ag-]Br,Br[Ag-]Br.CCCCCCCCCCCCCCCC[n+]1ccn(C)c1,575.222,0.003,,24,HaCat,MTT,"McLaughlin, 2021, Chemosphere",10.1016/j.chemosphere.2020.129432,
3-hexadecyl-1-methyl-1H-imidazol-3-ium dichloroargentate(I),C20H39AgCl2N2,,CN1C=C[N+](CCCCCCCCCCCCCCCC)=C1.Cl[Ag-]Cl,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.Cl[Ag-]Cl,486.32,0.001,,24,HaCat,MTT,"McLaughlin, 2021, Chemosphere",10.1016/j.chemosphere.2020.129432,
3-hexadecyl-1-methyl-1H-imidazol-3-ium tetrabromocuprate(II),C40H78Br4CuN4,,CN1C=C[N+](CCCCCCCCCCCCCCCC)=C1.CN2C=C[N+](CCCCCCCCCCCCCCCC)=C2.Br[Cu-2](Br)(Br)Br,Br[Cu-2](Br)(Br)Br.CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.CCCCCCCCCCCCCCCC[n+]1ccn(C)c1,998.254,0.001,,24,HaCat,MTT,"McLaughlin, 2021, Chemosphere",10.1016/j.chemosphere.2020.129432,
3-hexadecyl-1-methyl-1H-imidazol-3-ium tetrachlorocuprate(II),C40H78Cl4CuN4,1427005-80-8,CN1C=C[N+](CCCCCCCCCCCCCCCC)=C1.CN2C=C[N+](CCCCCCCCCCCCCCCC)=C2.Cl[Cu-2](Cl)(Cl)Cl,CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.CCCCCCCCCCCCCCCC[n+]1ccn(C)c1.Cl[Cu-2](Cl)(Cl)Cl,820.45,0.002,,24,HaCat,MTT,"McLaughlin, 2021, Chemosphere",10.1016/j.chemosphere.2020.129432,CAS for neutral compound
"3-hexyl-1,2-dimethyl-1H-imidazol-3-ium tetrafluoroborate",C11H21BF4N2,384347-21-1,F[B-](F)(F)F.C1=C[N+](=C(N1C)C)CCCCCC,CCCCCC[n+]1ccn(C)c1C.F[B-](F)(F)F,268.107,0.079,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=1.9 (uM)
"3-hexyl-1-methyl-1H-imidazol-3-ium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate",C14H19F9N2O3S,1001557-05-6,O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,466.366,>10,,4,CaCo-2,MTS,"Pereiro, 2013, ACS Sustain. Chem. Eng.",10.1021/sc300163n,Lg(EC50)=4 (uM)
"3-hexyl-1-methyl-1H-imidazol-3-ium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate",C14H19F9N2O3S,1001557-05-6,O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,466.366,>10,,4,HepG2,MTS,"Pereiro, 2013, ACS Sustain. Chem. Eng.",10.1021/sc300163n,Lg(EC50)=4 (uM)
"3-hexyl-1-methyl-1H-imidazol-3-ium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate",C14H19F9N2O3S,1001557-05-6,O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,466.366,7.015,,24,CaCo-2,MTS,"Vieira, 2019, Chemosphere",10.1016/j.chemosphere.2018.10.159,
"3-hexyl-1-methyl-1H-imidazol-3-ium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate",C14H19F9N2O3S,1001557-05-6,O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,466.366,5.741,,24,HepG2,MTS,"Vieira, 2019, Chemosphere",10.1016/j.chemosphere.2018.10.159,
"3-hexyl-1-methyl-1H-imidazol-3-ium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate",C14H19F9N2O3S,1001557-05-6,O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,466.366,6.606,,24,EA.hy926,MTS,"Vieira, 2019, Chemosphere",10.1016/j.chemosphere.2018.10.159,
"3-hexyl-1-methyl-1H-imidazol-3-ium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate",C14H19F9N2O3S,1001557-05-6,O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,466.366,2.178,,24,HaCat,MTS,"Vieira, 2019, Chemosphere",10.1016/j.chemosphere.2018.10.159,
3-hexyl-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C17H24N2O3,1811535-37-1,O=C([O-])C=1C=CC=CC1O.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.O=C([O-])c1ccccc1O,304.39,2,0.69-3.31 (CI),24,3215 LS,MTS,"Egorova, 2015, ACS Med. Chem. Lett.",10.1021/acsmedchemlett.5b00258,pH at CC50: 5.6
3-hexyl-1-methyl-1H-imidazol-3-ium 2-hydroxybenzoate,C17H24N2O3,1811535-37-1,O=C([O-])C=1C=CC=CC1O.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.O=C([O-])c1ccccc1O,304.39,1.96,0.79-3.14 (CI),24,CaCo-2,MTS,"Egorova, 2015, ACS Med. Chem. Lett.",10.1021/acsmedchemlett.5b00258,
3-hexyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C12H19F6N3O4S2,382150-50-7,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,447.423,0.643,,24,MCF-7,MTT,"Kumar, 2008, Environ. Toxicol.",10.1002/tox.20443,"After 24-h incubation, cells were grown for 2 more days, and then the MTT was carried out."
3-hexyl-1-methyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C12H19F6N3O4S2,382150-50-7,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,447.423,0.18,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-hexyl-1-methyl-1H-imidazol-3-ium bromide,C10H19BrN2,85100-78-3,[Br-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Br-],247.18,6.874,,24,PC12,MTT,"Li, 2012, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2012.06.013,
3-hexyl-1-methyl-1H-imidazol-3-ium bromide,C10H19BrN2,85100-78-3,[Br-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Br-],247.18,1.3193,0.6882 (SEM),24,Sf-9,MTT,"Wu, 2018, J. Hazard. Mater.",10.1016/j.jhazmat.2018.01.028,
3-hexyl-1-methyl-1H-imidazol-3-ium bromide,C10H19BrN2,85100-78-3,[Br-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Br-],247.18,0.2553,0.0194 (SEM),48,Sf-9,MTT,"Wu, 2018, J. Hazard. Mater.",10.1016/j.jhazmat.2018.01.028,
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,0.933,0.001 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=2.97, 0.07 (CI) (uM)"
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,7.553,7.341-7.771 (CI),24,Colo320HSR,MTS,"Egorova, 2020, J. Mol. Liq.",10.1016/j.molliq.2019.111751,
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,3.836,1.432-6.240 (CI),24,CaCo-2,MTS,"Egorova, 2021, J. Mol. Liq.",10.1016/j.molliq.2020.114870,
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,7.54,2.55-12.54 (CI),24,3215 LS,MTS,"Egorova, 2015, ACS Med. Chem. Lett.",10.1021/acsmedchemlett.5b00258,
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,6.21,0.08 (SEM),24,CaCo-2,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,6.95,0.14(SEM),24,NIH/3T3,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,9.76,8.96-10.56 (CI),24,U937,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,5.13,4.73-5.53 (CI),24,Jurkat,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,1.23,1.14-1.32 (CI),24,HL60,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,7.39,6.69-8.09 (CI),24,K562,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,16.76,14.88-18.64 (CI),24,HEK293,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,17.87,16.67-19.07 (CI),24,A549,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,11.9,10.6-13.2 (CI),24,A2780,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,0.072,0.00626 (SD),24,B-13,MTT,"Abdelghany, 2020, Food Chem. Toxicol. ",10.1016/j.fct.2020.111593,
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,0.048,0.0144 (SD),48,B-13,MTT,"Abdelghany, 2020, Food Chem. Toxicol. ",10.1016/j.fct.2020.111593,
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,0.46,0.0183 (SD),24,B-13/H,MTT,"Abdelghany, 2020, Food Chem. Toxicol. ",10.1016/j.fct.2020.111593,
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,0.22,0.0249 (SD),48,B-13/H,MTT,"Abdelghany, 2020, Food Chem. Toxicol. ",10.1016/j.fct.2020.111593,
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,0.708,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=2.85 (uM)
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,5.24,4.79 (SD),24,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,0.24,0.18 (SD),48,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-hexyl-1-methyl-1H-imidazol-3-ium chloride,C10H19ClN2,171058-17-6,[Cl-].C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.[Cl-],202.729,0.72,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-hexyl-1-methyl-1H-imidazol-3-ium dicyanamide,C12H19N5,927902-57-6,N#C[N-]C#N.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.N#C[N-]C#N,233.319,1.75,,24,MCF-7,MTT,"Guo, 2021, J. Mol. Liq.",10.1016/j.molliq.2021.116835,
3-hexyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C10H19F6N2P,304680-35-1,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,312.238,>1,,48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,lg(EC50)=3 (uM)
3-hexyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C10H19F6N2P,304680-35-1,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,312.238,>1,,72,C6,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,lg(EC50)=3 (uM)
3-hexyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C10H19F6N2P,304680-35-1,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,312.238,0.813,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=2.91 (uM)
3-hexyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C10H19F6N2P,304680-35-1,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,312.238,15.67,3.78 (SD),24,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-hexyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C10H19F6N2P,304680-35-1,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,312.238,6.87,1.62 (SD),48,CaCo-2,MTT,"García-Lorenzo, 2008, Green Chem.",10.1039/b718860a,
3-hexyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate(V),C10H19F6N2P,304680-35-1,F[P-](F)(F)(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.F[P-](F)(F)(F)(F)F,312.238,0.81,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-hexyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C10H19BF4N2,244193-50-8,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,254.08,1.53,,24,MCF-7,MTS,"Wang, 2012, Adv. Mater. Res. ",10.4028/www.scientific.net/AMR.610-613.721,"pEC50=2.814, 0.045 (RMSE)."
3-hexyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C10H19BF4N2,244193-50-8,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,254.08,0.891,0.001 (CI),48,IPC-81,WST-1,"Ranke, 2004, Ecotoxicol. Environ. Saf.",10.1016/S0147-6513(03)00105-2,"lg(EC50)=2.95, 0.08 (CI) (uM)"
3-hexyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C10H19BF4N2,244193-50-8,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,254.08,3.94,3.64-4.24 (CI),24,U937,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-hexyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C10H19BF4N2,244193-50-8,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,254.08,4.26,3.86-4.66 (CI),24,Jurkat,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-hexyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C10H19BF4N2,244193-50-8,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,254.08,1.57,1.37-1.77 (CI),24,HL60,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-hexyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C10H19BF4N2,244193-50-8,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,254.08,7.08,6.38-7.78 (CI),24,K562,Flow cytometry (7AAD),"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-hexyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C10H19BF4N2,244193-50-8,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,254.08,27.25,24.75-29.75 (CI),24,HEK293,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-hexyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C10H19BF4N2,244193-50-8,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,254.08,14.8,13.36-16.24 (CI),24,A549,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-hexyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C10H19BF4N2,244193-50-8,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,254.08,12.38,11.3-13.46 (CI),24,A2780,PrestoBlue,"Dzhemileva, 2021, Green Chem.",10.1039/d1gc01520f,Triggers mitochondrial apoptosis in Jurkat cells.
3-hexyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C10H19BF4N2,244193-50-8,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,254.08,0.955,,48,IPC-81,WST-1,"Ranke, 2007, Ecotoxicol. Environ. Saf.",10.1016/j.ecoenv.2006.08.008,Lg(EC50)=2.98 (uM)
3-hexyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C10H19BF4N2,244193-50-8,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,254.08,11.5,1.05 (SD),24,HeLa,WST-1,"Stepnowski, 2004, Hum. Exp. Toxicol.",10.1191/0960327104ht480oa,
3-hexyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C10H19BF4N2,244193-50-8,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,254.08,0.34,,24,LoVo,MTT,"Guo, 2021, J. Mol. Liq.",10.1016/j.molliq.2021.116835,
3-hexyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate,C10H19BF4N2,244193-50-8,F[B-](F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.F[B-](F)(F)F,254.08,0.96,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-hexyl-1-methyl-1H-imidazol-3-ium trifluoromethanesulfonate,C11H19F3N2O3S,460345-16-8,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,316.345,0.074,0.031 (SD),72,HCT-116,MTS,"Kuczak, 2022, J. Hazard. Mater.",10.1016/j.jhazmat.2021.128160,Inhibits G2/M phase. triggers p53-independent apoptosis
3-hexyl-1-methyl-1H-imidazol-3-ium trifluoromethanesulfonate,C11H19F3N2O3S,460345-16-8,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,316.345,0.118,0.027 (SD),72,MCF-7,MTS,"Kuczak, 2022, J. Hazard. Mater.",10.1016/j.jhazmat.2021.128160,
3-hexyl-1-methyl-1H-imidazol-3-ium trifluoromethanesulfonate,C11H19F3N2O3S,460345-16-8,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,316.345,0.043,0.024 (SD),72,U251,MTS,"Kuczak, 2022, J. Hazard. Mater.",10.1016/j.jhazmat.2021.128160,Inhibits G1/G0 phase. triggers autophagy
3-hexyl-1-methyl-1H-imidazol-3-ium trifluoromethanesulfonate,C11H19F3N2O3S,460345-16-8,O=S(=O)([O-])C(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)F,316.345,0.56,0.1 (SD),72,NHDF,MTS,"Musiał, 2021, ACS Sustain. Chem. Eng.",10.1021/acssuschemeng.1c02277,
3-hexyl-1-methyl-1H-imidazol-3-ium trifluorotris(perfluoroethyl)phosphate(V),C16H19F18N2P,713512-19-7,FC([P-](C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F,612.28,<0.1,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-hexyl-1-methyl-1H-imidazol-3-ium trifluorotris(perfluoropropyl)phosphate(V),C19H19F24N2P,943229-71-8,FC([P-](C(F)(F)C(F)(F)C(F)(F)F)(F)(F)(F)C(F)(F)C(F)(F)C(F)(F)F)(F)C(F)(F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.FC(F)(F)C(F)(F)C(F)(F)[P-](F)(F)(F)(C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)F,762.301,<0.05,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-hexyl-1-methyl-1H-imidazol-3-ium tris((trifluoromethyl)sulfonyl)methanide,C14H19F9N2O6S3,1196206-01-5,O=S(=O)([C-](S(=O)(=O)C(F)(F)F)S(=O)(=O)C(F)(F)F)C(F)(F)F.C1=C[N+](=CN1C)CCCCCC,CCCCCC[n+]1ccn(C)c1.O=S(=O)([C-](S(=O)(=O)C(F)(F)F)S(=O)(=O)C(F)(F)F)C(F)(F)F,578.497,<0.1,,48,IPC-81,WST-1,"Stolte, 2006, Green Chem.",10.1039/b602161a,
3-hexyl-1-vinyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C13H19F6N3O4S2,866947-51-5,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C=CN1C=C[N+](=C1)CCCCCC,C=Cn1cc[n+](CCCCCC)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,459.434,0.209,,24,A549,WST-8,"Chen, 2014, JCCS",10.1002/jccs.201300632,The incubation time is unclear.
3-hexyl-1-vinyl-1H-imidazol-3-ium bromide,C11H19BrN2,74921-79-2,[Br-].C=CN1C=C[N+](=C1)CCCCCC,C=Cn1cc[n+](CCCCCC)c1.[Br-],259.191,1.644,,24,A549,WST-8,"Chen, 2014, JCCS",10.1002/jccs.201300632,The incubation time is unclear.
3-hexyl-1-vinyl-1H-imidazol-3-ium chloride,C11H19ClN2,1092070-37-5,C=CN1C=C[N+](CCCCCC)=C1.[Cl-],C=Cn1cc[n+](CCCCCC)c1.[Cl-],214.74,0.561,,24,A549,WST-8,"Chen, 2014, JCCS",10.1002/jccs.201300632,The incubation time is unclear.
3-nonyl-1-vinyl-1H-imidazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C16H25F6N3O4S2,866947-53-7,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.C=CN1C=C[N+](=C1)CCCCCCCCC,C=Cn1cc[n+](CCCCCCCCC)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,501.515,0.091,,24,A549,WST-8,"Chen, 2014, JCCS",10.1002/jccs.201300632,The incubation time is unclear.
3-nonyl-1-vinyl-1H-imidazol-3-ium bromide,C14H25BrN2,1438425-82-1,[Br-].C=CN1C=C[N+](=C1)CCCCCCCCC,C=Cn1cc[n+](CCCCCCCCC)c1.[Br-],301.272,0.181,,24,A549,WST-8,"Chen, 2014, JCCS",10.1002/jccs.201300632,The incubation time is unclear.
